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 Summary 
The thesis aims at using arene-ruthenium complexes as building blocks for the synthesis of 
diverse compounds to obtain potential mesomorphic and/or biological properties. The thesis 
consists of three main projects. 
The first project deals with supramolecular assemblies. New supramolecular di- and 
tetranuclear ruthenium arrangements, the latter bearing a cavity, were designed. H-bonding 
was the key interaction involved in the synthesis of the spacer ligands, which exist as dimers. 
Different spacer ligands and different ruthenium clips were used in synthesizing a whole 
family of the corresponding ruthenium assemblies/cages. Several analytical methods were 
employed to characterise the compounds and to study their arrangements.  
The second project involves more classical ruthenium cages, including hexanuclear prisms 
and octanuclear cubes. Anthracene- and pyrene-core dendrimers were developed as potential 
guests, using key reactions such as click, Suzuki and Sonogashira coupling. Owing to the poor 
stability of the anthracene derivatives, their proper characterization and encapsulation could 
not be carried out. Pyrene derivatives showed better stability and were therefore studied 
further. The pyrene dendrimers, bearing cyanobiphenyl dendrons, displayed liquid-crystalline 
properties. Two pyrene dendrimers could be successfully encapsulated into hexanuclear 
arene-ruthenium prisms by the carceplex method. However, no mesomorphic properties were 
observed for the encapsulated systems.  
The third project had as objective to study the biological properties of a system comprising of 
an arene-ruthenium moiety and [60]fullerene. Two such compounds were successfully 
synthesised. However, these compounds could not be tested for their potential biological 
activities because of their poor solubility in aqueous media.  
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1.1  Ruthenium Complexes  
1.1.1 Catalytic Applications 
Ruthenium, the d-block element that belongs to the “platinum group metals”, is one of the 
rarest metals on Earth. It is obtained commercially from the wastes of nickel refining. Ru 
complexes are mostly used as catalysts for several, mechanically diverse, processes. Their 
ability to assume a vast range of oxidation states (-II to +VIII) and coordination geometries, 
and the major influence of ligands on the complexes have made Ru complexes very versatile 
catalysts.
[1]
 Before the 1980s, a limited number of reactions, such as oxidation with RuO4 and 
hydrogenation with ruthenium hydroxide were known.
[2]
 Since then, the chemistry of Ru has 
progressed and is better understood, leading to higher scope for Ru catalysts. Thus, their 
ability of high electron transfer, high Lewis acidity, low redox potentials and their stability 
have given rise to the development of a large number of new reactions catalysed by Ru 
complexes, some of which are listed below:
[3]
 
 Hydrogenation: homogeneous or heterogeneous catalysis of the hydrogenation of 
substrates, like olefins, with either molecular hydrogen or by hydrogen transfer 
reactions. 
 Oxidation: oxidative transformations of alcohols, amines, amides and hydrocarbons 
catalysed by low-valent Ru complexes.   
 Isomerization: isomerization, like Claisen rearrangement of β,γ-unsaturated oxygen 
and nitrogen containing compounds catalysed by low-valent Ru complexes. 
 Nucleophilic addition: nucleophilic attack on alkynes and nitriles activated by Ru 
catalysts. 
 C-C bond formation: selective C-C bond formation reactions catalysed by low-valent 
Ru complexes. 
 
Among all these Ru-catalysed reactions, the C-C bond formation, more specifically olefin 
metathesis, is a powerful method used extensively in organic synthesis. The work on olefin 
metathesis has been pioneered by Yves Chauvin, Robert H. Grubbs and Richard R. Schrock 
who were awarded the Nobel Prize in 2005. Ruthenium alkylidenes have been successful 
catalysts for metathesis transformations, including ring-closing metathesis, cross-metathesis, 
enyne metathesis and ring-opening metathesis polymerisation (Figure 1.1). Most of these 
reactions are catalysed by Grubbs 1
st
 and 2
nd
 generation Ru catalysts or Hoveyda-Grubbs Ru 
catalysts (Figure 1.2).
[4]
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Figure 1.1 Schematic representation of common Ru catalysed metathesis reactions 
 
 
Figure 1.2 The 1
st
 and 2
nd
 generation of Grubbs and Hoveyda-Grubbs catalysts 
 
Besides the widespread applications of Ru as catalysts, the unique properties of this precious 
metal have made its complexes to find interesting applications in other fields. For instance, 
many Ru complexes are being explored for their potential biological activities.
[5]
  
 
1.1.2 Biological Applications 
Belonging to the same group, ruthenium has mostly been inspired by the well-established 
chemistry and applications of platinum and its compounds. Just as in the case of catalysis, Ru 
has followed in the steps of Pt into biological applications. The area of metal-based anticancer 
drugs has been dominated by the Pt drug, cisplatin and closely related Pt antitumor agents, 
such as carboplatin and oxaliplatin (Figure 1.3). Since it got FDA (US Food and Drug 
Administration) approval in 1978, cisplatin has been used extensively in the treatment of 
several cancers including ovarian and testicular cancers.
[6]
 Despite its resounding success in 
treating some cancers, cisplatin has several limitations, among which kidney toxicity, nausea, 
and bone marrow suppression are a few.
[6c]
 Hence, the search for a better anticancer drug 
continues.  
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Figure 1.3 Structures of cisplatin, carboplatin and oxaliplatin 
 
The application of platinum compounds in the treatment of cancer questions the ability of 
other metal complexes to do the same. In fact, metals such as Fe,
[7]
 Ti,
[8]
 Ga,
[9]
 and Ru
[10]
 have 
compounds that show interesting medicinal properties. Among these metals, Ru has attracted 
the attention of several research groups worldwide as complexes of this d
7
 metal display 
ligand exchange kinetics similar to those of platinum complexes.
[11]
 Ruthenium is being 
considered as a promising alternative to platinum because it shows many advantages 
compared to platinum. Ru has more coordination sites, can undergo more changes in 
oxidation state, is less toxic than Pt and is able to mimic Fe in binding to biomolecules. All 
these properties have led many researchers to believe that the future of metal-based anticancer 
drug might be a Ru drug that will show anticancer activity similar to or even better than 
cisplatin and that can treat a broader range of tumours and with less side effects.
[12]
  
 
The idea of using Ru complexes as potential anticancer agent first came to Clarke in 1980 
after Durig et al. reported, in 1976, the ability of fac-Ru(NH3)3Cl3 to induce filamentous 
growth of E. Coli cells in a manner comparable to cisplatin.
[13]
 Following this discovery, 
Clarke et al. tested the anticancer properties of fac-Ru(NH3)3Cl3 and related cis-Ru(NH3)4Cl2 
(Figure 1.4). Despite their good antitumor activity, the poor solubility of both compounds 
made them unsuitable for pharmaceutical use.
[14]
  
 
 
Figure 1.4 Structures of fac-Ru(NH3)3Cl3 and cis-Ru(NH3)4Cl2 
 
This work of Clarke instigated the study of the cytotoxic properties of Ru complexes, 
eventually resulting in a large number of these compounds that can be categorised according 
to the ligand type; amine and imine: {mer-Ru(tpy)Cl3, where tpy = 2,2′:6′,2′′-terpyridine
[15]
 
and (HIm)[trans-(Im)2Cl4Ru],
[16]
 where Im = imidazole}, polyaminopolycarboxylate: 
{Cl2(cdta)Ru,
[17]
 where cdta = 1,2-cyclohexanediaminotetraacetate and cis-Cl2(pdta)Ru,
[18]
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where pdta = 1,2-propylendiaminetetraacetate}, DMSO: cis- and trans-Cl2(MeSO)4Ru
[19]
 
(Figure 1.5).  
 
 
Figure 1.5 Structures of octahedral cytotoxic Ru complexes 
 
From all the biologically active ruthenium complexes, only two entered clinical trials, 
imidazolium-trans-dimethylsulfoxide-imidazole-tetrachlororuthenate (NAMI-A) and 
imidazolium-trans-bis(1H-indazole)-tetrachlororuthenate (KP1019) (Figure 1.6).
[6c, 14, 20]
  
Even though their structures resemble, these two Ru(III) complexes have different modes of 
action as anticancer drugs. While NAMI-A shows little cytotoxicity towards many cancer cell 
lines, KP1019 has high antitumoral activity and NAMI-A has pronounced antimetastatic 
effects (ability to prevent the release of cancer cells from the tumour into other parts of the 
body) on several cancer models whereas none is shown by KP1019.
[21]
  
 
 
Figure 1.6 Structures of NAMI-A and KP1019 
 
Both Ru(III) complexes have successfully completed Phase I of clinical trial and it has been 
observed that the reduction of the Ru(III) of NAMI-A to Ru(II), with ascorbic acid prior to 
administration, gives rise to increased antimetastatic activity. This is in agreement with the 
hypothesis made earlier by Clarke about “activation by reduction”, whereby the Ru(III) is 
believed to be reduced to Ru(II) species, the transformation being favoured by the chemically 
reducing environment created by the low molecular oxygen concentration and lower pH in 
tumour cells than in healthy ones.
[11b, 14, 22]
 Ru(II) species, in general, show better binding 
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ability and hence better reactivity than Ru(III). In view of this, the area of Ru(II) arene 
complexes is rapidly growing, with the synthesis and evaluation of a series of these 
compounds for their potential biological activities.
[5, 6c, 23]
   
 
1.1.3 Arene-Ruthenium Complexes 
Arene is a ligand that commonly binds to a metal through more than two atoms. η6-Arene, 
whereby the ligand gives three electron pairs to the metal, tends to maintain its planar 
structure after coordination to the metal. For these ligands, a mixture of π-bonding (co-axial 
bonding from the p orbitals of the ligand to the vacant d orbitals of the metal) and back π-
bonding (lateral bonding from filled d orbitals of the metal to the π* antibonding p orbitals of 
the ligand) helps to generate stable complexes. This and its strong π-acceptor behaviour has 
made arene one of the mostly used ligands in Ru(II) chemistry.
[6c, 12, 23-24]
  
 
Hence, since the discovery of the first dinuclear chloride-bridged arene complexes [(η6-
arene)Ru(µ2-Cl)Cl]2 by Winkhaus and Singer in 1967, this area of Ru chemistry has 
undergone exponential expansion. These dimers, which can be easily synthesised from 
RuCl3·xH2O starting material, show very good stability under atmospheric conditions and 
hence do not require special storage. They also show good solubility in common organic 
solvents as well as in water. This very important amphiphilic property of the arene-Ru unit 
comes from the hydrophobic nature of the arene ligand combined with the hydrophilicity of 
the metal centre. Moreover, the chloride ligands on the dimers undergo facile replacement 
with other ligands, while the arene remains intact, due to the robust Ru-arene bond (Scheme 
1.1). All these properties make them popular building blocks for metallo-assemblies.
[1]
 The 
arene also plays the crucial role of protecting the metal against oxidation to Ru(III). Among 
the many different assemblies, arene-ruthenium metallo-cages are under intensive 
investigation. Their adaptable cavity and their host-guest properties make these arene-Ru 
metallo-cages versatile drug-delivery systems.
[23c, 24c]
 In our group, a wide range of η6-arene 
ligands have been used to coordinate to Ru(II), such as benzene, hexamethylbenzene, p-
cymene and other functionalised arenes.
[6c, 23]
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Scheme 1.1 The synthesis of arene-Ru building blocks 
 
1.1.4 Mononuclear Arene-Ruthenium Complexes as Anticancer Drugs 
A large number of mononuclear Ru complexes have been synthesised and evaluated for their 
antitumor activity after the entrance of NAMI-A and KP1019 into clinical trial. Furthermore, 
with the discovery of the higher activity of Ru(II) compared to Ru(III), research has been 
growing in the Ru(II) chemistry. As seen from the previous section, arene is found to be a 
crucial ligand for many reasons, one of which being the stability of the Ru(II) species. Also, 
the facile cleavage of the chloride bridges allows for the synthesis of a series of half-sandwich 
arene-Ru complexes, which in turn allows multiple anchoring possibilities to introduce 
biologically active groups to the three coordination sites.  
  
Recently, two classes of ruthenium anticancer agents have been developed, centred on arene-
Ru compounds (Figure 1.7). The first class, developed by Sadler, consists of an arene-Ru with 
a chelating ethylenediamine ligand (en) and a chloride occupying the three remaining 
coordination sites, [(η6-arene)Ru(en)Cl]+ (Figure 1.7(a)).[24g] It is water soluble and shows 
activity against A2780 human ovarian cancer cells in vitro and in vivo. Its cytotoxicity against 
primary tumours was found to be similar to anticancer agent carboplatin and it shows better 
activity than cisplatin.
[12]
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Figure 1.7 The two half-sandwich mononuclear arene-Ru complexes, (a) [(η6-
biphenyl)Ru(en)Cl]
+
 PF6
- 
and (b) RAPTA-C 
 
The second class comprises of the ruthenium arene pta (pta = 1,3,5-triaza-7-
phosphaadamantane), RAPTA agents developed by Dyson. The RAPTA complexes are a 
family of Ru(II) compounds with monodentate pta ligand and a η6-arene ligand. The synthesis 
is very simple, leading to mononuclear arene-Ru complexes that are stable under 
physiological environment.
[25]
 RAPTA-C, the most popular member of the RAPTA family, 
displays antimetastatic activity in vivo and is able to selectively target cancer cell lines (Figure 
1.7(b)). It has a relatively lower activity than cisplatin, but it exhibits selective cytotoxicity 
towards TS/A (a metastasizing mouse cell line) cancer cell lines in vivo, with the pta ligand 
playing a crucial role in determining the selectivity.
[26]
 
 
1.1.5 Multinuclear Arene-Ruthenium Complexes for Anticancer Treatment 
Inspired by the higher cytotoxicity shown by the trinuclear platinum complex, [trans, trans, 
trans-(NH3)2NH2Pt(Cl)(CH2)6NH2Pt(NH3)2NH2(CH2)6NH2Pt(NH3)2(Cl)][NO3]4,
[27]
 
researchers started exploring the possibility of having better anticancer activities from 
multinuclear complexes.
[28]
 Mendoza-Ferri et al. reported the structure-activity relationships 
of dinuclear pyridinone-derived arene-Ru complexes (Figure 1.8(a)). In vitro studies show the 
antiproliferative activity, determined against the human cancer cell lines SW480 (colon) and 
A2780 (ovary), to be similar to oxaliplatin in SW480 and better cytotoxicity than cisplatin in 
A2780.
[29]
 Inspired by these results, other groups started research in this area, one of which is 
the diruthenium complex, [(Ru(tpy)Cl)2(µ-bbn)]
2+
 (tpy = 2,2′:6′,2′′-terpyridine and bbn = 
bis[4(4′-methyl-2,2′-bipyridyl)]-1 (Figure 1.8(b)). For the complex n = 12, higher activity 
compared to cisplatin was observed against two breast cancer cell lines.
[30]
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Figure 1.8 Dinuclear Ru complexes, (a) pyridinone-derived arene-Ru complex and (b) 
[(Ru(tpy)Cl)2(µ-bbn)]
2+ 
 
The chemistry of multinuclear complexes does not stop at dinuclear compounds. Numerous 
molecular assemblies, tetra-, hexa-, octanuclear Ru complexes have been produced by 
combining two different strategies developed by Stang and Fujita who work on “molecular 
clip”[31] and “molecular panelling”[32] respectively. These two strategies constitute a very 
important part in modern supramolecular chemistry. With controlled architecture of the shape 
and size of the complex, a variety of coordination-driven self-assembled 2D and 3D 
supramolecular ensembles have been built. The desired frameworks can be obtained by the 
choice of appropriate building blocks. Hence, if the precursor units of rigid structures with 
predefined bite angles are combined in the appropriate stoichiometric ratio, the desired 
arrangement is formed. A panorama of spatially and electronically tunable supramolecular 
arrangements now exists and some have found applications in the biomedical field. For 
instance, a cationic hexanuclear metallo-prism is formed from arene-Ru building blocks with 
𝑂𝑂 ∩ 𝑂𝑂 bridges and triazine trigonal panels (or spacer ligands); these complexes show 
anticancer properties (Figure 1.9).
[33]
  
 
 
Figure 1.9 Supramolecular assembly of a metallo-prism 
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Among the many research groups whose work was inspired by this supramolecular chemistry, 
our group has reported the synthesis of a wide range of multinuclear arene-ruthenium 
complexes in the form of metallo-cages.
[23b]
 These cages are supramolecular arrangements 
bearing a cavity formed during the assembly of the different subunits. Changing the Ru clips 
and the spacer ligands changes the shape and size of the cavity. Generally, the spacer ligand is 
the one that determines the geometry of the metallo-assembly, giving rise to the formation of 
cages in the shape of rectangles, prisms and cubes (Table 1.1). There are some cases where 
the clip has an as important role to play in the architecture of the assembly as the spacer 
ligand. For instance, two complexes of platinum and palladium have been reported recently, 
consisting of π-extended tetrathiafulvalene ligand with four pyridyl units that bind to the 
metal centres, each metal coordinated to a (diphenylphosphino)ferrocene unit.
[34]
 These 
octacationic self-assembled complexes possess an ovoid internal cavity, which is different 
from the common cubic or cuboid formed by tetradentate spacer ligands (Figure 1.10).  
 
Table 1.1 The different clips and spacer ligands and examples of the geometries they give 
 
 
 
Ru Clips Spacer ligand Geometry of 
assembly
Arene
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Figure 1.10 The X-ray crystal structures of the Pd complex (a) lateral view and (b) top 
view
[34]
 
 
1.2 Host-Guest Chemistry 
The term “Host-Guest Chemistry” was coined by Cram in 1974, to describe the 
“complexation and decomplexation” happening during an enzymatic reaction during which 
molecular recognition is of utmost importance for the substrate-enzyme systems.
[35]
 In 1967, 
Pedersen reported the binding of metal ions with crown ethers to give highly structured 
complexes.
[36]
 Two years later, Lehn, Sauvage and Dietrich published their work on cryptands 
that involved the study of the binding properties of these molecules.
[37]
 The basic principle 
behind this chemistry is the size compatibility between the host and the guest. Also, the 
complementary binding forces, which are weak non-covalent interactions like van der Waals, 
eventually leading to the assembly of the host and the guest are crucial.
[35a]
 In 1987, Donald J. 
Cram, Jean-Marie Lehn and Charles J. Pedersen were awarded the Noble Prize for their work 
on this concept, which has found widespread applications. The term host-guest chemistry is 
well defined in the following citation by Cram:
[35a]
  
“… a host-guest relationship involves a complementary stereoelectronic arrangement of 
binding sites in host and guest… the host component is defined as an organic molecule or ion 
whose binding sites converge in the complex… the guest component is defined as any 
molecule or ion whose binding sites diverge in the complex…” 
 
Thus, the host possesses convergent binding sites while the guest has divergent ones. The 
interactions existing in the host-guest system are important in determining the stability of the 
a                                                                          b
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assembly. These interactions can be hydrophobic, H-bonding, π-π aromatic interactions and 
ion-ion and dipole interactions. Apart from the selective binding affinity between the host and 
the guest, the two components need to have complementary geometric size/shape according to 
the lock and key principle.  
 
In order to get a better understanding of how the host-guest strategy works, thermodynamic 
experiments, like isothermal titration calorimetry, were performed. Results from the 
experiments between guest molecules and the cavity confirmed that depending on the type of 
interaction happening inside the cavity, the encapsulation will be either entropy- or enthalpy-
driven. Since entropy changes occur mostly when there is desolvation or a change in 
conformation, the host-guest systems, in general, are most likely to be enthalpy-driven. Thus, 
the π-π and C-H-π interactions between the guest molecule and the inner surface of the cavity 
give rise to enthalpic combination. Therefore, encapsulation is mainly enthalpy-driven, with 
probably some favourable entropic changes in terms of loss of solvent molecules surrounding 
the guest during encapsulation.
[38]
 
 
Chemists have designed a large array of host-guest systems ranging from crown ethers to 
cyclodextrins to calixarenes, capable of hosting guest molecules or ions based on 
complementary/attractive forces between the two species. Host-guest chemistry is now 
applied in many areas including catalysis, sensors and pharmaceuticals. Host-guest systems 
have become a very popular method of drug-delivery in recent years and are believed to give 
rise to improvement in efficiency and biocompatibility.
[23b]
 Researchers have even 
encapsulated cisplatin in order to reduce the severe side effects of the drug.
[39]
 Thus, the 
arene-ruthenium arrangements allow the encapsulation of organic molecules of sizes that can 
fit in the cavity. The guest, usually a planar aromatic compound, is held by π-stacking to the 
spacer ligand of the host. A series of these complexes have been tested for their medicinal 
properties and interesting results have been obtained, comparable to cisplatin.
[40]
  
 
1.2.1 Carceplex Systems 
For small aromatic molecules that need to be encapsulated, the concept of host-guest has 
worked very well, allowing the guest molecule to enter and exit the cavity without disruption 
of the host molecule (Figure 1.11(a)). But in the case of highly branched aromatic molecules 
that can fit in the cavity, the movement in and out of the cage is restricted as the passage is not 
large enough.
[41]
 In such instances, carceplex systems are used, whereby the guest molecule 
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gets trapped permanently as the host is assembled around it (Figure 1.11(b)). The driving 
force for the incarceration is the interaction between the guest molecule and the interior of the 
forming shell.
[42]
 With the portal size being too small, the guest molecule can only be 
liberated via rupture of the cage. It is also possible for several molecules to be imprisoned 
inside the cavity that is big enough to accommodate the guests.
[43]
 Besides its growing use in 
drug-delivery, carceplex systems are being applied in other areas, for instance, it is being 
employed as stabilizers for highly reactive species.
[43b]
  
 
 
Figure 1.11 Schematic representation of encapsulation of a guest molecule by the (a) host-
guest and (b) carceplex methods 
 
1.2.2 Trojan Horse Concept 
Drug-delivery strategies are engineered technologies that allow controlled release of drugs 
into targeted cells. This system has helped in avoiding many side effects associated with 
unwanted interactions of the drug with parts of the body that are not targeted. Trojan-Horse is 
a common way of referring to drug-delivery based on the strategy of transporting potential 
drugs, which are not water-soluble, inside the hydrophobic cavity of a cage with hydrophilic 
exterior and releasing the drug in the target cells. Drug-delivery employing Trojan-Horse 
concept can be advantageous compared to other modes used. Some of the advantages can be 
the higher local drug concentration and improved therapeutic efficacy.
[44]
 From the various 
types of Trojan-Horse published, the horse was found to adopt different forms such as 
liposomes, engineered viruses,
[45]
 nanotubes
[46]
 and supramolecular assemblies.
[23d, 47]
  
 
Host Guest
+
3 + 3 +
a
b
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Introduced by our group, the supramolecular assemblies have been used to encapsulate drugs 
into the hydrophobic cavity of the metallo-assembly, with two main objectives: (1) 
transportation of mostly hydrophobic drug and (2) release of the treatment inside the targeted 
cancer cells.
[47a]
 The first supramolecular Trojan Horse system involved the encapsulation of 
non-water soluble M(acac)2 complexes into water-soluble hexanuclear arene-ruthenium prism 
via carceplex assembly until its release in the cancer cells (Figure 1.12). This “complex-in-a-
complex” assembly was confirmed by X-ray crystallography, which demonstrates the bending 
of the plane of the triazine ligands due to strong interactions with the guest complex. 
 
 
Figure 1.12 Encapsulation of M(acac)2 into supramolecular Trojan Horse 
 
1.2.3 Encapsulation of Pyrene-Core Dendrimers and their Biological Properties 
In our group, a series of successful arene-Ru assemblies showing interesting anticancer 
properties have been developed. One such example is a family of pyrene-core dendrimers 
encapsulated in tetra- and hexanuclear arene-Ru complexes with the pyrene-core inside the 
hydrophobic cavity of the cage and the dendritic arm left dangling out (Figures 1.13, 1.14). 
This system was found to exhibit enhanced cytotoxicity compared to either the host or the 
guest alone. The IC50 values (the half maximal inhibitory concentration that indicates how 
much of a particular drug is needed to inhibit a given biological process by half) of these 
systems were comparable to those of cisplatin when evaluated against human ovarian A2780 
(cisplatin sensitive) and A2780cisR (acquired resistance to cisplatin) cancer cell lines.
[48]
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Figure 1.13 Encapsulation in a hexanuclear metallo-cage of dendrimers of second generation: 
(a) poly(arylester), (b) poly(benzylether) and (c) polyester 
 
 
Figure 1.14 HyperChem simulation of the structure of the encapsulation of the poly(arylester) 
dendrimer of second generation into a hexanuclear Ru prism 
 
1.3 Aim of the Present Thesis 
The work done by Anaïs Pitto-Barry during her thesis has shown that dendrimers displaying 
liquid-crystalline properties could be successfully encapsulated into arene-Ru metallo-cages 
Ru
Ru
Ru
Ru Ru
RuR
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by host-guest chemistry.
[48]
 Moreover, these macromolecular assemblies show biological 
activities against human ovarian cancer cells. This thesis work is a continuation of the project 
initiated by Anaïs Pitto-Barry, consisting of the synthesis and the study of liquid-crystalline 
dendrimers in combination with arene-Ru metallo-cages as potential anticancer drugs and as 
hybrid liquid-crystalline materials.  
 
So far, only monosubstituted pyrene-core dendrimers have been tested for their biological 
activities, alone and encapsulated. Therefore, the goal of this work was to synthesise new 
aromatic-core dendrimers possessing two dendritic chains that have liquid-crystalline 
properties and to encapsulate them into arene-Ru metallo-cages in order to determine any 
possible biological activities they might display inside cancer cells. Moreover, studying the 
liquid-crystalline property of the host-guest systems was also envisaged. 
 
Furthermore, there were two other objectives for this work. One was to use a different 
approach in assembling the supramolecular cages other than the coordination-driven method; 
hence, self-assembly of arene-Ru cages by H-bonding was tested. The description of new and 
larger spacer ligands and the syntheses of the corresponding half-sandwich complexes and 
metallo-rectangles have been studied. The properties of these new metallo-assemblies as host-
guest as well as carceplex systems have been evaluated. The other aim involved the 
association of arene-Ru units with [60]fullerene. Half-sandwich mononuclear [60]fullerene-
based arene-Ru complexes were thus synthesised for their potential biological activities. The 
introduction for these two topics, hydrogen bonding self-assembly and [60]fullerene, will be 
done in the corresponding chapters.  
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2.1 Hydrogen Bonding 
When hydrogen is bonded to electronegative atoms, such as N, O and F, the covalently 
bonded electron pair is pulled strongly to the nucleus of the electronegative atom, leaving a 
partial positive charge on the hydrogen atom and a partial negative charge on the 
electronegative atom. The partial positive charge allows the hydrogen to attract negatively 
charged species, an anion or a lone pair of electrons. This dipole-dipole attraction between the 
H atom, covalently bonded to an electronegative atom, and another electronegative atom is 
called hydrogen bonding. Hence, the IUPAC definition of hydrogen bonding is the 
“association between an electronegative atom and a hydrogen atom attached to a second, 
relatively electronegative atom”. The terms “donor” and “acceptor” are commonly used when 
dealing with hydrogen bonding: the donor (D) is the electronegative atom (X) to which the H 
atom is covalently bonded and the acceptor (A) is the neighbouring electronegative atom (Y) 
that possesses the negative charge or lone pair of electrons (Figure 2.1).
[49]
 
 
 
Figure 2.1 Schematic representation of a H-bonded system 
 
The strength of H-bond is intermediate between that of dipole forces between molecules and 
covalent bonds within a molecule. The H-bond is about 1/10 as strong as covalent bonds. 
Nevertheless, multiple H-bonds between two molecules result in a union that displays 
sufficient strength and good stability.  
 
There have not been any Nobel Prize winners for the discovery of H-bonding because since 
the realization of its significance in the early 1900s, many important researchers have been 
working on and contributed to the understanding of this complex concept, among whom were 
Werner, Huggins, Rodebush and Pauling.
[50]
 Hydrogen bond is still today a growing area of 
research due to its enormous importance. One example of the role of H-bonding is water 
(Figure 2.2). Each water molecule can potentially form four intermolecular hydrogen bonds 
with neighbouring water molecules. Compared to other binary compounds formed between 
hydrogen and elements of group 6, like H2S, where H-bonding is absent, H2O has the highest 
boiling point, despite its smaller molar mass. Also, compared to other larger molar mass 
X       H                  Y:
δ- δ+
donor acceptor
H-bondingcovalent bond
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molecules where H-bonding is present, like HF, the boiling point of H2O is still higher as it 
partakes in more hydrogen bonds per molecule. Hence, H-bonding can account for the unique 
properties of water (Figure 2.2).
[51]
  
 
 
Figure 2.2 Hydrogen bonding in water 
 
H-bonding has a very important role to play in the structure and function of several biological 
systems, like DNA. The double strands in DNA are held together by hydrogen bonds between 
the H atoms attached to N on one strand and lone pairs on another N or an O on the other 
strand. The H-bonding between the complementary nucleotide Watson-Crick base pairs and 
π-stacking interactions give rise to the stable double helical structure of DNA. Two H-bonds 
occur between the adenosine and the thymine base pairs and triple hydrogen bonds exist 
between the cytosine and the guanine (Figure 2.3(a)). Furthermore, the construction of 
polypeptides uses extensively H-bonds between N-H and C=O groups. Intra- and inter-chain 
H-bonding interactions in α-helices and β-sheets, respectively, establish the secondary 
structure of proteins (Figure 2.3(b)).
[49]
   
 
 
Figure 2.3 Hydrogen bonding between base pairs (a) and peptides (b) 
δ+
δ+
δ+
δ-
δ-
δ-
δ+
antiparallel β-sheets parallel β-sheets
α-helix
a
b
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Supramolecular chemistry, as defined by Nobel Prize winners Lehn, Cram and Pedersen, is 
the “chemistry beyond the molecule”, and two fundamental features of this discipline are 
molecular recognition and self-assembly. Non-covalent interactions are used for the synthesis 
of supramolecules, enabling preparation of these complex assemblies from simple fragments, 
which may sometimes be difficult by covalent interactions. Hydrogen bonding is one of the 
preferred types of non-covalent interactions in supramolecular chemistry because H-bonded 
mediated self-assembly has been shown to be a good strategy for creating well-defined 
supramolecular architectures. Its directionality, stability, reversibility and specificity 
constitute some of the features that make H-bonding so versatile compared to other non-
covalent interactions.
[52]
 Appropriate choice of donor/acceptor pairs makes it possible for H-
bonding to be directional and to have tunable strengths. Hence, H-bonds can be classified as 
follows: 
 Strong H-bonds: formed between charged species and have bond strengths in the 
range 15-40 kcal·mol
-1
 and have the shortest bond lengths.  
 Moderate H-bonds: are mostly electrostatic interactions found in biomolecules with 
bond strengths in the order 4-15 kcal·mol
-1
 with moderate bond lengths. 
 Weak H-bonds: formed between an electronegative species and a significantly less 
electronegative complement of bond strengths less than 4 kcal·mol
-1
 and have the 
longest bond lengths. 
 
Based on the several biological examples where H-bonding exists, researchers have been 
inspired to build synthetic systems with H-bonding to benefit from its unique properties. The 
careful selection of acceptor/donor pairs is able to give the desired strength and stability of 
each hydrogen bond as well as the number and arrangement of the hydrogen bonds in the 
system. Similar to the base pairing in DNA, the well-defined through-space directionality and 
hence high selectivity of H-bonds have been used by many researchers. Thus, many examples 
of supramolecular assemblies involving H-bonding interactions have been reported in 
different fields of chemistry, especially in organic and polymer chemistry.
[52a, 53]
   
 
 Studies have shown that H-bonds could be made stronger and/or more selective by 
introducing arrays of donors (D) and acceptors (A) sites. These H-bonded systems are built by 
the use of parallel arrays of H-bonds and they feature two or more contiguous H-bonds on a 
heterocyclic scaffold. Units consisting of up to six consecutive H-bonds have been reported, 
but those of the triple and quadruple units are the most studied derivatives in molecular 
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recognition and self-assembly processes. It was found that the arrangement of the D and A 
sites, as well as the solvent in which the complexes are formed are determining factors for the 
strength of the H-bonds, called the association constant (Ka) or dimerization constant (Kdim) in 
case of homodimers.
[52c]
 
 
For triple H-bonded complexes, the general trend in their stability is as follows: 
 
ADA-DAD < ADD-DAA < AAA-DDD 
 
The DDD-AAA arrangement was found to have the highest association constant (Ka = 10
5
-
10
6
 M
-1
) and ADA-DAD pair the lowest (Ka = 10
2
-10
3
 M
-1
).
[54]
 With the same primary H-
bonding interactions between the D/A pairs, the difference in Ka can only be the result of 
another type of interaction. Hence, Jorgensen rationalised these differences as the impact of 
the secondary electrostatic interactions on the stability of H-bonding arrays.
[55]
 Since the D/A 
partners are in close proximity, due to the H-bonding between them, this gives rise to 
substantial electrostatic interactions. The partial positive charges on the protons and the partial 
negative charges on the electronegative atoms result in attractive forces between opposite 
charges and repulsive forces between like charges. The net of the secondary interactions can 
therefore account for the stronger/weaker binding, depending on the arrangement of the D/A 
sites in the molecules. Hence, parallel H-bond arrays, having all the H-bond donor groups in 
one partner and the acceptor sites in the other in an AAA-DDD arrangement seems to result in 
the strongest association with all secondary electrostatic interactions between neighbouring 
H-bond pairs being attractive.
[52c]
 
 
Among the many triple H-bonding modes, the H-bonded melamine-cyanuric acid motif with a 
ADA-DAD array has been one of the most widely used in the formation of the so-called 
“rosette” supramolecular structures. In this system, a single rosette constitutes of a cyclic 
aggregate of three melamine and three cyanuric acid units. The lattice formed in organic 
solution shows very good stability arising from nine hydrogen bonds surrounding each 
melamine or cyanuric acid molecule (Figure 2.4).
[56]
 Based on this arrangement, a series of 
macromolecules have been developed using melamine and cyanuric acid derivatives. Two 
strategies were adopted in designing these rosette structures: preorganization and peripheral 
crowding, favouring the formation of 1:1 cyclic aggregates.
[56-57]
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Figure 2.4 Melamine and cyanuric acid rosette structure 
 
Four H-bonding systems have also attracted the attention of many research groups, as a result 
of which a vast series of quadruple H-bond complexes have been synthesised. Out of the six 
possible H-bond permutations, only three have been extensively studied: ADAD-DADA, 
AADD-DDAA, ADDA-DAAD (Figure 2.5).
[52c, 58]
  The AAAA-DDDD array is not much 
explored and even though these complexes with four consecutive H-bond donors and 
acceptors show the highest stability (Ka ˃ 10
12
 M
-1
), similar to triple systems, their application 
is not so popular. One example of an AAAA-DDDD quadruple H-bond array is the highly 
stable cationic complex formed by the equimolar assembly between guanidinium 
dibenzimidazole and diisoquinoline-[1,8]-naphthyridine (Figure 2.5).
[58c]
  
 
 
Figure 2.5 Examples of quadruple H-bond arrays and their Ka values 
 
Many different scaffolds have been used in designing and building up quadruple H-bonding 
self-assembled systems, and the most popular one is probably the 2-ureido-4-[1H]-
pyrimidinone (UPy). Upy dimers, with a DDAA H-bond array, have high dimerization 
constants (Kdim ˃ 10
7
 M
-1
) and they can be readily synthesised.
[61f]
 The high dimerization 
constant of UPy arises from the limited repulsive secondary interactions and two attractive 
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secondary interactions within the motif, as well as the intramolecular H-bond that creates 
order within the molecule by prearrangement of the motif.
[59]
 UPy unit can also associate with 
other units to form heterocomplexes that are stable with high association constants. Thus, 
Meijer and co-workers have developed a series of UPy derivatives.
[60]
 UPy consisting of a 
linear four H-bond DDAA-AADD array has been used as building block for the construction 
of various assemblies. Inspired by this unit, numerous derivatives of UPy have been used as 
DDAA modules, with varying dimerization constants (Figure 2.6).
[52b, 52d, 53c, 61]
 
 
 
Figure 2.6 Homodimer structures of DDAA-AADD array modules, UPy, DeAP, UN and UC 
 
Developed by Zimmerman and co-workers in the late 1990s, ureidodeazapterin (DeAP) 
shows very high stability (Figure 2.6). Three major DDAA-AADD dimers are present in the 
DeAP systems: two homodimers, X.X and Y.Y (arising from the two possible tautomers) and 
one heterodimer X.Y. Some undesired DADA-ADAD homodimers, Z.Z, are also detected in 
small amount (Figure 2.7).
[53c]
  
 
 
                                                                      Chapter 2: Hydrogen Bonded Metallo-Assemblies 
27 
 
 
Figure 2.7 The different protomeric forms of the AADD H-bonding array of DeAP 
 
A few years later, the same group developed a ureidodeazapterin-based module, linking two 
DeAP units with a semi-rigid spacer bearing a Fréchet-type dendron (of first, second and third 
generation) attached to it. This molecule exists as two tautomers, with a DDAADDAA H-
bond array in both forms. The two different conformations, symmetrical and non-
symmetrical, give rise to different aggregates, polymeric and cyclic, respectively (Figure 
2.8).
[52a]
  
 
  
Figure 2.8 Different conformations of spacer unit DeAP and the corresponding assemblies 
with third generation dendron 
 
The dimerization constant of ureidonaphthyridine (UN) is the lowest in this series because 
intramolecular H-bonding occurs to stabilise the folded conformer rather than the unfolded 
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one (Figure 2.9).
[62]
 This problem is less in the ureidocytosine (UC) units, developed by 
Hailes and co-workers, where the unfolded dimer is the most stable conformer.
[63]
 Similar to 
UC, ureidoimidazo[1,2-a]pyrimidine (UImp) has highly stable unfolded dimer.
[52b]
 
 
 
Figure 2.9 The folded and unfolded conformers of UC dimer 
 
Among the different macrostructures that have been successfully designed and constructed by 
H-bonds, there are several networks bearing cavities that have been formed as a result of non-
covalent, complementary interactions. The formation of these cyclic aggregates, or cages, by 
H-bonding requires a high binding/association constant and a highly preorganised monomeric 
subunit.
[61a]
 Another type of interaction that has been found to produce macrocycles and cages 
is metal coordination. Fujita and Stang have worked, independently, on the design of cyclic 
frameworks by coordinating different ligands, like 4,4′-dipyridine, to the metal centres, like 
Pt(II).
[32c, 64]
 Mendoza et al. generated molecular squares and triangles by combining H-
bonding and metal-templated self-assembly. Upon mixing the difunctional UPy dimers, which 
can easily be preorganised by functionalisation of the phenylene ring or the amine, and a 
Pd(II) species in a 1:1 molar ratio, different cyclic aggregates were formed (Figure 2.10). 
These results led to the start of the application of H-bonding and metal complexation in 
designing molecular architectures of higher complexity.
[61f]
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Figure 2.10 Schematic representation of cyclic aggregates (a) propeller-shaped triangle, (b) 
propeller-shaped square and (c) tubular-shaped tetramer. 
 
2.2 Aim 
Supramolecular chemistry combining H-bonding and metal complexation has flourished since 
Mendoza and co-workers published their findings on this method. Thus, the objective of this 
project was to move from directional-bonding coordination-driven self-assembly of Ru cages 
to H-bonding and metal coordination self-assembly, in order to take advantage of the pool of 
information associated with each technique. Hence, a series of new assemblies was developed 
consisting of arene-Ru clips and ureidopyrimidone derivatives with a DDAA H-bond array as 
the spacer ligand. Five new dinuclear Ru panels and a family of new arene-Ru rectangles 
were generated from this work. 
 
2.3 Synthesis 
2.3.1 Synthesis of Spacer Ligands 
Four different ligands (4-6, 10) were synthesised by a four step synthetic route (Scheme 2.1). 
The first step involves an alkylation reaction between diethyl carbonate and a ketone in the 
presence of NaH in refluxing THF. The product obtained after purification was found to be a 
mixture of tautomers: the enol form and the desired ketone form as the major product (1 and 
7). Isolation of the ketone was not carried out, and the product was used for further reactions 
without separation.  
= =
a                                                    b                                                                 c
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Scheme 2.1 Synthesis of H-bonded systems (4-6, 10). Reagents and conditions: i. NaH, THF, 
66°C, 16h, 1: 76%, 7: 88%, ii. EtOH, 90°C, 16h, 2: 75%, 8: 43%,  iii. THF, rt, 8h, 3: 
quantitative yield, 9: 64%, iv. DMF/NEt3, 70°C, 16h, 4: 37%, 5: 72%, 6: 50%, 10: 73% 
 
The second step is the ring-closure of the β-ketoester (1 and 7) with guanidinium carbonate in 
refluxing ethanol. The isocytosine derivative (2 and 8) reacts with 1,1′-carbonyldiimidazole 
(CDI) in THF, due to limited solubility of the isocytosines, to give the blocked isocytosine 
isocyanate derivate (3 and 9). An excess (two equivalents) of CDI was used to ensure 
complete conversion of the isocytosine. The imidazolide was then reacted with different 
amines in DMF/NEt3 solvent mixture in a sealed tube to produce head-to-tail 
ureidopyrimidinone dimer with a DDAA H-bond array (4, 6 and 10). The different ligands 
were synthesised to test the effect of: (1) adding a methyl group to the methylene spacer, (2) 
elongating the spacer chain, hence increasing flexibility and (3) reducing the length of the 
aliphatic chain from C11 to C4.  
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2.3.2 Macromolecular Assemblies 
 [(η6-p-cym)Ru(µ2-Cl)Cl]2, its hexamethylbenzene derivative, [(η
6
-hmb)Ru(µ2-Cl)Cl]2, and 
four other dinuclear arene-Ru clips synthesised from [(η6-p-cym)Ru(µ2-Cl)Cl]2 were used for 
molecular assembly. As in the case of the ligands, different clips were used for complexation 
to test the effect of the bridge and the arene on the ability of the resulting product to self-
assemble and to form monocrystals.  
 
Clips 11-14 (Figure 2.11) were synthesised, following literature procedures.
[43a, 47a]
 In these 
complexes, each ruthenium is coordinated to a chloride ligand that allows substitution by 
other ligands. 
 
 
Figure 2.11 Structures of Ru clips 11-14 
 
These Ru clips were then reacted with the ureido dimers under different conditions to give 
either the dinuclear panels (15, 20, 25, 30, 31) or the tetranuclear rectangular assemblies (16-
19, 21-24, 26-29) (Schemes 2.2 and 2.3). The dinuclear panels are obtained by simply stirring 
the ruthenium dimer with the ligand in CHCl3 at room temperature for 24h. In these panels, 
the dichloro-bridge is broken, leaving each Ru with two chloride ligands and one vacant site 
that is taken up by the ureido ligand with the coordination of the pyridyl nitrogen to the 
Ru(II). With the ligand behaving as one single component with two available coordinating 
sites, two ruthenium dichloride species get attached to the two pyridyl nitrogen atoms of every 
bidentate ligand (Scheme 2.2). 
 
i i ii iii
11 12 13 14
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Scheme 2.2 Synthesis of dinuclear Ru assemblies (15, 20, 25, 30, 31). Reagents and 
conditions: i. CHCl3, rt, 24h, 15: 98%, 20: 96%, 25: 93%, 30: 95%, 31: 90% 
 
In the case of the cages, a vacant site is created on each Ru centre by loss of the chloride 
ligand in the form of AgCl, resulting in the in-situ preparation of the activated intermediate 
species in the syn symmetry exclusively. When the ligand is added to the mixture, two 
bidentate dimers link together two Ru clips to form a cationic tetrameric cyclic arrangement 
adopting a rectangular shape, with four triflate counter anion (Scheme 2.3). 
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Scheme 2.3 Synthesis of tetranuclear Ru assemblies (16-19, 21-24, 26-29). Reagents and 
conditions: i. AgCF3SO3, CH2Cl2, rt, 24h or MeOH, rt, 16h, 16: 23%, 17: 72%, 18: 72%, 19: 
38%, 21: 46%, 22: 65%, 23: 53%, 24: 23%, 26: 21%, 27: 61%, 28: 57%, 29: 21% 
 
2.4 Characterization 
2.4.1 Proton NMR Spectroscopy 
For all the ligands (4-6, 10), sharp 
1
H NMR spectra in CDCl3 were observed (Figure 2.12). 
Well-defined typical signature for UPy’s NH was observed downfield, in the region expected 
for H-bonded dimers. It was also observed that changes brought to the molecule gave rise to 
shifting of some proton signals (Figure 2.12). For instance, adding a methyl group to the 
spacer results in an upfield shift for H5 and H6 protons from 12.16 and 11.03 ppm to 12.10 
and 10.81 ppm, respectively. In the case of elongating the spacer by one carbon atom, an 
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upfield shift of H5 and H6 protons is observed from 12.16 and 11.03 ppm to 11.91 and 10.42 
ppm. On the other hand, shortening the aliphatic side chain from C11 to C4 causes no change 
in the chemical shifts of H5 and H6 protons (Figure 2.12). The H4 protons are the most 
downfield in 5, when the spacer is more flexible and shortening the aliphatic side chain results 
in an upfield shift of the H4 proton from 13.02 ppm in 5 to 12.95 ppm in 4 (Figure 2.12). 
Hence, alterations brought to the dimer have an effect on the H-bonds holding the dimer 
together and inter- and intramolecular H-bondings are affected in different ways.  
 
 
Figure 2.12
 1
H NMR spectra (400 MHz, CDCl3) of ligands 4-6 and 10 
 
The effect of concentration on the chemical shifts of the NH protons (H4, H5 and H6) in dimer 
4 was tested. There was no apparent change in the chemical shift across a broad range of 
concentration (1 mM to 50 µM). From this observation, only a lower limit to the dimerization 
constant, Kdim > 10
7
 M
-1
 could be estimated, which is among the largest stability constants 
reported to date for neutral, H-bonded species. 
 
For the two sets of Ru complexes, the dinuclear and the tetranuclear, the resolution of the 
proton signals was found to differ. The spectra of the dinuclear species show peaks that are 
H4 H5 H610
6
5
4
H4 H5 H6
H4 H5 H6
H4 H5 H6
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sharp and well-defined, like in the case of the uncoordinated dimers (Figure 2.13). Besides a 
slight upfield shift of the H4 proton of the ureido derivatives after coordination of the dimer to 
the Ru, the other two NH signals (H5 and H6) did not undergo any major shifting. The H9 
peaks, however, underwent a downfield shift due to their close proximity to the Ru centre. 
Only a slight upfield shift was observed for the H8 peaks, being further away and therefore 
less affected by the Ru(II) centre. An example of the comparison between uncoordinated 
ligand and the corresponding dinuclear Ru complex is shown in Figure 2.13, whereby the 
1
H 
NMR spectra of compound 4 and its dinuclear Ru complex 15 are compared. The shifts 
observed between the two spectra are indicated by dotted lines, namely the shifting of the H4, 
H6, H8 and H9 protons.  
 
In the case of the rectangles, for most of the complexes, broad and ill-defined peaks were 
obtained, with some signals not visible on the spectra. For instance, the NH signals (H4, H5, 
H6) are broadened completely into the baseline for most of the rectangular systems (see Figure 
2.20 for 
1
H NMR spectrum of 17).  
 
 
Figure 2.13 
1
H NMR spectra (400 MHz, CDCl3) of 4 and 15 
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2.4.2 DOSY 
Diffusion-ordered NMR spectroscopy (DOSY) is a 2D NMR experiment developed in 1992 
to measure diffusion coefficients and in case of spherical molecules, the hydrodynamic radii 
of such molecules in solution using the Stokes-Einstein equation can be determined.
[65]
 The 
2D spectrum consists of one axis representing typical chemical shift information and diffusion 
coefficient (D) on another. This technique allows the different species contained in a mixture 
to be distinguished, as D is related to the size of the particle. The diffusion coefficient is 
dependent on the size and shape of the molecule in a particular solvent at a particular 
temperature.
[66]
 This NMR tool has found widespread applications in biology and chemistry 
where DOSY is being used to determine the dimensions of polydispersed supramolecular 
aggregates.
[67]
 
 
In order to confirm the composition of the metal coordination/H-bonding self-assembly of the 
Ru/ureido systems, DOSY experiments were run on the complexes. For all the dinuclear 
complexes (15, 20, 25, 30 and 31) DOSY experiments were run in CDCl3 using similar 
concentrations and at room temperature. Figure 2.14 shows the 2D spectra of compounds 15, 
20 and 25, which display single diffusion coefficient for each compound, indicating the 
formation of single species. It was also observed that the diffusion coefficients differ only 
very slightly for the five complexes (-9.30 > log D > -9.41) and hence, the standard errors 
associated with the differences between these values are too significant to be ignored. 
Comparing the DOSY spectrum of the free ligand to its corresponding dinuclear Ru complex, 
a decrease in log D value was observed. For example, compound 4 has log D value of -9.25 
while compound 15 has a log D value around -9.32. It can be concluded that for the dinuclear 
system, the complexes have very similar diffusion coefficients and that the minor differences 
among the UPy ligands do not have any apparent significance on the diffusion of the 
corresponding complexes, which have similar hydrodynamic volumes in solution.  
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Figure 2.14 DOSY spectra (400 MHz, CDCl3) of compounds 15, 20 and 25 
 
For the tetranuclear complexes, the DOSY experiments were run mostly in CD3CN, and it 
was observed that the complexes have diffusion coefficients in the range of -9.12 to -9.30 x 
10
10
. Similar to the dinuclear system, the differences are too small to account for any 
structure/diffusion relationship among these complexes. Thus, even with clips of different 
lengths, for example 11 and 14, their corresponding complexes show very close D values and 
hence have almost the same hydrodynamic volumes in solution. The difference in D values is 
however slightly more important when comparing a tetranuclear assembly to its 
corresponding dinuclear complex bearing the same UPy ligand. Thus, complexes 15 and 17 
have diffusion coefficients of -9.38 x 10
10
 and -9.54 x 10
10
 respectively in CDCl3. This 
difference can be associated to the larger hydrodynamic volume of the rectangle than the 
dinuclear panel. An example of the comparison of free ligand 4 and its corresponding 
tetranuclear Ru complex 17 is shown in Figure 2.15.  
 
 
Figure 2.15 DOSY spectra (400 MHz, CDCl3) of 4 and 17  
15
20
25
Log D
ppm
Log D
4
17
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                                                                      Chapter 2: Hydrogen Bonded Metallo-Assemblies 
38 
 
2.4.3 NOE/ROE and DFT Calculations  
A very powerful tool in NMR spectroscopy for structural studies of chemical systems is the 
Nuclear Overhauser Effect (NOE). This technique relies on relaxation phenomena between 
dipolar coupled spins and manifests itself in changes in signal intensities of nuclear sites when 
other specific nuclear sites are perturbed by means of a radio-frequency (rf) pulse.
[68]
 
Therefore, the experimental observation of NOE supplies information about, and implies, 
spatial proximities between given nuclear sites and can prove extremely useful in structural 
studies of the supramolecular systems considered in this thesis (See Annex 2).
[69]
 A 
widespread variation of the NOE experiment is the Rotating-frame Overhauser Effect (ROE), 
where an rf pulse is applied so as to spin-lock the magnetization in the transverse plane. This 
technique is utilised in cases where NOE enhancements are close to zero. Also this latter 
technique may therefore be utilised for structural studies aiming to determine internuclear 
distances between sites experiencing non-negligible dipolar couplings. 
 
In order to corroborate the experimental findings, a computational study has also been 
undertaken (See Annex 2).
[70]
 The structures thus obtained were used to calculate the 
magnetic shielding tensors of both 
1
H and 
13
C nuclei with the GIAO method at the same level 
of theory of the DFT optimizations.
[71]
 The geometry optimizations supplied internuclear 
distances to be compared to those determined experimentally by means of NMR/NOE 
measurements whereas the calculations of the magnetic shieldings allowed comparison with 
the experimental 
1
H and 
13
C chemical shifts observed for structure 4 in simple 1D solution-
phase NMR spectra. 
 
Structure 4 is expected to form in solution a dimer via formation of four H-bonds, resulting in 
the head-to-tail configuration as shown in Figure 2.16.  
 
 
Figure 2.16 Dimeric structure of 4 in a head-to-tail configuration 
ab
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Figure 2.17 1D ROE spectra (400 MHz, CDCl3) of 4 with protons H9 (a), H7 (b) and H3 (c) 
irradiated 
 
Figure 2.17(a), (b) and (c) shows 1D ROE spectra obtained when irradiating protons H3, H7 
and H9, respectively. Figure 2.18 shows, as histogram, the differences between internuclear 
distances measured from the NOE enhancements of the spectra in (a), (b) and (c), and those 
obtained from the structures optimised with DFT methods. The smaller those differences, the 
better the agreement between experiments and calculations are. In this histogram, the 
differences calculated, assuming a monomeric non-H-bonded structure 4, are shown in blue 
whereas those calculated, assuming the head-to-tail dimer, are shown in red. This histogram 
clearly shows a much better agreement of the experimental data sets when the dimeric 
structure is considered, with differences generally smaller than 1 Å in both cases (Figure 
2.18). In particular, proton sites that are on opposite sides of structure 4, such as, H3 and H9, 
necessarily require intermolecular pathways that may only exist in the dimeric form in order 
to interpret the experimentally-observed NOE enhancements.  
 
H9
H3
H7
H4
H5
H6 H9 H8 H3 H7 H2
a
c
b
4
                                                                      Chapter 2: Hydrogen Bonded Metallo-Assemblies 
40 
 
Figure 2.18 Difference in Δr between DFT-calculated and ROE measured distances 
 
The experimental data based on ROE measurements strongly suggests the existence of 4 as a 
H-bonded dimer in solution. An independent further assessment may be also carried out by 
considering the chemical shifts of the 
13
C and 
1
H resonances as measured in conventional 1D 
spectra and as calculated with DFT methods, as described above. Figure 2.19(a) shows the 
correlation between experimental 
13
C chemical shifts and those calculated for the monomeric 
structure. The quality of the correlation may be indicated by a coefficient R
2
 = 0.996. Figure 
2.19(b) shows the good correlation when the dimeric structure was used to calculate the 
chemical shifts. In this latter case R
2
 = 0.999, with all carbon sites being very accurately 
described by DFT calculations. Figure 2.19(c) shows the correlation between experimental 
1
H 
chemical shifts and those calculated for the monomeric structure. In this case, the NH protons 
lay completely out of the correlation line where all other proton sites may be found. These 
protons are involved in the H-bonding network that assembles the dimeric structure. If solvent 
effects are included in the calculations, no substantial improvement is obtained. Figure 
H3
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H7
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2.19(d) shows the analogous correlation when the dimeric structure was considered in the 
calculations. In this case the chemical shifts of the NH protons correlate very well with the 
calculated ones, with a coefficient R
2
 = 0.998. These results indicate that, in order to interpret 
the chemical shifts observed experimentally for 
13
C and 
1
H in structure 4, a dimeric 
arrangement needs to be considered. This is particularly true for the protons of the NH groups 
involved in the H-bonding system.  
 
 
 Figure 2.19 Experimental v/s DFT-calculated 
13
C and 
1
H chemical shifts for the (a and c) 
monomeric and (b and d) dimeric forms 
 
All the NMR data experimentally observed as ROE 
1
H enhancements and 
1
H and 
13
C 
chemical shifts strongly support the hypothesis of a structure 4 existing as a head-to-tail dimer 
in solution. In the case of the tetranuclear species, qualitative ROE/NMR analysis of 
compound 17 confirms the predicted rectangular self-assembled arrangement. Figure 2.20 
shows the NOE spectrum of 17: with H9 being irradiated, the peak corresponding to the 
benzoquinone Ru bridge of the clip, H19 was observed on the spectrum (See Annex 2). 
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Figure 2.20 1D ROE spectra (400 MHz, CDCl3) of 17 with protons H9 (a) and H19 (b) 
irradiated 
 
2.4.4 UV-Vis Spectroscopy 
The binding of the various metallo-assemblies were studied by UV-visible spectroscopy; the 
electronic absorption spectra were acquired in CH2Cl2 at concentrations around 10
-5
 M in the 
range 250-700 nm (Table 2.1). The di- and tetranuclear complexes were found to have 
different spectra. The dinuclear complexes have similar spectra, with a high energy shoulder 
around 288 nm, which may be attributed to ligand 𝜋 → 𝜋 ∗ transitions and a broad and low 
energy band at around 410 nm.
[72]
 The latter may be assigned to mixed metal-ligand charge 
transfer (MLCT), intra-ligand charge transfer (ILCT) from spacer ligand to 𝑂𝑂 ∩ 𝑂𝑂 
bridging ligand and ligand 𝜋 → 𝜋 ∗ transitions.[73] Figure 2.21 shows the stacking of the UV-
Vis spectra of compounds 16, 21 and 26 measured in CH2Cl2 and the similarity between these 
three naphthoquinone ruthenium derivatives. The spectra show that the differences between 
the three compounds bearing three different spacer ligands are negligible.  
 
 
 
 
 
H9
H8
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                                                                      Chapter 2: Hydrogen Bonded Metallo-Assemblies 
43 
 
Table 2.1 λmax values of the different series of metallo-cycles 
Clips Metallo-cycles λmax (nm) ε (M
-1
·cm
-1
) x 10
5
 
11 
16 
306 2.38 
433 1.66 
639 0.55 
693 0.62 
21 
310 2.56 
434 4.32 
644 0.55 
696 0.58 
26 
310 2.57 
434 1.57 
641 0.51 
693 0.51 
12 
17 
299 3.64 
498 3.39 
22 
300 3.72 
497 2.23 
27 
298 3.42 
496 3.07 
13 
18 
324 2.27 
504 2.27 
23 
326 2.20 
509 2.28 
28 
325 2.31 
503 2.40 
14 
19 383 0.28 
24 384 0.26 
29 387 0.28 
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Figure 2.21 UV spectra of compounds 26, 21 and 16 in CH2Cl2 
 
Changing the spacer ligand coordinated to the Ru(II) does not change the spectra of the di- 
and tetranuclear complexes. However, the spectra change a lot when modifying the bridging 
ligand of the Ru clip. Thus, complexes bearing the same Ru clip have similar spectra. 
Comparing those similar spectra allows the effect of the different ligands to be determined. 
But like in the case of dinuclear complexes, the differences in the spacer ligands cannot be 
seen by this technique. When the different series bearing the different clips were compared 
with each other, the effect of the Ru clip can be studied. For instance, relative to the dinuclear 
systems, the series of complexes bearing clip 14 undergo a hypsochromic shift of about 20 nm 
(Table 2.1).  
 
Moreover, comparing the metallo-cycles obtained from Ru clips 11 and 12, more bands are 
observed for the series from clip 11 and a slight bathochromic shift with Ru clip 12 (about 10 
nm) is observed (Table 2.1). A presumably lower contribution to ILCT between the spacer 
ligand and the benzoquinone compared to the same charge transfer between the same ligand 
and the naphthoquinone bridging ligand of clip 11.
[72b, 74]
 Similarly, addition of a chloride on 
the benzoquinone bridge results in a bathochromic shift of the bands of the metallo-cycle 
from Ru clip 13 compared to those of clip 12 (Table 2.1). 
: 16
: 21
: 26
nm
A
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2.4.5 Electrospray Ionization Mass Spectrometry 
The electrospray ionization (ESI) mass spectra of ligands 4-6 and 10, run in CH2Cl2 and 
MeOH, show the peak of highest intensity corresponding to either [Mmonomer+H]
+
 or 
[Mmonomer-H]
-
 for the positive and negative modes, respectively. A possible reason for the 
observation of the monomer and not the dimer of the ligands may be the presence of methanol 
molecules that undergo an exchange with monomer, hence obstructing the dimer formation.  
 
In the case of the Ru(II) complexes, the ESI MS was run in acetonitrile to avoid any exchange 
to take place between the solvent molecule and the complex. The spectra of the dinuclear 
complexes 15, 20, 25, 30 and 31 all show the peak corresponding to the m/z of [Mdimer-Cl]
+
 
with a separation of 1 Da between the components of the mentioned peak, which is expected 
of a singly charged ion. For example, the ESI mass spectrum of complex 20 shows several 
species, among which the [M-Cl]
+
 peak observed at m/z = 1403.2. An expansion of this peak 
reveals the characteristic Ru8 isotope pattern with a 1 Da separation between the peaks 
(Figure 2.22).  
 
 
Figure 2.22 The ESI mass spectra of complex 20 in acetonitrile 
 
For the tetranuclear complexes, the ESI mass spectra show the peak of the ion 
[Mdinuclear+Tf]
2+
, with the isotope peaks that differ by 0.5 Da, characteristic of doubly charged 
ions. Hence, the tetranuclear assembly is confirmed as the mass detected corresponds to that 
of the tetranuclear complex. For instance, the spectrum of complex 17 shows the peak at m/z 
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= 1556 that corresponds to the mass of the tetranuclear system after the loss of two triflate 
ions (Figure 2.23).  
 
 
Figure 2.23 The ESI mass spectra of complex 17 in acetonitrile 
 
2.5 Conclusion 
A series of novel multinuclear arene-Ru(II) assemblies were synthesised and characterised. 
The use of H-bonding self-assembly together with metal coordination to make metallo-cages 
has proven to be successful. The arrangements originating from this straightforward synthetic 
route show good stability under atmospheric conditions. A major part of the characterization 
of these complexes was made using the different tools associated with the NMR: 
1
H NMR, 
DOSY and NOE/ROE, complemented by DFT calculations. IR, UV-visible and ESI mass 
spectrometry supported the observations and conclusions made from NMR analysis.  
 
2.6 Experimental Part 
 
 
1 
A suspension of NaH on dispersion oil (3.55 g, 88.7 mmol) and diethyl carbonate (8 mL, 65.9 
mmol) in dry THF (55 mL) was heated under reflux under argon. A solution of 2-tridecanone 
(5.68 g, 28.6 mmol) in dry THF (10 mL) was added dropwise over 2h to the mixture and was 
heated under reflux overnight. The dense suspension was carefully poured into a mixture of 
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saturated aqueous NH4Cl, 5% HCl and ice and extracted with diethyl ether. The organic layer 
was washed with saturated aqueous NH4Cl and dried over MgSO4 and the solvent evaporated. 
The crude product was purified by CC (eluent hexane/diethyl ether, 10/1). 1 was formed with 
the enol isomer (15%) as a transparent liquid with a yield of 76% (5.89 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 4.22 (q, 
3
JH-H = 7.1 Hz, 2H, H5), 3.42 (s, 2H, H4), 2.52 
(t, 
3
JH-H = 7.4 Hz, 2H, H3), 1.60 (t, 
3
JH-H = 7.4 Hz, 3H, H6), 1.25-1.33 (m, 18H, aliphatic 
chain), 0.88 (t, 
3
JH-H = 6.8 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 203.00; 167.28; 61.25; 49.32; 43.05; 31.91; 
29.60; 29.44; 29.36; 29.33; 29.03; 23.48; 22.68; 14.10. 
 
MS (ESI(+)) = 271.5 [M+H]
+ 
 
 
2 
A suspension of guanidinium carbonate (0.48 g, 2.70 mmol) and 1 (1.47 g, 5.40 mmol) in 
ethanol (20 mL) was heated under reflux. After overnight stirring, mixture was cooled to rt, 
the white precipitate formed was filtered off and washed with ethanol. The residue was dried 
under vacuum. 2 was obtained as a white solid with a yield of 75% (0.53 g). 
 
1H NMR (400 MHz, DMSO, ppm): δ = 10.57 (s, 1H, H6), 6.42 (s, 2H, H5), 5.35 (s, 1H, H4), 
2.20 (t, 
3
JH-H = 7.6 Hz, 2H, H3), 1.48-1.56 (m, 2H, H2), 1.24-1.30 (m, 16H, aliphatic chain), 
0.85 (t, 
3
JH-H = 6.6 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, DMSO, ppm): δ = 170.22; 163.23; 155.93; 100.03; 37.46; 31.71; 
29.44; 29.41; 29.39; 29.27; 29.12; 29.05; 27.93; 22.51; 14.38. 
 
MS (ESI(-)) = 529.2 [2M-H]
- 
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3 
A suspension of 2 (0.40 g, 0.94 mmol) and CDI (0.30 g, 1.89 mmol) in dry THF (35 mL) was 
stirred under argon at rt for 8h. The solvent was removed and the residue was triturated with 
acetone (60 mL). The precipitate was filtered and the residue dried under vacuum. 3 was 
obtained as a white solid with a quantitative yield (0.42 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.16 (s, 1H, H5), 8.85 (m, 1H, H6), 7.64 (m, 1H, H7), 
7.01 (m, 1H, H8), 5.81 (s, 1H, H4), 2.65 (t, 
3
JH-H = 7.7 Hz, 2H, H3), 1.75 (quint, 
3
JH-H = 7.6 Hz, 
2H, aliphatic chain), 1.26-1.43 (m, 16H, aliphatic chain), 0.87 (t, 
3
JH-H = 6.6 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 160.80; 157.17; 156.67; 138.01; 127.85; 117.69; 
104.04; 76.72; 32.90; 31.91; 29.58; 29.44; 29.33; 29.27; 29.10; 27.58; 22.69; 14.13. 
 
MS (ESI(+)) = 360.4 [M+H]
+ 
 
 
4 
4-(Aminomethyl)pyridine (0.44 mL, 5.06 mmol) and 3 (2.00 g, 5.56 mmol) were placed in a 
sealed tube containing dry DMF (20 mL). To this solution, triethylamine (7.5 mL) was added 
and the mixture was stirred at 70°C. After overnight reaction, the mixture was cooled to rt, the 
solvent was removed under vacuum and the residue was triturated in methanol. The mixture 
was filtered and the residue washed with methanol, chloroform and EtOAc. 4 was obtained as 
a white solid with a yield of 37% (0.74 g).  
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1
H NMR (400 MHz, CDCl3, ppm): δ = 12.95 (s, 2H, H4), 12.16 (s, 2H, H5), 11.03 (t, 
3
JH-H = 
6.0 Hz, 2H, H6), 8.55 (d, 
3
JH-H = 5.9 Hz, 4H, H9), 7.27 (d, 
3
JH-H = 5.4 Hz, 4H, H8), 5.83 (s, 2H, 
H3), 4.46 (d, 
3
JH-H = 5.7 Hz, 4H, H7), 2.46 (t, 
3
JH-H = 7.7 Hz, 4H, H2), 1.59-1.64 (m, 4H, 
aliphatic chain), 1.25-1.35 (m, 32H, aliphatic chain), 0.87 (t, 
3
JH-H = 6.8 Hz, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.20; 157.01; 152.54; 152.79; 150.01; 147.76; 
122.09; 106.09; 42.49; 31.91; 29.58; 29.56; 29.43; 29.32; 29.15; 28.86; 26.97; 22.70; 14.13. 
 
MS (ESI(-)) = 398.5 [Mmonomer-H]
- 
 
IR (KBr) (cm
-1
) = 1699 (s, NH), 1658 (s, NH), 1590 (s, NH); 1260 (s, CN). 
 
 
5 
4-(2-Aminoethyl)pyridine (0.11 g, 0.91 mmol) and 3 (0.35 g, 1.00 mmol) were reacted 
following the procedure for 4 in DMF (5 mL) and triethylamine (1.5 mL) at 70°C overnight. 
The product was purified by the same method used for compound 4. 5 was obtained as a 
white solid with a yield of 72% (0.27 g).  
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 13.02 (s, 2H, H4), 11.91 (s, 2H, H5), 10.42 (t, 
3
JH-H = 
5.4 Hz, 2H, H6), 8.49 (d, 
3
JH-H = 6.1 Hz, 4H, H9), 7.18 (d, 
3
JH-H = 6.1 Hz, 4H, H8), 5.81 (s, 2H, 
H3), 3.54 (dt, 
3
JH-H = 8.1 Hz, 
4
JH-H = 6.1 Hz, 4H, H16), 2.94 (t, 
3
JH-H = 7.5 Hz, 4H, H7), 2.47 (t, 
3
JH-H = 7.7 Hz, 4H, H2), 1.64 (quint, 
3
JH-H = 7.6 Hz, 4H, aliphatic chain), 1.26-1.38 (m, 32H, 
aliphatic chain), 0.87 (t, 
3
JH-H = 6.5 Hz, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.12; 156.66; 154.59; 152.66; 149.82; 148.09; 
124.23; 105.91; 40.21; 34.97; 32.73; 31.91; 29.59; 29.58; 29.45; 29.33; 29.18; 28.87; 26.99; 
22.770; 14.13. 
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MS (ESI(+)) = 414.9 [Mmonomer+H]
+
 
 
IR (KBr) (cm
-1
) = 1702 (s, NH), 1654 (s, NH), 1579 (s, NH); 1256 (s, CN). 
 
 
6 
4-(1-Aminoethyl)pyridine (0.11 g, 0.91 mmol) and 3 (0.35 g, 1.00 mmol) were reacted 
following the procedure for 4 in DMF (5 mL) and triethylamine (1.5 mL) at 70°C overnight. 
The product was purified by the same method used for compound 4. 6 was obtained as a 
white solid with a yield of 50% (0.19 g).  
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.91 (s, 2H, H4), 12.10 (s, 2H, H5), 10.81 (d, 
3
JH-H = 
7.2 Hz, 2H, H6), 8.52 (d, 
3
JH-H = 6.0 Hz, 4H, H9), 7.30-7.33 (m, 4H, H8), 5.87 (s, 2H, H3), 4.92 
(quint, 
3
JH-H = 7.0 Hz, 2H, H7), 2.43 (t, 
3
JH-H = 7.7 Hz, 4H, H2), 1.56-1.63 (m, 10H, H17, 
aliphatic chain), 1.25-1.28 (m, 32H, aliphatic chain), 0.86 (t, 
3
JH-H = 6.4 Hz, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.08; 156.10; 154.60; 153.40; 152.60; 150.09; 
121.16; 106.12; 49.42; 32.71; 31.91; 29.58; 29.56; 29.42; 29.33; 29.15; 28.86; 26.96; 22.70; 
21.98; 14.14. 
 
MS (ESI(+)) = 412.4 [Mmonomer-H]
-  
 
IR (KBr) (cm
-1
) = 1695 (s, NH), 1662 (s, NH), 1593 (s, NH); 1265 (s, CN) 
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7 
A suspension of NaH on dispersion oil (3.55 g, 88.7 mmol), diethyl carbonate (8 mL, 65.9 
mmol) and 2-hexanone (3.5mL, 28.6 mmol) were stirred in dry THF (55+10 mL) following 
same procedure as for 1. 7 was obtained as a transparent liquid with the yield of 88% (4.33 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 4.19 (q, 
3
JH-H = 7.2 Hz, 2H, H5), 3.43 (s, 2H, H4), 2.53 
(t, 
3
JH-H = 7.4 Hz, 2H, H3), 1.52-1.63 (m, 2H, H7), 1.26-1.31 (m, 5H, H2, H6), 0.91 (t, 
3
JH-H = 
7.2 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 203.01; 168.12; 61.05; 48.89; 41.73; 25.46; 
22.20; 14.1; 13.89. 
 
 
8 
Guanidinium carbonate (2.26 g, 12.0 mmol) and 7 (4.33 g, 25.0 mmol) were stirred in ethanol 
(50 mL) following the procedure of 2. 8 was obtained as a white solid with a yield of 43% 
(1.82 g). 
 
1H NMR (400 MHz, DMSO, ppm): δ = 10.60 (s, 1H, H6), 6.44 (s, 2H, H5), 5.37 (s, 1H, H4), 
2.20 (t, 
3
JH-H = 7.7 Hz, 2H, H3), 1.50 (quint, 
3
JH-H = 8.3 Hz, 2H, H2), 1.28 (sept, 
3
JH-H = 7.2 
Hz, 2H, H7), 0.87 (t, 
3
JH-H = 7.6 Hz, 3H, H1). 
 
13
C{
1H} NMR (100 MHz, DMSO, ppm): δ = 155.56; 99.66; 64.88; 29.63; 21.71; 15.13; 
13.62. 
 
MS (ESI(+)) = 168.4 [M+H]
+ 
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9 
8 (1.67 g, 10.0 mmol) and CDI (3.24 g, 20.0 mmol) were stirred in dry THF (160 mL) 
following similar procedure as 3. 9 was obtained as a white solid with a yield of 64% (1.67 g). 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.82 (m, 1H, H6), 7.64 (m, 1H, H9), 7.03 (m, 1H, H8), 
5.82 (s, 1H, H4), 2.65 (t, 
3
JH-H = 7.7 Hz, 2H, H3), 1.68-1.79 (m, 2H, H7), 1.43-1.53 (m, 2H, 
H2), 0.99 (t, 
3
JH-H = 7.3 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 160.75; 156.60; 137.99; 128.03; 117.66; 104.08; 
32.64; 29.54; 22.24; 13.72. 
 
MS (ESI(+)) = 261.2 [M+H]
+ 
 
 
10 
4-(Aminomethyl)pyridine (0.10 mL, 1.0 mmol), 9 (0.28 g, 1.1 mmol) and triethylamine (1.5 
mL) were stirred in dry DMF (5 mL) following similar procedure as 4. 10 was obtained as a 
white solid with a yield of 73% (0.21 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.90 (s, 1H, H4), 12.16 (s, 1H, H5), 11.03 (s, 1H, H6), 
8.55 (d, 
3
JH-H = 6.1 Hz, 2H, H9), 7.27 (d, 
3
JH-H = 6.0 Hz, 2H, H8), 5.84 (s, 1H, H3), 4.48 (d, 
3
JH-H = 5.8 Hz, 2H, H7), 2.45 (t, 
3
JH-H = 7.7 Hz, 2H, H2), 1.62 (quint, 
3
JH-H = 7.4 Hz, 2H, H20), 
1.39 (sext, 
3
JH-H = 7.4 Hz, 2H, H15), 0.93 (t, 
3
JH-H = 7.3 Hz, 3H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.18; 157.01; 154.53; 152.75; 49.99; 147.76; 
122.10; 106.10; 42.49; 32.44; 28.99; 21.99; 13.61. 
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MS (ESI(+)) = 302.4 [Mmonomer+H]
+
 
 
 
11 
A mixture of [(η6-p-cym)Ru(µ2-Cl)Cl]2 (0.63 g, 1.00 mmol), anhydrous sodium acetate (0.16 
g, 2.00 mmol) and 5,8-dihydroxy-1,4-naphthaquinone (0.19 g, 1.00 mmol) in ethanol (75 mL) 
was stirred at 90°C for 16h. The precipitate formed was then filtered and washed with 
ethanol, water, acetone, diethyl ether and pentane to give 11 as a green solid in a yield of 80% 
(0.58 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 6.95 (s, 4H, H1), 5.48 (d, 
3
JH-H = 5.7 Hz, 4H, H2), 5.22 
(d, 
3
JH-H = 5.7 Hz, 4H, H3), 2.87 (sept, 
3
JH-H = 6.7 Hz, 2H, H4), 2.22 (s, 6H, H5), 1.30 (d, 
3
JH-H 
= 6.9 Hz, 12H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 170.91; 137.05; 111.92; 100.30; 98.04; 82.80; 
79.59; 30.72; 22.40; 17.93. 
 
 
12 
[(η6-p-cym)Ru(µ2-Cl)Cl]2 (0.31 g, 0.50 mmol), anhydrous sodium acetate (0.08 g, 1.00 mmol) 
and 2,5-dihydroxy-1,4-benzoquinone (0.07 g, 0.50 mmol) in ethanol (30 mL) were reacted 
and purified following the procedure for 11. 12 was obtained as a red solid with a yield of 
89% (0.30 g). 
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1
H NMR (400 MHz, CDCl3, ppm): δ = 5.79 (s, 2H, H1), 5.62 (d, 
3
JH-H = 5.7 Hz, 4H, H2), 5.38 
(d, 
3
JH-H = 5.7 Hz, 4H, H3), 2.91 (sept, 
3
JH-H = 7.0 Hz, 2H, H4), 2.29 (s, 6H, H5), 1.31 (d, 
3
JH-H 
= 6.9 Hz, 12H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 184.45; 139.12; 119.46; 102.29; 97.03; 81.55; 
79.60; 31.70; 22.87; 19.09. 
 
 
13 
[(η6-p-cym)Ru(µ2-Cl)Cl]2 (0.31 g, 0.50 mmol), anhydrous sodium acetate (0.08 g, 1.00 mmol) 
and chloranilic acid (0.10 g, 0.50 mmol) were stirred in methanol (30 mL) at rt for 2h. The 
mixture was filtered and the residue washed with diethyl ether to afford 13 as a red solid with 
a yield of 87% (0.32 g). 
 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 5.72 (d, 
3
JH-H = 5.7 Hz, 4H, H2), 5.47 (d, 
3
JH-H = 5.7 
Hz, 4H, H3), 2.94 (sept, 
3
JH-H = 7.0 Hz, 2H, H4), 2.34 (s, 6H, H5), 1.36 (d, 
3
JH-H = 6.9 Hz, 
12H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 184.72; 137.45; 118.41; 102.36; 98.62; 82.07; 
76.44; 31.72; 21.53; 18.59. 
 
 
14 
[(η6-p-cym)Ru(µ2-Cl)Cl]2 (0.63 g, 1.00 mmol) and ammonium oxalate monohydrate (0.14 g, 
1.00 mmol) were added to a CHCl3/MeOH (20/20 mL) solvent mixture and heated at 62°C for 
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6h. The mixture was filtered and washed with cold methanol to afford 14 as an orange solid 
with a yield of 90% (0.57 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 5.55 (d, 
3
JH-H = 5.7 Hz, 4H, H2), 5.32 (d, 
3
JH-H = 5.8 
Hz, 4H, H3), 2.87 (sept, 
3
JH-H = 2.8 Hz, 2H, H4), 2.21 (s, 6H, H5), 1.29 (d, 
3
JH-H = 6.9 Hz, 
12H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 171.78; 99.88; 95.57; 80.49; 78.48; 31.19; 
22.51; 18.60.  
 
General procedure for dinuclear panels (15, 20, 25, 30 and 31): a mixture of Ru dichloride 
dimer (15, 20, 25, 30: [(η6-arene)Ru(µ2-Cl)Cl]2 (0.03 g, 0.06 mmol) and 31: [(η
6
-hmb)Ru(µ2-
Cl)Cl]2 (0.06 g, 0.09 mmol)) and UPy derivative (15 and 30: 4 (0.04 g, 0.06 mmol), 20: 5 
(0.05 g, 0.06 mmol), 25: 6 (0.05 g, 0.06 mmol) and 31: 10 (0.04 g, 0.09 mmol)) was stirred in 
CHCl3 (2 mL) at rt for 16h. Diethyl ether was added to precipitate the product that was 
obtained by filtration.  
  
 
15 
Yield = 98% (0.17 g) 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.83 (s, 2H, H4), 12.15 (s, 2H, H5), 11.10 (s, 2H, H6), 
8.92 (d, 
3
JH-H = 6.0 Hz, 4H, H9), 7.30 (d, 
3
JH-H = 5.8 Hz, 4H, H8), 5.82 (s, 2H, H3), 5.40 (d, 
3
JH-H = 5.8 Hz, 4H, H11), 5.19 (d, 
3
JH-H = 5.8 Hz, 4H, H12), 4.46 (d, 
3
JH-H = 5.7 Hz, 4H, H7), 
2.99 (sept, 
3
JH-H = 6.9 Hz, 2H, H13), 2.47 (t, 
3
JH-H = 7.8 Hz, 4H, H2), 2.10 (s, 6H, H10), 1.63 
(quint, 
3
JH-H = 7.5 Hz, 4H, aliphatic chain), 1.23-1.36 (m, 44H, H14, aliphatic chain), 0.87 (t, 
3
JH-H = 6.8 Hz, 6H, H1). 
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13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 194.92; 156.76; 154.60; 152.99; 123.17; 106.01; 
103.60; 82.63; 82.35; 31.84; 30.61; 29.53; 29.41; 29.27; 29.10; 28.83; 26.88; 22.64; 22.27; 
18.29; 14.09; 0.97. 
 
MS (ESI(+)) = 1375.1 [M-Cl]
+ 
 
Anal. Calcd. (found) for C64H94N10O4Cl4Ru2 (1411.46) = C, 54.06 (54.46); H, 6.75 (6.71); N, 
9.80 (9.92)% 
 
UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 408 nm (ε = 0.15 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3421 (s, NH); 1697 (s, NH); 1660 (s, NH); 1587 (s, NH); 1257 (s, CN). 
 
 
20 
Yield = 96% (0.17 g) 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.91 (s, 2H, H4), 11.86 (s, 2H, H5), 10.41 (s, 2H, H6), 
8.85 (d, 
3
JH-H = 5.7 Hz, 4H, H9), 7.20 (d, 
3
JH-H = 5.7 Hz, 4H, H8), 5.79 (s, 2H, H3), 5.40 (d, 
3
JH-H = 5.7 Hz, 4H, H11), 5.18 (d, 
3
JH-H = 5.7 Hz, 4H, H12), 3.53 (q, 
3
JH-H = 6.5 Hz, 4H, H16), 
2.92-2.99 (m, 6H, H7, H13), 2.47 (t, 
3
JH-H = 7.7 Hz, 4H, H2), 2.04 (s, 6H, H10), 1.66 (quint, 
3
JH-
H = 7.6 Hz, 4H, aliphatic chain), 1.24-1.37 (m, 44H, H14, aliphatic chain), 0.86 (t, 
3
JH-H = 6.6 
Hz, 6H, H1).  
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.12; 156.51; 154.36; 152.79; 150.66; 125.13; 
105.80; 103.39; 96.96; 82.79; 82.14; 39.57; 34.27; 32.68; 32.85; 30.58; 29.53; 29.41; 29.27; 
29.13; 28.86; 26.88; 22.64; 22.26; 18.17; 14.10. 
 
MS (ESI(+)) = 1403.2 [M-Cl]
+ 
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UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 402 nm (ε = 0.18 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3425 (s, NH); 1698 (s, NH); 1659 (s, NH); 1586 (s, NH); 1255 (s, CN). 
 
 
 
25 
Yield = 93% (0.16 g) 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.81 (s, 2H, H4), 12.09 (s, 2H, H5), 10.90 (d, 
3
JH-H = 
6.9 Hz, 2H, H6), 8.90 (d, 
3
JH-H = 5.7 Hz, 4H, H9), 7.32 (d, 
3
JH-H = 4.6 Hz, 4H, H8), 5.84 (s, 2H, 
H3), 5.39 (q, 
3
JH-H = 5.4 Hz, 4H, H11), 5.20 (q, 
3
JH-H = 4.7 Hz, 4H, H12), 4.91 (quint, 
3
JH-H = 
7.1 Hz, 2H, H7), 3.00 (sept, 
3
JH-H = 7.1 Hz, 2H, H13), 2.44 (t, 
3
JH-H = 7.8 Hz, 4H, H2), 2.10 (s, 
6H, H10), 1.63 (quint, 
3
JH-H = 7.5 Hz, 4H, aliphatic chain), 1.23-1.30 (m, 44H, H14, aliphatic 
chain), 0.86 (t, 
3
JH-H = 6.6 Hz, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 173.01; 165.76; 155.92; 154.72; 154.34; 152.76; 
122.18; 115.94; 106.04; 103.77; 96.75; 82.44; 82.33; 49.08; 32.63; 31.85; 30.58; 29.53; 
29.39; 29.27; 29.10; 28.82; 26.83; 22.64; 22.23; 21.51; 18.21; 14.09. 
 
MS (ESI(+)) = 1402.2 [M-Cl]
+
 
 
UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 409 nm (ε = 0.18 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3421 (s, NH); 1698 (s, NH); 1658 (s, NH); 1585 (s, NH); 1255 (s, CN). 
 
30 
Yield = 95% (0.07 g) 
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1
H NMR (400 MHz, CDCl3, ppm): δ = 8.93 (d, 
3
JH-H = 6.3 Hz, 2H, H9), 7.30 (d, 
3
JH-H = 5.7 
Hz, 2H, H8), 5.83 (s, 2H, H3), 5.43-5.47 (m, 4H, H11), 5.22-5.33 (m, 4H, H12), 4.46-4.50 (m, 
2H, H7), 2.95-3.02 (m, 2H, H13), 2.45-2.49 (m, 4H, H2), 2.09 (s, 6H, H10), 1.27-1.41 (m, 20H, 
H14, aliphatic chain), 0.92-0.95 (m, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 155.86; 154.74; 154.33; 128.91; 126.22; 123.24; 
103.69; 103.69; 102.00; 82.58; 82.22; 65.81; 32.31; 30.63; 22.79; 22.38; 22.21; 21.92; 18.23; 
15.22; 13.97; 13.90; 13.64; 13.56. 
 
MS (ESI(+)) = 1178.8 [M-Cl]
+ 
 
UV-Vis (CH2Cl2, 5.0 x 10
-5
 M): λmax = 414 nm (ε = 0.01 x 10
5
 M
-1
·cm
-1
) 
 
 
31 
Yield = 90% (0.10 g) 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 12.83 (s, 2H, H4), 12.11 (s, 2H, H5), 11.06 (s, 2H, H6), 
8.65-8.70 (m, 4H, H9), 7.14-7.30 (m, 4H, H8), 5.80 (s, 2H, H3), 5.54 (s, 4H, H7), 2.45-2.55 (m, 
4H, H2), 1.97-2.13 (m, 36H, H10), 1.60-1.65 (m, 4H, H11), 1.30-1.37 (m, 4H, H12), 0.86-0.97 
(m, 6H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 154.37; 154.22; 123.27; 123.11; 101.75; 93.24; 
92.43; 91.26; 91.22; 90.64; 89.54; 42.11; 32.39; 31.52; 29.09; 29.00; 28.86; 22.12; 22.08; 
21.95; 21.88; 16.78; 16.29; 16.16; 15.86; 15.74; 15.61; 15.56; 15.40; 13.75; 13.66; 13.58.  
 
MS (ESI(+)) = 1233.9 [M-Cl]
+
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General procedure for cyclic tetramers (16-19, 21-24 and 26-29): a mixture of one equivalent 
of Ru clip (16, 21, 26: 11 (0.04g, 0.06 mmol), 17, 22, 27: 12 (0.04g, 0.06 mmol), 18, 23, 28: 
13 (0.04g, 0.06 mmol), 19, 24, 29: 14 (0.04g, 0.06 mmol)) and three equivalents of 
AgCF3SO3 (0.04 g, 0.18 mmol) was stirred in methanol (4 mL) for 16 or CH2Cl2 (4 mL) for 
17 at rt for 2h, after which the mixture was filtered. UPy derivative (16-19: 4 (0.04 g, 0.06 
mmol), 21-24: 5 (0.04 g, 0.06 mmol), 26-29: 6 (0.05 g, 0.06 mmol)) was added to the filtrate 
and the mixture stirred overnight at rt. In case of MeOH, the solvent was evaporated and the 
residue was redissolved in CH2Cl2 (2 mL) and in the case of CH2Cl2 as solvent of reaction, 
the volume of the solvent was halved. Diethyl ether was added to precipitate the product, 
which was collected by filtration.   
 
 
 
16 
Yield = 23% (0.10 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.34 (d, 
3
JH-H = 5.8 Hz, 8H, H9), 7.32 (d, 
3
JH-H = 6.1 
Hz, 8H, H8), 7.17 (s, 8H, H18), 5.90 (s, 4H, H3), 5.80 (d, 
3
JH-H = 6.1 Hz, 8H, H12), 5.57 (d, 
3
JH-
H = 6.1 Hz, 8H, H11), 4.54 (s, 8H, H7), 2.79 (sept, 
3
JH-H = 4.8 Hz, 4H, H13), 2.57 (quint, 
3
JH-H = 
6.9 Hz, 8H, H2), 2.07 (s, 12H, H10), 1.64-1.71 (m, 8H, aliphatic chain), 1.26-1.31 (m, 88H, 
H14, aliphatic chain), 0.87 (t, 
3
JH-H = 6.0 Hz, 12H, H1). 
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13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 172.67; 170.71; 156.85; 154.31; 153.34; 
151.64; 137.30; 125.87; 123.68; 122.68; 119.49; 111.38; 105.27; 103.32; 98.97; 83.88; 82.91; 
41.42; 31.81; 31.65; 30.37; 29.29; 29.12; 28.83; 28.47; 26.36; 22.39; 21.27; 16.28; 13.40. 
 
MS (ESI(+)) = 1607.0 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 3.6 x 10
-6
 M): λmax = 306 nm (ε = 2.38 x 10
5
 M
-1
·cm
-1
), 434 nm (ε = 1.66 x 
10
5
 M
-1
·cm
-1), 639 nm (ε = 0.55 x 105 M-1·cm-1), 693 nm (ε = 0.62 x 105 M-1·cm-1) 
 
IR (KBr) (cm
-1
) = 3334 (s, NH); 1704 (s, NH); 1659 (s, NH); 1535 (s, NH); 1274 (s, CN). 
 
17 
Yield = 72% (0.12 g) 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 12.73 (s, 4H, H4), 11.98 (s, 4H, H5), 11.06 (t, 
3
JH-H = 
6.0 Hz, 4H, H6), 8.04-8.10 (m, 8H, H9), 7.30-7.37 (m, 8H, H8), 5.85-5.89 (m, 8H, H12), 5.74 
(s, 44H, H19), 5.63-5.69 (m, 8H, H11), 5.62 (s, 4H, H3), 4.38 (d, 
3
JH-H = 5.1 Hz, 8H, H7), 2.82 
(sept, 
3
JH-H = 5.6 Hz, 4H, H13), 2.44 (t, 
3
JH-H = 8.0 Hz, 8H, H2), 2.10 (s, 12H, H10), 1.55-1.62 
(m, 8H, aliphatic chain), 1.28-1.31 (m, 88H, H14, aliphatic chain), 0.88 (t, 
3
JH-H = 6.0 Hz, 12H, 
H1). 
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 183.53; 152.04; 128.57; 123.48; 122.43; 
117.00; 83.08; 81.53; 31.66; 31.34; 30.79; 29.07; 28.96; 28.82; 28.69; 28.34; 26.23; 23.05; 
22.11; 21.11; 16.99; 13.11. 
 
MS (ESI(+)) = 1557.1 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 2.0 x 10
-6
 M): λmax = 299 nm (ε = 3.64 x 10
5
 M
-1
·cm
-1), 496 nm (ε = 3.39 x 
10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3330 (s, NH); 1700 (s, NH); 1659 (s, NH); 1521 (s, NH); 1257 (s, CN) 
 
18 
Yield = 72% (0.12 g) 
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1
H NMR (400 MHz, CD3OD, ppm): δ = 8.24 (d, 
3
JH-H = 5.8 Hz, 8H, H9), 7.44 (d, 
3
JH-H = 6.0 
Hz, 8H, H8), 6.10 (d, 
3
JH-H = 6.1 Hz, 8H, H12), 5.91 (d, 
3
JH-H = 6.4 Hz, 12H, H11, H3), 4.55 (s, 
8H, H7), 2.90 (sept, 
3
JH-H = 5.6 Hz, 4H, H13), 2.48-2.53 (m, 8H, H2), 2.24 (s, 12H, H10), 1.62-
1.71 (m, 8H, aliphatic chain), 1.28-1.38 (m, 88H, H14, aliphatic chain), 0.87-0.90 (m, 12H, 
H1). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 152.22; 145.84; 135.10; 128.84; 126.16; 
122.66; 119.47; 117.30; 84.94; 83.21; 82.76; 79.88; 33.39; 31.65; 31.20; 29.34; 29.11; 23.33; 
22.41; 21.52; 19.92; 13.43; 13.38. 
 
MS (ESI(+)) = 1625.0 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 2.0 x 10
-6
 M): λmax = 324 nm (ε = 2.27 x 10
5
 M
-1
·cm
-1), 508 nm (ε = 2.27 x 
10
5
 M
-1
·cm
-1
) 
 
19 
Yield = 38% (0.08 g) 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 12.81 (s, 4H, H4), 12.06 (s, 4H, H5), 10.98 (s, 4H, 
H6), 8.29-8.38 (m, 8H, H9), 7.85-7.88 (m, 8H, H8), 5.66-5.81 (m, 12H, H3, H12), 5.48-5.55 (m, 
8H, H11), 4.43-4.55 (m, 8H, H7), 2.75-2.82 (m, 4H, H13), 2.37-2.42 (m, 8H, H2), 2.10 (s, 12H, 
H10), 1.50-1.62 (m, 8H, aliphatic chain), 1.23-1.36 (m, 88H, H14, aliphatic chain), 0.86 (t, 
3
JH-
H = 8.0 Hz, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 172.81; 170.59; 156.73; 154.38; 153.35; 
151.61; 151.56; 123.56; 122.67; 119.48; 105.33; 101.72; 97.36; 82.18; 81.58; 31.90; 31.63; 
30.88; 29.34; 29.24; 29.20; 29.08; 28.95; 28.64; 26.56; 22.38; 21.55; 21.43; 21.37; 21.24; 
17.23; 13.39. 
 
MS (ESI(+)) = 1507.1 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 383 nm (ε = 0.28 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3067 (s, NH); 1698 (s, NH); 1661 (s, NH); 1589 (s, NH); 1260 (s, CN). 
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21 
Yield = 46% (0.10 g) 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.18 (d, 
3
JH-H = 5.6 Hz, 8H, H9), 7.23-7.25 (m, 8H, 
H8), 7.15 (s, 8H, H19), 5.60 (d, 
3
JH-H = 6.1 Hz, 12H, H12, H3), 5.42 (d, 
3
JH-H = 6.0 Hz, 12H, 
H11), 3.30 (q, 
3
JH-H = 6.6 Hz, 4H, H16), 2.80-2.87 (m, 4H, H13), 2.77 (q, 
3
JH-H = 6.7 Hz, 4H, 
H7), 2.47-2.54 (m, 4H, H2), 2.07 (s, 12H, H10), 1.27-1.34 (m, 88H, H14, aliphatic chain), 0.89 
(t, 
3
JH-H = 6.5 Hz, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 172.56; 171.51; 170.62; 156.24; 155.86; 
154.50; 153.76; 153.00; 152.79; 152.21; 151.83; 151.65; 137.22; 136.83; 126.24; 126.05; 
125.89; 122.70; 119.51; 112.23; 111.62; 105.18; 103.20; 103.03; 99.11; 98.31; 84.06; 83.70; 
83.05; 82.76; 39.95; 34.45; 31.94; 31.71; 31.63; 30.40; 30.36; 29.42; 29.33; 29.23; 29.18; 
29.15; 29.07; 29.01; 28.72; 28.46; 26.39; 22.45; 22.39; 21.29; 21.11; 16.30. 
 
MS (ESI(+)) = 1635.1 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 2.8 x 10
-6
 M): λmax = 310 nm (ε = 2.56 x 10
5
 M
-1
·cm
-1), 435 nm (ε = 1.83 x 
10
5
 M
-1
·cm
-1), 644 nm (ε = 0.55 x 105 M-1·cm-1), 696 nm (ε = 0.58 x 105 M-1·cm-1) 
 
IR (KBr) (cm
-1
) = 3336 (s, NH); 1710 (s, NH); 1659 (s, NH); 1535 (s, NH); 1274 (s, CN). 
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22 
Yield = 65% (0.13 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.17 (d, 
3
JH-H = 5.8 Hz, 8H, H9), 7.38 (d, 
3
JH-H = 5.7 
Hz, 8H, H8), 6.01 (d, 
3
JH-H = 6.0 Hz, 4H, H12), 5.79 (d, 
3
JH-H = 6.1 Hz, 12H, H11, H3), 3.13-
3.23 (m, 8H, H16), 2.83-2.90 (m, 4H, H13), 2.57 (t, 
3
JH-H = 7.6 Hz, 8H, H7), 2.17 (s, 6H, H10), 
1.66-1.72 (m, 8H, aliphatic chain), 1.28-1.36 (m, 96H, H14, aliphatic chain), 0.90 (t, 
3
JH-H = 
6.5 Hz, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 153.78; 127.89; 123.44; 120.27; 84.79; 83.13; 
33.11; 32.60; 30.79; 30.54; 23.78; 22.54; 14.49. 
 
MS (ESI(+)) = 1585.1 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 2.2 x 10
-6
 M): λmax = 497 nm (ε = 2.23 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3421 (s, NH); 1524 (s, NH); 1257 (s, CN) 
 
23 
Yield = 53% (0.11 g) 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 11.74 (s, 4H, H5), 10.75 (s, 4H, H6), 8.12 (d, 
3
JH-H = 
5.9 Hz, 8H, H9), 7.30 (d, 
3
JH-H = 5.8 Hz, 8H, H8), 5.96 (d, 
3
JH-H = 6.3 Hz, 8H, H12), 5.76 (d, 
3
JH-H = 6.1 Hz, 8H, H11), 5.58 (s, 4H, H3), 3.06-3.15 (m, 8H, H16), 2.87 (sept, 
3
JH-H = 6.9 Hz, 
12H, H13, H7), 2.50 (t, 
3
JH-H = 7.6 Hz, 8H, H2), 2.10 (s, 12H, H10); 1.64-1.66 (m, 8H, aliphatic 
chain); 1.29-1.38 (m, 88H, H14, aliphatic chain), 0.90 (t, 
3
JH-H = 6.5 Hz, 12H, H1).  
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 152.23; 128.57; 126.27; 122.43; 119.24; 83.09; 
82.04; 31.36; 30.94; 29.07; 28.81; 28.76; 28.20; 26.13; 22.11; 21.05; 13.12. 
 
MS (ESI(+)) = 1653.0 [M-2Tf]
2+
 
 
UV-Vis (CH2Cl2, 2.1 x 10
-5
 M): λmax = 326 nm (ε = 2.20 x 10
5
 M
-1
·cm
-1), 509 nm (ε = 2.25 x 
10
5
 M
-1
·cm
-1
) 
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IR (KBr) (cm
-1
) = 3367 (s, NH); 1703 (s, NH); 1658 (s, NH); 1498 (s, NH); 1225 (s, CN). 
 
24 
Yield = 23% (0.09 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.41 (d, 
3
JH-H = 5.8 Hz, 8H, H9), 7.50 (d, 
3
JH-H = 5.8 
Hz, 8H, H8), 6.10 (s, 4H, H3), 5.80 (d, 
3
JH-H = 5.9 Hz, 8H, H12), 5.58 (d, 
3
JH-H = 5.9 Hz, 8H, 
H11), 3.58 (t, 
3
JH-H = 6.6 Hz, 8H, H16), 3.00 (t, 
3
JH-H = 6.7 Hz, 8H, H7), 2.84 (sept, 
3
JH-H = 6.9 
Hz, 4H, H13), 2.60 (t, 
3
JH-H = 7.7 Hz, 8H, H2), 2.13 (s, 12H, H10), 1.64-1.68 (m, 8H, aliphatic 
chain), 1.28-1.40 (m, 88H, H14, aliphatic chain), 0.90 (t, 
3
JH-H = 6.9 Hz, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 166.16; 152.41; 127.65; 126.40; 118.76; 102.01; 
97.31; 82.36; 80.46; 79.94; 77.48; 47.12; 46.90; 31.62; 29.28; 29.22; 29.14; 29.02; 28.93; 
22.29; 21.19; 21.15; 16.50; 12.99. 
 
MS (ESI(+)) = 1535.1 [M-2Tf]
2+
 
 
UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 383 nm (ε = 0.26 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3338 (s, NH); 1706 (s, NH); 1657 (s, NH); 1632 (s, NH); 1258 (s, CN). 
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26 
Yield = 21% (0.09 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.38 (s, 8H, H9), 7.40-7.44 (m, 8H, H8), 7.15-7.18 
(m, 8H, H18), 5.81-5.89 (m, 12H, H12, H3), 5.56-5.59 (m, 12H, H11, H7), 2.79 (sept, 
3
JH-H = 7.2 
Hz, 4H, H13), 2.46-2.52 (m, 8H, H2), 2.07 (s, 12H, H10), 1.46-1.63 (m, 20H, aliphatic chain, 
H17), 1.26-1.36 (m, 88H, H14, aliphatic chain), 0.86-0.91 (m, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 153.00; 138.56; 123.42; 123.03; 120.26; 
104.86; 100.85; 85.73; 83.95; 33.12; 33.08; 31.98; 30.73; 30.59; 30.49; 30.06; 23.80; 22.45; 
17.35; 14.52. 
 
MS (ESI(+)) = 1635.1 [M-2Tf]
2+
 
 
UV-Vis (CH2Cl2, 3.1 x 10
-6
 M): λmax = 434 nm (ε = 1.57 x 10
5
 M
-1
·cm
-1), 641 nm (ε = 0.51 x 
10
5
 M
-1
·cm
-1), 693 nm (ε = 0.51 x 105 M-1·cm-1)   
 
IR (KBr) (cm
-1
) = 3286 (s, NH); 1703 (s, NH); 1659 (s, NH); 1532 (s, NH); 1275 (s, CN) 
 
27 
Yield = 61% (0.12 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.21-8.26 (m, 8H, H9), 7.44-7.49 (m, 8H, H8), 5.93-
6.00 (m, 12H, H12, H3), 5.74-5.79 (m, 12H, H11, H7), 2.86 (sept, 
3
JH-H = 7.7 Hz, 4H, H13), 
2.47-2.53 (m, 4H, H2), 2.17 (s, 12H, H10), 1.52-1.66 (m, 20H, aliphatic chain, H17), 1.29-1.35 
(m, 88H, H14, aliphatic chain), 0.87-0.91 (m, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 185.48; 185.37; 154.15; 153.91; 153.85; 
126.52; 125.02; 123.35; 120.18; 117.01; 105.06; 105.01; 104.78; 102.66; 99.87; 99.67; 84.76; 
84.69; 83.58; 83.31; 83.18; 33.10; 33.07; 32.55; 30.79; 30.75; 30.66; 30.52; 30.49; 30.42; 
30.11; 28.49; 23.77; 22.56; 22.51; 21.72; 18.20; 18.15; 14.49. 
 
MS (ESI(+)) = 1585.1 [M-2Tf]
2+ 
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UV-Vis (CH2Cl2, 2.2 x 10
-6
 M): λmax = 298 nm (ε = 3.42 x 10
5
 M
-1
·cm
-1), 496 nm (ε = 3.07 x 
10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3293 (s, NH); 1700 (s, NH); 1658 (s, NH); 1523 (s, NH); 1257 (s, CN). 
 
28 
Yield = 57% (0.12 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.10-8.16 (m, 8H, H9), 7.38-7.40 (m, 8H, H8), 5.89-
5.92 (m, 12H, H12, H3), 5.73-5.77 (m, 8H, H11), 3.47-3.50 (m, 4H, H7), 2.86 (sept, 
3
JH-H = 6.0 
Hz, 4H, H13), 2.47-2.53 (m, 16H, H2, H16), 2.24 (s, 12H, H10), 1.24-1.56 (m, 96H, H14, 
aliphatic chain), 0.87-0.91 (m, 12H, H1). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 179.07; 153.80; 125.84; 125.34; 123.34; 
120.17; 105.42; 84.74; 83.97; 33.11; 32.71; 30.74; 30.55; 30.02; 28.50; 23.76; 22.52; 21.64; 
21.39; 18.20; 14.49. 
 
MS (ESI(+)) = 1652.9 [M-2Tf]
2+
 
 
UV-Vis (CH2Cl2, 2.3 x 10
-6
 M): λmax = 325 nm (ε = 2.31 x 10
5
 M
-1
·cm
-1), 506 nm (ε = 2.40 x 
10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3336 (s, NH); 1704 (s, NH); 1658 (s, NH); 1497 (s, NH); 1256 (s, CN). 
 
29 
Yield = 21% (0.09 g) 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 8.47 (d, 
3
JH-H = 6.1 Hz, 8H, H9), 7.55 (d, 
3
JH-H = 6.0 
Hz, 8H, H8), 5.80-5.82 (m, 12H, H12, H3), 5.57 (d, 
3
JH-H = 6.0 Hz, 8H, H11), 2.86 (sept, 
3
JH-H = 
6.4Hz, 12H, H13, H7), 2.52-2.61 (m, 8H, H2), 2.29 (s, 12H, H10), 1.52-1.63 (m, 20H, H17, 
aliphatic chain), 1.28-1.40 (m, 88H, H14, aliphatic chain), 0.88-0.91 (m, 12H, H1). 
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13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 154.25; 143.13; 125.92; 124.68; 123.38; 
120.21; 103.59; 98.79; 83.79; 82.16; 81.18; 78.95; 33.07; 32.34; 30.73; 30.58; 30.48; 30.35; 
30.04; 28.55; 23.74; 22.67; 22.65; 17.94; 14.46. 
 
MS (ESI(+)) = 1535.1 [M-2Tf]
2+ 
 
UV-Vis (CH2Cl2, 1.0 x 10
-5
 M): λmax = 387 nm (ε = 0.28 x 10
5
 M
-1
·cm
-1
) 
 
IR (KBr) (cm
-1
) = 3276 (s, NH); 1660 (s, NH); 1633 (s, NH); 1242 (s, CN) 
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3.1 Introduction 
3.1.1 Anthracene 
Tricyclic aromatic hydrocarbon, anthracene, consists of a π electron cloud overlap that gives 
the molecule semiconductor properties. Anthracene is hence used as organic semiconductors 
for applications in organic solar cells and display devices like OLED (organic light-emitting 
diode).
[75]
 In the anthracene molecule, the 14 carbon atoms are not equivalent, with the “9” 
and “10” positions being the most reactive ones and therefore undergoing facile electrophilic 
substitutions. For instance, oxidation of anthracene gives anthraquinone, which is the starting 
material for the production of a large spectrum of dyes and pigments. Furthermore, 9,10-
dibromoanthracene is one of the most common reactants employed to introduce the 
anthracene moiety in a molecule. With the availability of two reactive sites, 9,10-
dibromoanthracene can undergo a number of organic transformations by reactions such as 
Suzuki coupling,
[76]
 click
[77]
 and Sonogashira coupling.
[78]
 
 
3.1.2 Suzuki Coupling Reaction  
In 1979, Suzuki and co-workers published the successful cross coupling reaction of 1-
alkenylboranes with 1-alkenyl halides, which had never been achieved before.
[79]
 This 
process, later termed the Suzuki coupling, is the reaction of organohalides or related 
electrophiles with organoboron reagents (Scheme 3.1). The coupling reaction was made 
possible by two important factors: (1) the use of palladium catalyst and (2) the introduction of 
a base in the reaction medium. Many Pd(0) catalysts have been used for Suzuki coupling 
reaction; Pd(PPh3)4, PdCl2(PPh3)2 and Pd(OAc)2 with PPh3 being among the most common. 
The role played by the base is crucial because it speeds up the reaction and without a base, the 
reaction cannot occur. Hence, the choice of the appropriate base is fundamental for the 
success of the coupling reaction.
[79a]
 Moreover, it has been found that different halides give 
different reactivities since the relative reactivity of the halides decreases in the order: I > Br > 
Cl.
[80]
  
 
Suzuki coupling reaction provides many advantages that make it a crucial step in organic 
chemistry laboratories, including industries. The reaction is relatively simple, with readily 
available reagents, and is run under mild conditions. Furthermore, it is insensitive to the 
presence of water, highly tolerant of many functional groups on either coupling partners and 
is high yielding.
[79, 80b, 81]
 This straightforward methodology for various C-C bond formation is 
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also regio- and stereoselective, and all kinds of C-B bonds have been proven to undergo 
coupling reactions, including (sp
3
)C-B, (sp
2
)C-B and (sp)C-B bonds.
[81]
 
 
Experiments were carried out on the coupling reaction of alkenyl boranes and organohalides 
to study the mechanism of the reaction and a possible one was proposed as follows (Scheme 
3.1):
[82]
 
 Step A: oxidative addition of the organic halide to the Pd(0) catalyst to generate 
Pd(II)R′′X 
 Step B: addition of a sodium alkoxide or hydroxide, resulting in the metathetical 
displacement of the halide ion from Pd(II)R′′X to form an alkoxo- or 
hydroxopalladium(II) complex, Pd(II)R′′OR′ 
 Step C: transmetalation of Pd(II)R′′OR′ with the alkenyl borane occurs, giving 
Pd(II)R′′R  
 Step D: reductive elimination of Pd(II)R′′R giving the cross coupling product R′′R 
and the catalyst is regenerated. 
 
During the different steps, there is retention of configuration for alkenyl halide but in the case 
of allylic and benzylic halides, inversion of configuration occurs.
[80a, 82]
 
 
 
Scheme 3.1 Mechanism between alkenyl boranes (R‒B(CH3)2)and organic halides (R′′‒X) 
catalysed by Pd(0) complexes and bases (NaOR′) 
 
Suzuki coupling reaction was used to functionalise anthracene derivatives. One example is the 
synthesis of 9,10-bis(1,2-diphenylstyryl)anthracene (BDSA) and 9,10-bis(4′-
triphenylsilylphenyl)anthracene (BTSA), which contain anthracene as the main backbone and 
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1,2-diphenylstyryl or tetraphenylsilane as side units (Figure 3.1). BDSA and BTSA were used 
as blue-light emitting materials for deep blue OLEDs and one of the deepest blue for pure-
blue emission was reported for OLEDs by these materials.
[76b]
  
 
 
Figure 3.1 Structures of blue-light materials BDSA and DTSA 
 
3.1.3 Click Chemistry 
Click chemistry, termed by Sharpless et al. in 2001, is the assembly of two small units with 
heteroatom links; the reaction is versatile, efficient, high yielding with simple purification 
methods, stereospecific and conducted in easily removable solvents.
[83]
 Among the diverse 
examples of such reactions, Cu(I)-catalysed Huisgen 1,3-dipolar cycloaddition of azides and 
alkynes is one of the prime ones of click reaction.
[84]
 This reaction has drawn considerable 
attention because of the many advantages associated with it as compared to the thermal 
Huisgen reaction that requires elevated temperatures and is non-regioselective. Thus, on one 
hand, when the Cu-catalysed reaction is run under mild conditions it produces exclusively 
1,4-disubstituted triazoles.
[85]
 On the other hand, click reactions catalysed by Ru complexes 
give the 1,5-disubstituted regioisomer.
[86]
 
 
Cu(I) catalysis has shown to boost the azide-alkyne cycloaddition reaction by being a fast, 
robust and regioselective method of synthesizing triazoles.
[87]
 Three sources of Cu(I) can be 
employed: (1) Cu(I) salts, (2) Cu(II) salts with a reducing agent and (3) oxidation of Cu(0) to 
Cu(I). Cu(II) salts are preferred because when used with a slight excess of the reducing agent, 
high level of Cu(I) is maintained at all times. One of the most common catalytic systems used 
is CuSO4/sodium ascorbate because of the easy workup and the higher purity of the starting 
material.
[87-88]
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The important features of click chemistry have made it useful in many fields and the reaction 
has found applications in supramolecular chemistry, medicinal chemistry and in making 
polymers, dendrimers and other complex structures.
[89]
 Moreover, obtaining highly 
functionalised 1,2,3-triazoles has given this heterocyclic scaffold various biological 
applications as well as in supramolecular and coordination chemistries.
[84a]
  
 
Many research groups have been working on understanding the mechanistic pathway of the 
Cu-catalysed azide-alkyne cycloaddition reaction. Combining computational and 
experimental studies, the mechanism can be suggested to proceed as described below 
(Scheme 3.2):
[84a]
 
Step A: Cu(I) undergoes π coordination with alkyne, increasing the CH acidity 
Step B: the rise in acidity allows the formation of a σ-coordinated Cu(I) acetylide alkyne and 
DFT calculations show that a second Cu(I) remains coordinated to the triple bond 
Step C: coordination of an azide at the π-coordinated Cu(I) centre occurs 
Step D: oxidative coupling 
Step E: ring contraction and Cu(I)-bound exhaustion via reductive elimination 
Step F: protonolysis of Cu(I) triazolide releasing free triazole and regenerating the Cu(I) 
catalyst 
 
 
Scheme 3.2 Proposed mechanism of the copper catalysed azide-alkyne cycloaddition reaction. 
 
α β
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Even if only few examples of click reaction in the chemistry of anthracene exist in literature, 
there are some interesting ones. For instance, a novel anthracene-based anion receptor was 
synthesised by click reaction done on 9-anthracenylmethyl azide with 5-tert-butyl-1,3-
diethynylbenzene with (EtO3)P3·CuI as catalyst, followed by alkylation with 
trimethyloxonium tetrafluoroborate (Figure 3.2). The receptor, bearing two triazolium groups, 
is the first reported example of fluorescent triazolium receptor for anions.
[77b]
 
 
 
Figure 3.2 Anthracene-based anion receptor 
 
3.1.4 Sonogashira Coupling Reaction 
Sonogashira coupling reaction, discovered in 1975 by Sonogashira, Tohda and Hagihara, is a 
palladium catalysed sp
2
-sp coupling reaction between aryl or alkenyl halides or triflates and 
terminal alkynes, with or without Cu(I) co-catalyst in an amine solvent.
[90]
 Being one of the 
most popular ways of alkynylating aryl or alkenyl halides, Sonogashira coupling has been a 
crucial method in organic chemistry. In typical Sonogashira reactions, Cu(I) salts are used as 
co-catalyst as they accelerate the reaction by taking part in transmetalation of the alkynes, 
hence increasing the reactivity of the system, which allows room temperature alkynylation to 
take place. Yet, some shortcomings are associated with Cu(I) salts, one of which is the 
homocoupling of the terminal alkynes. In order to avoid the undesirable formation of the 
homocoupled products, the reaction has to be carried out in an oxygen-free atmosphere.
[91]
  
 
Some of the traditionally employed catalysts for the Sonogashira coupling reaction are the 
triphenylphosphane-based complexes Pd(PPh3)4 and Pd(PPh3)2Cl2 and the bidentate ligand-
based complexes like Pd(dppe)Cl2.
[91c]
 Hence, a broad spectrum of catalytical systems have 
been developed for this coupling reaction: (1) copper-free,
[92]
 (2) ligand-free Pd species,
[93]
 (3) 
non-Pd-based catalysts
[94]
 and (4) non-Cu-based co-catalysts.
[95]
 In spite of the wide range of 
catalytical systems and reaction conditions evaluated, the typical Sonogashira coupling 
conditions with Cu(I) co-catalyst are almost exclusively applied for all types of synthetic 
processes.
[91c]
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Even though the exact mechanism of the Sonogashira coupling with Pd/Cu catalytic system 
has not yet been fully understood, a possible one was established, proceeding via the “Pd-
cycle” and the “Cu-cycle” (Scheme 3.3). The catalytically active Pd(0)L2 species is first 
formed from either Pd(0) or Pd(II) complexes through the intermediate formation of a 
Pd(II)L2(C≡CR′′)2 species that undergoes reductive elimination, generating Pd(0)L2 and 
diyne.
[96]
 Also, the reduction of Pd(II) to Pd(0) can be made possible by amines via the 
formation of iminium cations.
[97]
 Once the activated catalyst is obtained, the mechanistic 
cycle is ready to start: 
Step A: oxidative addition of the aryl or alkenyl halide to form Pd(II)R′L2X 
Step B: transmetalation of Pd(II)R′L2X with a copper acetylide formed in the “Cu-cycle” into                     
Pd(II)L2R′ (C≡CR′′) 
Step C: cis/trans isomerization 
Step D: reductive elimination to form the desired alkyne with regeneration of the catalyst. 
 
 
Scheme 3.3 Proposed mechanism for typical Pd/Cu catalysed Sonogashira coupling reaction 
 
The oxidative addition is the rate determining step and the reactivity of different sp
2
 species 
were found to vary: alkenyl substrates are more reactive than aryls and the halides affect the 
reactivity in the general order of reactivity of: RI > RBr > RCl. Furthermore, the base is 
believed to take part in the “Cu-cycle” in the formation of the copper acetylide. The base 
helps in the π-alkyne copper complex by making the alkyne terminal proton more acidic.[91b]  
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Sonogashira coupling has been used in the functionalisation of anthracene molecules for 
different applications.
[78]
 One example is the synthesis of oligomers consisting of anthracene 
core unit and 4-alkylethynylbenzene end-capper (Figure 3.3). These oligomers show good 
thermal stability and high oxidation potentials, making them good candidates for organic 
field-effect transistors (OFETs) that are used in low-cost electronic devices and for their 
integrated circuits.
[98]
  
 
 
Figure 3.3 4-Alkylethynylbenzene end-capped oligomers of anthracene 
 
3.2 Aim 
Anthracene can be used as the backbone for macromolecules because of the ease of 
functionalising the molecule. Hence, the introduction of dendrimers was envisaged onto 
anthracene in order to produce bis-functional anthracene-core dendrimers. Since the 
anthracene core is aromatic and planar, it can take part in π-π interactions making 
encapsulation into cages possible. Thus, the goal of the project is to synthesise anthracene-
core dendrimers, to encapsulate them into arene-Ru cages, to study their interactions with the 
cages and to evaluate any potential anticancer activities of the organic molecules and the 
encapsulated systems. 
 
3.3 Synthesis 
3.3.1 Synthesis of Anthracene Compounds 
The first step is a Suzuki coupling reaction on a 9,10-dibromoanthracene that was first reacted 
with 4-hydroxyphenylboronic acid in the presence of Pd(PPh3)4 and sodium carbonate in dry 
THF under reflux overnight (Scheme 3.4). After purification by extraction and column 
chromatography, the mono-functionalised product 32 was isolated as a yellow solid. Since 
double functionalisation could not be done in one step, compound 32 was reacted under the 
same conditions as the previous reaction to afford the disubstituted product 33 that was 
obtained as a yellow fluorescent solid. 
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The mono- and disubstituted compounds, 32 and 33, were esterified with 4-pentynoic acid in 
the presence of N,N′-dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino)pyridinium p-
toluenesulfonate (DPTS) in dry CH2Cl2 to give the mono- and diester 34 and 35, 
respectively.
[99]
 Compound 35 was obtained in a low yield since the monoester was also 
formed during the reaction (Scheme 3.4). Compounds 32-35 were all found to readily undergo 
degradation and were therefore kept in the dark and at reduced temperatures. Because of the 
problem occurring during the following step of the reaction, as will be discussed in section 
4.3.2 below, modifications had to be brought to the structure of the molecule.  
 
 
Scheme 3.4 Synthesis of mono- and disubstituted anthracene compounds 34 and 35. Reagents 
and conditions: i. 4-hydroxyphenylboronic acid, Pd(PPh3)4, Na2CO3, THF, reflux, 16h, 32: 
66%, 33: 62%, ii. DCC, DPTS, CH2Cl2, 0°C to rt, 16h, 34: 80%, 35: 21% 
 
The second series of ligand was synthesised by functionalising anthraquinone instead of 9,10-
dibromoanthracene as described in Scheme 3.5. The first step involves the protection of the 
alcohol group of 4-pentyn-1-ol with tert-butyldimethylsilyl chloride (TBDMSCl) in the 
presence of triethylamine to give 36 as a colourless liquid.
[100]
 Upon addition of n-
butyllithium (n-BuLi) to a solution of 36 in dry THF at 0°C, the solution turned from 
colourless to slightly yellow, forming a pentynyllithium intermediate. Anthraquinone was 
then added to the mixture and the solution turned rust-colour. After overnight stirring, wet 
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THF and stannous chloride (SnCl2·2H2O) were added and deoxygenation took place.
[101]
 The 
dipentynyl substituted anthracene product 37 was isolated clean after extraction and two 
column chromatographies. Deprotection of the alcohol groups on 37 using 
tetrabutylammonium fluoride (TBAF) in THF from 0°C to room temperature results in diol 
38, purified by extraction and column chromatography (Scheme 3.5).
[102]
  
 
 
Scheme 3.5 Synthesis of compound 39. Reagents and conditions: i. TBDMSCl, NEt3, CH2Cl2, 
rt, 16h, 80%, ii. 
n
BuLi, SnCl2·2H2O, THF, rt, 16h, 80%, iii. TBAF, THF, 0°C to rt, 2h, 70%, 
iv. EDC, DPTS, CH2Cl2, 0°C to rt, 16h, 76% 
 
Esterification of 38 with pentynoic acid in the presence of N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide (EDC) and DPTS in dry CH2Cl2 gave diester 39, which was isolated by 
extraction, column chromatography and recrystallization from heptane. A Huisgen 1,3-dipolar 
cycloaddition click reaction was then run on 39, bearing two terminal alkyne groups, with a 
dendron having a terminal azide group, SG110 (SG110, compound synthesised by Sebastiano 
Guerra) using CuSO4/sodium ascorbate catalytic system in THF/H2O mixture (Scheme 
3.6).
[83, 84b, 84c, 84e, 85, 87-88]
 Reaction was run overnight, at room temperature, with the reaction 
mixture changing from yellow to pale yellow with blue deposit. After extraction, column 
        Chapter 3: Encapsulation of Anthracene-Core Dendrimers into Arene-Ru Metallo-Cycles 
 
80 
 
chromatography and recrystallization from acetone, the yellow product 40 was isolated in 
high yield. 
 
 
Scheme 3.6 Synthesis of compound 40. Reagents and conditions: i. CuSO4, NaAsc, 
THF/H2O, rt, 16h, 90% 
 
As will be shown by the 
1
H NMR data in section 3.4.1 below, compound 40 is very unstable 
and degradation takes place during the purification process. Two possible reasons for the 
degradation of the compound are: (1) the endoperoxide formation
[103]
 or (2) the 
photodimerization of the anthracene,
[104]
 both occurring at the 9 and 10 positions (Figure 3.4). 
The reason behind the degradation is the labile double bonds at these two positions of the 
anthracene. Even though the alkyne groups are supposed to stabilise these positions,
[105]
 
degradation of the compound appears to be inevitable for this particular system.  
 
 
Figure 3.4 Structure of photodimer and endoperoxide from anthracene 
 
To avoid the above problem, another anthracene core was chosen that does not possess any 
labile double bonds at the 9 and 10 positions. Therefore, anthraquinone, being a good 
substitute for anthracene, was used as starting material. Substitution of both amine groups by 
bromides on the anthraquinone derivatives was first carried out successfully using CuBr2 and 
        Chapter 3: Encapsulation of Anthracene-Core Dendrimers into Arene-Ru Metallo-Cycles 
 
81 
 
tert-butyl nitrite (
t
BuONO) in refluxing acetonitrile for 2h (Scheme 3.7).
[106]
 Compound 41 
was obtained as a yellow powder and was used for the next step, which is a Sonogashira 
coupling with 36 using a Pd(PPh3)4/CuI catalytic system in NEt3/CH2Cl2 (3:1 ratio) at 60°C 
overnight. After column chromatography and washing the solid with warm methanol, clean 
product 42 was obtained in a good yield. The deprotection of the TBDMS group by TBAF 
with and without the use of acetic acid did not give the diol. Another attempt was made by 
direct Sonogashira coupling of 41 with a bismesogenic compound (RH) bearing a terminal 
alkyne, but isolation of the pure product failed after several column chromatographies 
(Scheme 3.7). Efforts made to recrystallise the pure products also failed due to rapid 
degradation of the compounds. 
 
 
Scheme 3.7 Synthesis of 2,6-disubstituted anthracene compound 42. Reagents and conditions: 
i. 
t
BuONO, CuBr2, CH3CN, reflux, 2h, 70%, ii. Pd(PPh3)4, CuI, NEt3/CH2Cl2 (3:1), 60°C, 16h, 
83%, iii. TBAF, acetic acid, THF, 0°C to rt 
 
3.3.2 Carceplex Assemblies 
Since the anthracene-core is the part that should get encapsulated in the cage, reactions to 
encapsulate the mono- and disubstituted anthracene derivatives 32-35 were carried out 
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(Scheme 3.8). The reactions involved the carceplex assemblies, whereby the naphthoquinone 
Ru clip derivative, 11 (see Chapter 2 section 2.2.2) was first mixed with silver triflate in 
methanol for 2h. Mixture was then filtered and the spacer ligands, 2,4,6-tri(pyridine-4-yl)-
1,3,5-triazine (tpt) or 1,2-bis(4-pyridyl)ethylene (dpe), and the guest molecule were added to 
the mixture and heated under reflux overnight for two days. After workup, it was found that 
encapsulation by carceplex of the first series of ligands failed, most probably due to the 
geometry of the molecule. The phenyl rings on either side of the anthracene core are believed 
to be perpendicular to the anthracene plane, therefore causing obstruction when attempting to 
build a cage around the molecule.  In the second series of ligands, encapsulation of 37-39 was 
not possible into both hexanuclear (metallo-prism) and tetranuclear (metallo-rectangle) Ru 
cages because of the rapid degradation of the molecules. Since the degradation into either the 
endoperoxide or the photodimer disrupts the planarity of the molecules, entrapment into the 
cages becomes difficult.  
 
 
Scheme 3.8 Encapsulation of guest molecules 32-35, 37-39 into tetra- and hexanuclear Ru 
cages. Reagents and conditions: i. AgCF3SO3, guest (32-35, 37-39), MeOH, reflux, 2 days 
 
 
 
 
        Chapter 3: Encapsulation of Anthracene-Core Dendrimers into Arene-Ru Metallo-Cycles 
 
83 
 
3.4 Characterization 
3.4.1 Proton NMR Spectroscopy 
Comparing 34 to 35, a major upfield shift of H1 proton from 8.60 to 7.69 ppm can be observed 
as a result of substitution of the bromide with a phenol group (Figure 3.5). Moreover, in 34, 
H1 protons appear as a doublet while in 35, the same peak is doublet of doublets, due to the 
change in symmetry, as seen in Figure 3.5. On the other hand, when an alkyne group is 
attached to the anthracene instead of the phenol, the peak of the H1 protons undergoes a 
downfield shift. Hence, H1 protons in compound 35 appear at 7.70 ppm and are visible at 8.55 
ppm in 38. Also a slight upfield shift from 8.60 to 8.55 ppm is observed when comparing H1 
protons of compounds 34 and 38 caused by the replacement of the bromide by an alkyne 
group (Figure 3.5).  
 
 
Figure 3.5 
1
H NMR spectra (400 MHz, CD2Cl2) of 34, 35 and 38 
 
In the case of compound 40, an unexpected phenomenon is observed from the different 
1
H 
NMR spectra measured at different time intervals (Figure 3.6). The relative integrations of the 
peaks of the anthracene moiety to those of the dendron moiety were found to change with 
time. For instance, comparing H1 to H15 protons, the relative integrations for the peaks are 
changing, with the intensity of the H1 proton decreasing with time (Figure 3.6). The change is 
35
34
38
H1
H1
H1
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clearly seen for the aromatic protons. However, the aliphatic protons are more difficult to 
compare because of the poor resolution of the peaks. 
 
 
Figure 3.6 
1
H NMR spectra (400 MHz, CDCl3) of 40 at different time intervals 
 
3.5 Conclusion 
Suzuki coupling, click and Sonogashira coupling reactions have been employed successfully 
in functionalising anthracene derivatives under typical reaction conditions. The Suzuki 
coupled products, which were the most stable anthracene derivatives synthesised, did not 
possess the correct geometry for encapsulation in the arene-Ru cages used. The click product 
showed very low stability, as was observed by the 
1
H NMR spectroscopy and hence could not 
be used for encapsulation. Sonogashira coupling reaction on 41 gave the desired product 42, 
but failure to deprotect the alcohol groups prevented further steps of the synthesis to be 
carried out. Therefore it can be concluded that anthracene-core dendrimers could not be 
synthesised due to stability problems and the reactions might be successful provided the 
environment under which the reactions are carried out is completely inert and oxygen-free.  
 
 
t > 2 weeks
t = 1 week
t = 1 day
t = 1h H1
40
H15
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3.6 Experimental Part 
 
32 
An aqueous solution of Na2CO3 (2M, 20 mL) was added to a THF solution of 9,10-
dibromoanthracene (0.10 g, 0.30 mmol) under argon. 4-Hydroxyphenylboronic acid (0.08 g, 
0.60 mmol) and Pd(PPh3)4 (0.06 g, 0.06 mmol) were added to the mixture and stirred under 
reflux. After overnight reaction, the mixture was allowed to cool to rt, then diethyl ether (40 
mL) was added and brine was used to wash the mixture. The organic layer was washed with 
water and dried over MgSO4. The crude product obtained after evaporation of solvent was 
purified by CC (eluent CH2Cl2). 32 was obtained as a yellow powder with a yield of 66% 
(0.07 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.59 (dt, 
3
JH-H = 8.9 Hz, 
4
JH-H = 1.0 Hz, 2H, H1), 7.71 
(dt, 
3
JH-H = 8.8 Hz, 
4
JH-H = 1.0 Hz, 2H, H4), 7.59 (ddd, 
3
JH-H = 8.8, 6.5 Hz, 
4
JH-H = 1.2 Hz, 2H, 
H2), 7.38 (ddd, 
3
JH-H = 8.8, 6.5 Hz, 
4
JH-H = 1.2 Hz, 2H, H3), 7.28 (d, 
3
JH-H = 8.6 Hz, 2H, H5), 
7.06 (d, 
3
JH-H = 8.6 Hz, 2H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 155.19; 137.49; 132.45; 131.39; 130.68; 130.29; 
127.87; 127.44; 126.94; 125.50; 122.63; 115.41. 
 
MS (ESI(-)): 349.0 [M-H]
- 
 
 
33 
32 (0.17 g, 0.50 mmol), Na2CO3 (2M, 20 mL), 4-hydroxyphenylboronic acid (0.23 g, 1.00 
mmol) and Pd(PPh3)4 (0.11 g, 0.10 mmol) were reacted in dry THF (80 mL) following similar 
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procedure as for 32. After purification on two CC (eluent CH2Cl2/EtOAc 10/0.5), 33 was 
obtained as a yellow powder with a yield of 62% (0.11 g). 
 
1
H NMR (400 MHz, CD3OD, ppm): δ = 7.68 (dd, 
3
JH-H = 6.8 Hz,
 4
JH-H = 3.3 Hz, 4H, H1), 
7.29 (dd, 
3
JH-H = 6.9 Hz, 
4
JH-H = 3.3 Hz, 4H, H2), 7.21-7.24 (m, 4H, H5), 7.03-7.06 (m, 4H, 
H6). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 158.17; 138.21; 133.40; 131.65; 131.19; 
128.01; 125.81; 116.35. 
 
MS (ESI(+)): 362.3 [M+H]
+ 
 
 
34 
To a solution of 32 (0.10 g, 0.30 mmol) and 4-pentynoic acid (0.03 g, 0.30 mmol), in dry 
CH2Cl2 (50 mL) at 0°C, were added DCC (0.29 g, 1.40 mmol) and DPTS (0.08 g, 0.30 
mmol). The mixture was stirred under argon, with the temperature rising gradually to rt. After 
overnight stirring, the solvent was evaporated and the crude product was purified on CC 
(eluent CH2Cl2/heptane 10/3.8). 34 was obtained as a shiny pale yellow solid with a yield of 
80% (0.99 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.60 (dt, 
3
JH-H = 8.9 Hz, 
4
JH-H = 1.0 Hz, 2H, H1), 7.67 
(dt, 
3
JH-H = 8.8 Hz, 
4
JH-H = 1.0 Hz, 4H, H4, H5), 7.34-7.45 (m, 6H, H2, H3, H6), 2.90 (t, 
3
JH-H = 
7.3 Hz, 2H, H7), 2.67 (td, 
3
JH-H = 7.4 Hz, 
4
JH-H = 2.7 Hz, 2H, H8), 2.12 (t, 
3
JH-H = 2.6 Hz, 1H, 
H9). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 170.72; 150.80; 137.21; 136.28; 132.54; 
131.46; 130.57; 128.07; 127.59; 127.46; 126.14; 123.09; 122.08; 82.60; 69.53; 33.94; 14.80. 
 
MS (ESI(+)): 453.1 [M+Na]
+ 
        Chapter 3: Encapsulation of Anthracene-Core Dendrimers into Arene-Ru Metallo-Cycles 
 
87 
 
 
35 
To a stirring solution of 33 (0.10 g, 0.20 mmol) and 4-pentynoic acid (0.05 g, 0.50 mmol) in 
dry CH2Cl2 (50 mL) at 0°C, were added EDC (0.23 mL, 1.30 mmol) and DPTS (0.08 g, 0.20 
mmol). After overnight stirring with the temperature rising gradually to rt, the reaction 
mixture was washed three times with water. The organic phase was dried over MgSO4 and the 
solvent removed. Purification was done by CC (eluent CH2Cl2/heptane 10/3.8) and 35 was 
obtained as a shiny pale yellow solid with a yield of 21% (0.02 g).    
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 7.69 (dd, 
3
JH-H = 6.8 Hz, 
4
JH-H = 3.3 Hz, 4H, H1), 
7.54-7.50 (m, 4H, H5), 7.37-7.42 (m, 8H, H2, H6), 2.91 (t, 
3
JH-H = 7.1 Hz, 4H, H7), 2.73 (td, 
3
JH-H = 7.3 Hz, 
4
JH-H = 2.7 Hz, 4H, H8), 2.12 (t, 
3
JH-H = 2.7 Hz, 2H, H9). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 170.76; 150.64; 136.94; 136.66; 132.68; 
130.32; 127.13; 125.63; 122.05; 82.62; 69.50; 33.95; 14.81. 
 
MS (ESI(+)): 545.3 [M+Na]
+ 
 
 
36 
To a solution of 4-pentyn-1-ol (1.3 mL, 14.00 mmol), DMAP (0.08 g, 0.70 mmol) and 
triethylamine (2.38 mL, 16.80 mmol) in dry CH2Cl2 (100 mL), was added dropwise a solution 
of TBDMSCl (2.52 g, 16.80 mmol) in dry CH2Cl2 (50 mL). The mixture was stirred under 
argon at rt. After overnight reaction, extraction was done three times with brine. The aqueous 
layer was then washed three times with heptane. The combined organic phase was dried over 
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MgSO4 and the solvent removed. The crude product was purified by CC (eluent 
heptane/CH2Cl2 10/5) and 36 was obtained as a colourless liquid with a yield of 80% (2.21 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 3.70 (t, 
3
JH-H = 6.1 Hz, 2H, H5), 2.27 (td, 
3
JH-H = 7.1 
Hz, 
4
JH-H = 2.7 Hz, 2H, H3), 1.92 (t, 
3
JH-H = 2.7 Hz, 1H, H1), 1.74 (quint, 
3
JH-H = 7.1 Hz, 2H, 
H4), 0.89 (s, 9H, H7), 0.05 (s, 6H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 68.24; 61.47; 50.89; 31.53; 25.94; 14.85; -5.34. 
 
MS (ESI(+)): 419.8 [2M+Na]
+ 
 
 
37 
To a solution of 36 (2.38 g, 12.00 mmol) in dry THF (75 mL) at 0°C under argon was added 
an excess of 
n
BuLi (5.5 mL, 13.75 mmol) through a septum. The mixture was stirred at 0°C 
for 20 min during which the reaction mixture changed colour from colourless to slightly 
yellow. Anthraquinone (0.41 g, 2.00 mmol) was then added to the mixture and stirring was 
continued at rt overnight. The solution turned rust-red in colour upon the addition of 
anthraquinone. Wet THF (25 mL) was added after overnight stirring, followed by 
SnCl2·2H2O (0.90 g, 4.00 mmol). The mixture was further stirred for 30 min. After the 
reaction was over, the mixture was poured into hexane and extraction was done two times 
with 10% HCl and four times with water. The organic layer was dried over MgSO4 and the 
solvent evaporated. Purification by two CC (eluent heptane/CH2Cl2 10/5) gave 37 as a 
colourless liquid with a yield of 80% (0.91 g). 
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1
H NMR (400 MHz, CDCl3, ppm): δ = 8.55 (dd, 
3
JH-H = 6.7 Hz, 
4
JH-H = 3.3 Hz, 4H, H1), 7.54 
(dd, 
3
JH-H = 6.7 Hz, 
4
JH-H = 3.3 Hz, 4H, H2), 3.91 (t, 
3
JH-H = 6.1 Hz, 4H, H5), 2.85 (t, 
3
JH-H = 
7.0 Hz, 4H, H3), 2.02 (quint, 
3
JH-H = 6.7 Hz, 4H, H4), 0.94 (s, 18H, H7), 0.11 (s,12H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 132.25; 127.50; 126.46; 102.30; 97.43; 77.95; 
62.50; 31.90; 31.52; 25.94; 16.81.  
 
MS (ESI(+)): 593.9 [M+Na]
+ 
 
 
38 
 To a solution of 37 (1.35 g, 2.30 mmol) in THF (80 mL) at 0°C, was added an excess of 
TBAF (15 mL, 48.00 mmol). The mixture was stirred at rt for 2h and the solvent was 
evaporated. The residue was dissolved in CH2Cl2 and extraction was done with brine and 
saturated NH4Cl solution. The organic phase was dried over MgSO4 and the solvent 
evaporated. Purification of the crude product by CC (eluent CH2Cl2/EtOAc 10/2) resulted in 
38, a yellow solid obtained with a yield of 70% (0.57 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.54 (dd, 
3
JH-H = 6.7 Hz, 
4
JH-H = 3.3 Hz, 4H, H1), 7.55 
(dd, 
3
JH-H = 6.7 Hz, 
4
JH-H = 3.3 Hz, 4H, H2), 3.98 (t, 
3
JH-H = 6.2 Hz, 4H, H5), 2.90 (t, 
3
JH-H = 
7.0 Hz, 4H, H3), 2.09 (quint, 
3
JH-H = 6.7 Hz, 4H, H4). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 132.16; 127.20; 126.46; 102.28; 97.42; 77.90; 
61.97; 31.82; 16.84. 
 
MS (ESI(+ )): 365.5 [M+Na]
+ 
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39 
38 (0.47 g, 1.36 mmol), 4-pentynoic acid (0.39 g, 4.00 mmol), EDC (1.18 mL, 6.80 mmol) 
and DPTS (0.43 g, 1.36 mmol) were reacted in dry CH2Cl2 (100 mL) following the same 
procedure as 39. Purification was done by CC (eluent CH2Cl2/EtOAc 10/2) giving 39 as a 
yellow powder with a yield of 76% (0.52 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.52 (dd, 
3
JH-H = 6.6 Hz, 
4
JH-H = 3.2 Hz, 4H, H1), 7.56 
(dd, 
3
JH-H = 6.6 Hz, 
4
JH-H = 3.2 Hz, 4H, H2), 4.42 (t, 
3
JH-H = 6.3 Hz, 4H, H5), 2.88 (t, 
3
JH-H = 
7.0 Hz, 4H, H3), 2.53-2.61 (m, 8H, H8, H9), 2.17 (quint, 
3
JH-H = 6.7 Hz, 4H, H4), 1.99 (t, 
3
JH-H 
= 2.4 Hz, 2H, H10). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 171.79; 132.15; 127.18; 126.53; 118.39; 101.49; 
82.47; 78.13; 69.14; 63.63; 33.42; 28.23; 17.11; 14.46. 
 
MS (ESI(+)): 525.7 [M+Na]
+ 
 
 
40 
39 (0.50 g, 0.10 mmol) and the azide derivative SG110 (0.13 g, 0.22 mmol) were dissolved in 
dry THF (9 mL) under argon. A suspension of CuSO4 (0.02 g, 0.11 mmol) and NaAsc (0.04 
g, 0.22 mmol) in water (1 mL) was added to the THF solution. The resulting yellow solution 
        Chapter 3: Encapsulation of Anthracene-Core Dendrimers into Arene-Ru Metallo-Cycles 
 
91 
 
was stirred overnight, after which a blue deposit was formed. The solvent was evaporated and 
CH2Cl2 was added to the residue. Extraction was done three times with water and the organic 
phase was dried over MgSO4. After evaporation of the solvent, the crude product was purified 
by CC (eluent CH2Cl2/EtOAc 10/2). 40 was obtained as a yellow solid with a yield of 90% 
(0.15 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.52 (dd, 
3
JH-H = 6.8 Hz, 
4
JH-H = 3.1 Hz, 4H, H1), 8.21 
(d, 
3
JH-H = 8.5 Hz, 4H, H18), 8.11 (d, 
3
JH-H = 8.7 Hz, 4H, H14), 7.68 (d, 
3
JH-H = 8.2 Hz, 4H, 
H17), 7.55-7.60 (m, 4H, H2, H16), 7.32 (d, 
3
JH-H = 8.7 Hz, 4H, H13), 7.24 (s, 2H, H10), 6.99 (d, 
3
JH-H = 8.3 Hz, 4H, H15), 4.37 (t, 
3
JH-H = 6.2 Hz, 4H, H5), 4.32 (t, 
3
JH-H = 6.7 Hz, 4H, H12), 
4.19 (t, 
3
JH-H = 7.3 Hz, 4H, H19), 4.02 (t, 
3
JH-H = 6.6 Hz, 4H, H11), 3.03 (t, 
3
JH-H = 7.4 Hz, 4H, 
H9), 2.83 (t, 
3
JH-H = 7.0 Hz, 4H, H3), 2.78 (t, 
3
JH-H = 7.3 Hz, 4H, H8), 2.13 (quint, 
3
JH-H = 6.6 
Hz, 4H, H4), 1.72-1.83 (m, 12H, aliphatic H), 1.21-1.50 (m, 42H, aliphatic H), 0.92 (t, 
3
JH-H = 
6.3 Hz, 6H, H20). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 172.83; 165.96; 165.65; 159.70; 154.66; 146.31; 
146.22; 132.13; 131.85; 131.19; 130.81; 128.42; 128.13; 127.17; 127.03; 126.68; 126.58; 
121.79; 120.97; 118.38; 115.04; 101.57; 68.21; 65.26; 63.37; 50.20; 33.79; 31.62; 30.29; 
29.47; 29.42; 29.36; 29.25; 28.98; 28.74; 28.17; 26.49; 26.03; 25.75; 22.64; 21.09; 17.08; 
14.07. 
 
MS (ESI(+)): 1753.4 [M+Na]
+ 
 
 
41
 
2,6-Diaminoanthraquinone (0.23 g, 1.00 mmol) and CuBr2 (0.50 g, 2.25 mmol) were added to 
acetonitrile (50 mL), followed by 
t
BuONO (0.3 mL, 2.25 mmol). The mixture was stirred 
under reflux for 2
1
/2h during which evolution of gas was observed. 20% HCl (30 mL) was 
added to the mixture and stirred for 5 min. Water was then added and a light brown 
precipitate was formed, which was filtered off and washed with water. The residue was 
dissolved in boiling dioxane and charcoal was added to the mixture. Filtration of the hot 
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solution through celite gave a yellow filtrate. Upon cooling to rt, 41 precipitated from the 
solution and was collected as a pale yellow powder by filtration with a yield of 70% (0.25 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.43 (s, 2H, H1), 8.18 (d, 
3
JH-H = 8.3 Hz, 2H, H2), 7.95 
(d, 
3
JH-H = 8.3 Hz, 2H, H3). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 182.13; 137.41; 133.24; 130.38; 129.14; 128.16; 
126.50. 
 
MS (ESI(-)): 366.1 [M-H]
- 
 
 
42 
To a solution of 41 (0.36 g, 1.00 mmol) in dry and degassed CH2Cl2 (10 mL), were added CuI 
(0.01 g, 0.05 mmol) and degassed NEt3 (30 mL) under argon. The mixture was stirred for 5 
min, then Pd(PPh3)4 and 36 (0.59 g, 3.00 mmol) were added and stirred at 60°C overnight. 
After the reaction was complete, CH2Cl2 was added and extraction was done with water. After 
running CC (eluent CH2Cl2/heptane 5/3), the product was stirred in methanol at 40°C. The 
suspension was filtered and the residue was dried. 42 was obtained as a pale yellow solid with 
a yield of 83% (0.56 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.27 (s, 2H, H1), 8.21 (d, 
3
JH-H = 8.3 Hz, 2H, H2), 7.75 
(d, 
3
JH-H = 8.3 Hz, 2H, H3), 3.77 (t, 
3
JH-H = 6.1 Hz, 4H, H6), 2.57 (t, 
3
JH-H = 6.2 Hz, 4H, H4), 
1.84 (quint, 
3
JH-H = 6.7 Hz, 4H, H5), 0.92 (s, 9H, H8), 0.09 (s, 6H, H7). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 182.18; 136.63; 133.44; 131.86; 130.64; 130.20; 
127.32; 96.00; 79.82; 61.51; 31.50; 25.97; 18.39; 16.07; -5.28. 
 
MS (ESI(-)): 600.8 [M-H]
-
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4.1 Introduction 
Macromolecules, also referred to as polymer molecules, was termed by Nobel Prize winner 
Hermann Staudinger in the early 1920’s.[107] Biological macromolecules are critical 
components of the cells structure and are hence very important for life. Apart from biological 
macromolecules, there are other large molecules with great importance. Dendrimers, for 
instance, have a spectrum of applications including liquid crystal chemistry
[108]
 and 
biochemistry.
[109]
 Polyamidoamine derivatives (PAMAM)
[110]
 and poly-(2,2-
bis(hydroxymethyl) propionic acids (bis-MPA)
[111]
 are two of the dendrimers used in drug-
delivery systems.  
 
In order to expand the spectrum of dendrimers with biological properties, our group has 
initiated the application of the well-known poly(benzyl ether) dendrimer, developed by Percec 
et al.,
[108a]
 as potential biological agents. As was briefly mentioned in Chapter 1 section 1.2.3, 
a series of different dendrimers of different generations were tested as anticancer agents.
[48b]
 
Since the dendrimers are hydrophobic, they were transported in a hydrophilic vehicle that has 
a hydrophobic cavity. The dendrimers were attached to a planar π-conjugated pyrene moiety 
that gets encapsulated inside the hydrophobic cavity of the cage with the dendritic chain 
dangling out. The stability of these systems in biological media allowed their evaluation as 
potential drugs. Results show that the host-guest systems and the host alone show similar 
activities.
[48b]
 Another set of dendrimers tested was bis-MPA, which are water-soluble and 
biodegradable.
[48c]
 Unlike the poly(benzyl ether) systems, the biological activity of the 
pyrenyl bis-MPA dendrimers was determined, as well as that of the host-guest systems. 
Results show that the latter has higher activities than the host and guest alone.
[48c]
  
 
Apart from the biological activities of these macromolecules, their liquid-crystalline 
properties have a significant importance. It is well-known that dendrimers bearing mesogenic 
units tend to show liquid-crystalline properties. This property can however be affected or even 
be suppressed in some cases after coordination of the dendrimer to a metallic unit. In our 
group, the encapsulation of liquid-crystalline pyrenyl compounds, containing poly(arylester) 
dendrimers bearing cyanobiphenyl mesogens, into Ru cages has been studied. The 
encapsulated systems were evaluated on human ovarian cancer cell lines A2780 and A2780cis 
R.
[48a]
 For these systems to maintain the liquid-crystalline properties of the dendrimers, some 
conditions have to be met such as lowest possible global charge on the complex and soft 
counter anions, like dodecyl sulfate, that lower the melting points of the complex.
[99d]
 Hence, 
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the versatility, the ease of modification of the units and their potential to preferentially 
accumulate in tumour cells have made these systems a field of research with great 
perspectives.
[48a, 48c]
  
 
4.2 Aim 
Following the work done on anthracene, a different approach was used to enable the success 
of the encapsulation of aromatic-core dendrimers into Ru cages. Hence, due to the low 
stability of anthracene moiety, the latter was replaced by pyrene, which shows greater stability 
than anthracene. Moreover, with disubstituted pyrenes, two isomers (1,6- and 1,8-) are 
possible, making the study of the encapsulation more interesting. Cyanobiphenyl units were 
used in the dendritic chain to introduce mesomorphic properties to the pyrene-core 
dendrimers. Hence, the effect of attaching the liquid-crystalline dendrimers to the pyrene was 
also studied as well as the influence encapsulation has on the mesomorphic properties of the 
systems. Two generations of dendrimers were used to study the behaviour of the different 
generations on the potential of the molecules to be trapped in arene-Ru cages.  
 
4.3 Synthesis 
4.3.1 Synthesis of Pyrene Dendrimers 
The two dendrimer chains were synthesised following literature procedures.
[99b]
 The final step 
of the synthesis is the reaction of the dendrimers bearing an alcohol end group (LV79 and 
LV99, compounds synthesised by Thi Luyen Vuong. See Annex 3 for structures) with 2,2-
dimethyl-1,3-dioxane-4,6-dione (Meldrum’s acid) in toluene at 65°C (Scheme 4.1). At high 
temperatures, Meldrum’s acid undergoes a pericyclic reaction with loss of acetone and carbon 
dioxide and produces ketene, a highly reactive compound that in turn reacts with the alcohol 
to form 43 and 44 (Scheme 4.1).
[112]
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Scheme 4.1 Synthesis of compounds 43 and 44. Reagents and conditions: i. toluene, 65°C, 
24h, 43: 16%, 44: 76%  
 
Pyrene was functionalised by iodination using I2 and KIO3 in an acetic acid, water and 
concentrated sulphuric acid (100:10:1 ratio) from 90°C to 40°C (Scheme 4.2).
[113]
 Two 
isomers of the diiodopyrene were obtained after recrystallization from hot toluene: the 1,6-
isomer (45a) and the 1,8-isomer (45b). Separation of the isomers was not possible at this 
stage and the mixture of isomers was used for the following step, which involved a 
Sonogashira coupling with 4-pentyn-1-ol under the typical conditions: Pd(PPh3)4/CuI catalytic 
system and CH2Cl2/NEt3 (1:3 ratio).
[114]
 After several column chromatographies and 
recrystallizations, the 1,6- and 1,8-isomers were isolated separately as compounds 46a and 
46b, respectively (Scheme 4.2). 
 
 
Scheme 4.2 Synthesis of disubstituted pyrene compounds, 46a and 46b. Reagents and 
conditions: i. I2, KIO3, CH3COOH/H2O/H2SO4 (100:10:1 ratio), 90°C to 40°C, 4h, 25% ii. 
Pd(PPh3)4, CuI, CH2Cl2/NEt3 (1:3 ratio), 60°C, 16h, 46a: 7%, 46b: 31% 
 
Esterification using DCC and DPTS in CH2Cl2 was then carried out on the two isomers 46a 
and 46b with dendritic chains 43, 44 and zba01, as shown in Scheme 4.3 (zba01 was 
synthesised by Anaïs Pitto-Barry by the reaction between 2,2′-bis-(hydroxymethyl)propionic 
acid and 2,2′-dimethoxypropane in the presence of p-toluenesulfonic monohydrate in acetone 
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at room temperature for 2h. See Annex 3 for structure). After purification by several column 
chromatographies and preparative thick layer chromatographies, products 47-52 were isolated 
pure.  
 
 
Scheme 4.3 Synthesis of compounds 47-52. Reagents and conditions: i. ROH, DCC, DPTS, 
CH2Cl2, 0°C to rt, 16h, 47: 52%, 48: 25%, 49: 63%, 50; 55%, 51: 51%, 52: 80% 
  
4.3.2 Carceplex Assemblies 
In the aim of encapsulating the dendrimers, carceplex method was used. Nevertheless, the 
empty cages were first synthesised to help in proper characterization of the encapsulation 
systems (Scheme 4.4). The Ru clip 11 was used in the synthesis of both the hexanuclear prism 
and the octanuclear cube. Silver triflate was used to remove the chlorides, followed by 
addition of the spacer ligand, which coordinated to the Ru. 2,4,6-Tris(pyridin-4-yl)-1,3,5-
triazine (4-tpt) and 1,2,4,5-tetrakis(2-(pyridine-4-yl)vinyl)benzene (tetra-pvb) were used to 
afford the prism 53 and cube 54, respectively (Scheme 4.4).  
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Scheme 4.4 Synthesis of hexa- and octanuclear Ru assemblies. Reagents and conditions: i. 
AgCF3SO3, MeOH, reflux, 16h, 53: 70%, 54: 64% 
 
In order to test the ability of the pyrene-core dendrimers to be encapsulated in Ru cages, the 
intermediates 46a and 46b were first encapsulated by reacting clip 11, spacer ligand 4-tpt and 
the potential guest in one step. On one hand, the 1,6-pyrene isomer did not undergo 
encapsulation despite several attempts to encapsulate 46a in a prism by changing the solvent 
and the temperature of the reaction (See Table 4.1). On the other hand, 46b was successfully 
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encapsulated into the prism. Moreover, compounds 48 and 52 were used as potential guests 
and successful encapsulation into the prism was observed in both cases (Scheme 4.5).  
 
 
Scheme 4.5 Encapsulation of guest molecules (46b, 48 and 52) into hexanuclear Ru cages. 
Reagents and conditions: i. MeOH, reflux, 16h, 55: 42%, 56: 43%, 57: 27%, 58: 23% 
 
Encapsulation of the other 1,8-pyrene derivative 50 was not successful by the carceplex 
method. Therefore, a different route was taken to get the first generation dendrimer inside the 
hexanuclear metallo-prism. Compound 46b, which was successfully encapsulated into the 
cage, possesses free alcohol end groups that are available for functionalisation. Hence, an 
esterification was attempted on the encapsulated system, aiming to attach the first generation 
dendron onto the pyrene moiety (Scheme 4.6). But the desired encapsulated system was not 
obtained. Instead, the empty cage and the free esterified compound were obtained at the end 
of the reaction.  
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Scheme 4.6 Encapsulation of guest molecule 44 into a hexanuclear Ru cage. Reagents and 
conditions: i. DCC, DPTS, CH2Cl2, 0°C to rt, 16h. 
 
Since the geometry of the 1,6-isomer is different from the 1,8-isomer, the encapsulation (into 
the Ru prism) of one and not both can be explained in terms of steric hindrance from one of 
the two chains in the 1,6-isomer that is too close to one of the naphthoquinone moiety, hence 
creating an obstruction in building the cage around the molecule. Therefore, a bigger cage 
was used to accommodate for the 1,6-isomer and successful encapsulation was found into a 
cubic arrangement with tetra-pvb spacer ligand (Scheme 4.7).  
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Scheme 4.7 Encapsulation of guest molecule 46a into an octanuclear Ru cage. Reagents and 
conditions: i. AgCF3SO3, 46a, MeOH, reflux, 16h, 22% 
 
Attempts to entrap the other dendrimers into the Ru cages did not result in any successful 
cases over a range of varying conditions: different cages (prism, rectangle and cube), different 
solvent systems (CH2Cl2, MeOH, acetone, and mixtures of solvents), various reaction 
temperatures (room temperature, reflux) and different methods of encapsulation (host-guest 
and carceplex) (Table 4.1). 
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Table 4.1 Summary of different attempts made to encapsulate compounds 46-50 and 52 
Guest Host 
Spacer 
ligand 
Solvent of 
reaction 
Temperature 
of reaction 
Method Product 
46a 
Prism 4-tpt 
MeOH; 
CH2Cl2 
rt; reflux 
carceplex; 
host-guest 
X 
Rectangle dpe 
MeOH; 
acetone; 
CH2Cl2 
rt; reflux 
carceplex; 
host-guest 
X 
Cube 
tetra-pvb 
MeOH rt; reflux 
carceplex 59 
Zn-tpp 
carceplex; 
host-guest 
X 
46b 
Prism 4-tpt 
MeOH 
reflux carceplex 55 
Cube Zn-tpp rt; reflux 
carceplex; 
host-guest 
X 
47 
Cube tetra-pvb 
MeOH; 
CH2Cl2; 
THF 
rt; reflux 
carceplex; 
host-guest 
X 
Rectangle dpe CH2Cl2 X 
48 Prism 4-tpt MeOH reflux carceplex 56 
49 
Prism 
4-tpt; tris-
pvb 
MeOH; 
acetone; 
CH2Cl2 rt; reflux 
carceplex; 
host-guest 
X 
Rectangle dpe CH2Cl2 X 
Cube tetra-pvb CH2Cl2 X 
50 
Rectangle dpe CH2Cl2 
rt; reflux 
carceplex; 
host-guest 
X 
Prism 4-tpt MeOH X 
Cube tetra-pvb MeOH X 
52 Prism 4-tpt MeOH reflux carceplex 58 
 
From these attempts, no encapsulation was possible by the host-guest method. The 1,8-
disubstituted pyrenes encapsulate better into these cages as compared to their 1,6- analogues. 
Compound 46a was successfully encapsulated into an octanuclear cage whereas the other 1,6- 
derivatives bearing a dendrimer chain could not be encapsulated into these systems. For the 
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1,8-disubstituted molecules, encapsulation into the Ru cages was not successful for the G1 
derivative. The only 1,8-disubstituted compounds that could be encapsulated into these Ru 
cages are 46b, 48 and 52. Attempts to encapsulate the G1 derivatives of both isomers into 
tetra-, hexa- and octanuclear Ru cages failed, which may imply that these cages are not 
appropriate to encapsulate these molecules.  
 
4.4 Characterization 
4.4.1 Proton NMR Spectroscopy 
After attaching the dendrimers to the alcohol functional group of the pyrene molecules, 46a 
and 46b, the protons of the pyrene moiety do not undergo any chemical shifts, being far away 
and therefore less influenced by any changes occurring on the chains (Figure 4.1). On the 
other hand, shifting is observed for the protons H11 and H12 of the aliphatic chain, due to their 
closer proximity to the alcohol group. For instance, H12 protons are shifted upfield by about 
0.1 ppm from compound 46a to compounds 47, 49 and 51 and a more important upfield shift 
of about 0.5 ppm is observed for H11 protons, as can be seen in Figure 4.1 below. Similar 
observations were made for the 1,8-isomer compounds (46b, 48, 50, 52). 
 
 
Figure 4.1 
1
H NMR spectra (400 MHz, CD2Cl2) of compounds 46a, 47, 49 and 51 
 
H11
H11
H11
H11
H12
H12
H12
H12
51
49
47
46a
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In many cases, the 
1
H NMR spectra of the encapsulated systems are not well-defined, with 
some missing peaks. An example is the 
1
H NMR spectrum of complex 58, where the protons 
corresponding to the spacer ligand, 4-tpt are only barely visible as a broad peak (Figure 4.2). 
 
 
Figure 4.2 
1
H NMR spectra (400 MHz, CD2Cl2) of 53 and 58  
 
4.4.2 DOSY 
Encapsulation of the pyrene compounds into the cages was followed by DOSY analysis. The 
displacement coefficient D, obtained as log D on the y-axis of the DOSY spectrum, allows the 
different components to be distinguished, provided the concentrations, the solvent and the 
temperature of the different measurements are the same. DOSY, known to be a good method 
of separating different components based on their hydrodynamic volumes, has been used to 
prove encapsulation of the guest molecule by the host cage.  
 
In the case of complex 55, which involved the entrapment of compound 46b into prism 53, 
DOSY was run on the free components (46b and 53) and the encapsulated system. The 
stacking of the DOSY spectra in Figure 4.3 below shows the difference in the displacement of 
the components. Thus, 55 has a displacement value, log D, of about -9.28, while the free 
58
53
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guest, 46b displaces at log D = -8.85. The displacement of 55 is similar to that of 53 because 
after encapsulation, the small guest goes inside the cavity, therefore the overall hydrodynamic 
volume of the encapsulated system does not differ a lot from that of the empty cage 53.  
 
 
Figure 4.3 DOSY NMR spectrum (400 MHz, CD2Cl2) spectra of 46b, 53 and 55 
 
The DOSY of complex 56 is slightly more complicated than that of 55 because the differences 
between the log D values are not as significant as in the previous case. The free guest, 48, 
displaces at a log D value of around -9.25 while compound 56 has a log D = -9.30. The empty 
prism 53 also displaces at a value of about -9.24, hence confirming the encapsulation of 48 
into the prism (Figure 4.4). 
 
 
Figure 4.4 DOSY NMR spectrum (400 MHz, CD2Cl2) spectra of 48, 53 and 56 
Log D
46b
53
55
ppm
48
53
56
Log D
ppm
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Complex 59, which is the compound 46a entrapped in cube 54, has a similar DOSY spectrum 
as complex 55 since both involve a major change in hydrodynamic volume as a result of 
encapsulation. Complex 59 displaces at a log D value of about -9.33 while the free guest, 46a, 
displaces at log D = -8.90 (Figure 4.5). The major difference in the displacement coefficient 
indicates that 46a is no longer free, but instead, it displaces with the cage 54 due to the strong 
interaction between them.  
 
 
Figure 4.5 DOSY NMR spectrum (400 MHz, MeOD) spectra of 46a, 54 and 59 
 
4.4.3 X-Ray Crystallography 
Mono-crystals of complex 59 were obtained by slow diffusion of diethyl ether into a solution 
of the compound in CH2Cl2. Owing to the presence of some distortion of the guest molecule, 
the complete X-ray structure was not obtained (Figure 4.6). DFT simulations of the 
encapsulated guest were used to complete the structure of 59. The side view of the X-ray 
structure of 59 shows the bending of the spacer ligands into the cavity of the cage, arising 
from the strong π-π interactions between tetra-pvb and compound 46a. Hence, the distances 
“x” and “y” have a difference of more than 1.5 Å for this system (Figure 4.6).[115] This X-ray 
structure confirms that the interaction between the guest molecule and the host is not an out-
of-cavity one, but and in-cavity interaction. 
 
46a
54
59
Log D
ppm
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Figure 4.6 X-ray crystal structures of complex 59: (a) top view and (b) side view 
 
4.4.4 Mesomorphic Properties 
The thermal and mesomorphic properties of compounds 47-50 were studied by differential 
scanning calorimetry (DSC) and polarised optical microscopy (POM). From the DSC 
thermogram of compound 47, two mesophases appear to exist (Figure 4.7). The glass 
transition temperature (Tg) is at 26°C and two other transitions are observed at 36°C and 
169°C. Preliminary analysis by POM shows a nematic phase characterised by its Schlieren 
texture as the only mesophase for 47 and at room temperature, compound 47 presents a 
nematic glass phase (Figure 4.8). Also, crystallization of 47 is observed with decreasing the 
temperature from TI to around 120°C.  
  
x y
Distance x = 8.3 Å
Distance y = 6.8 Å
Guest = 
46a
a
b
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Figure 4.7 DSC thermogram of compound 47: second heating curve (red) and second cooling 
curve (blue)  
 
 
Figure 4.8 Textures of compound 47: (a) nematic glass at 24°C and (b) nematic phase 160°C 
 
The 1,8-isomer compound 48 was found to have more than one mesophase, from DSC 
analysis (Figure 4.9). The Tg was similar to compound 47 (26°C), but an overall of three 
mesophases was observed from the thermogram. However, from preliminary POM analysis 
only a Schlieren texture characteristic of a nematic phase was observed (Figure 4.10). It was 
also observed that the compound started to crystallise at around 124°C with lowering of the 
temperature from TI. 
 
 
Figure 4.9 DSC thermogram of compound 48: second heating curve (blue) and second 
cooling curve (red)  
Tg = 26°C
T = 36°C
T = 169°C
N
M
a b
Tg = 26°C
T = 116°C TI = 142°C
N
T = 42°C
M M´
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Figure 4.10 Textures of compound 48: (a) unidentified phase at 38°C and (b) a nematic phase 
at 122°C 
 
For compound 49, the DSC thermogram is very simple, with only one mesophase before 
isotropy (Figure 4.11). POM images show that the only mesophase existing for this 
compound is the nematic phase, characterised by the Schlieren texture (Figure 4.12). 
 
 
Figure 4.11 DSC thermogram of compound 49: second heating curve (blue) and second 
cooling curve (red)  
 
 
Figure 4.12 Nematic texture of compound 49 at 160°C 
 
Compound 50, unlike 49, was found to have two mesophases from its DSC thermogram 
(Figure 4.13). From POM, the first mesophase observed with increasing temperature was a 
smectic A phase characterised by the conic focal and homeotropic zone. For a short span of 
a b
Tg = 34°C
T = 168°C
N
Nematic texture of 57 at 160°C
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about 10°C a nematic phase characterised by its Schlieren texture is observed (Figure 4.14). 
Both compounds 49 and 50 have similar Tg of 34°C. 
 
 
Figure 4.13 DSC thermogram of compound 50: second heating curve (blue) and second 
cooling curve (red)  
 
 
Figure 4.14 Textures of compound 50: (a) smectic A at 135°C and (b) a nematic phase at 
151°C 
 
Compounds 47 and 48, bearing two mesogenic cyanobiphenyl units each, were compared 
with the cyanobiphenyl mesogen LV99 and a monosubstituted pyrene containing the 
mesogenic unit (compound Mono-G0, see structure in Annex 3). Similarly, for the first 
generation dendrons 49 and 50, comparison was made with the corresponding G1 mesogen 
LV79 and the monosubstituted pyrene containing the G1 mesogen (compound Mono-G1, see 
structure in Annex 3). The analysis for compounds LV79, LV99, Mono-G0 and Mono-G1 
were obtained from the work done by Thi Luyen Vuong and Anaïs Pitto-Barry. The different 
transitions observed from DSC for these compounds are summarised in Table 4.2 with the 
temperatures of transition (Tg and T) and the enthalpies of transition (∆H) for the 
corresponding phase transitions.  
Tg = 34°C
T = 152°C
TI = 163°C
NSmA
a b
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Table 4.2 Temperatures and enthalpies of transition for the mesogen bearing compounds 
Compound Tg (°C)
 b
 Transitions
a
 T (°C)
 b
 ∆𝐇 (kJ·mol-1)b 
LV99 - N → I 222 0.7 
Mono-G0 51 N → I 138 0.7 
47 26 
M → N 36 2.3 
N → I 169 1.2 
48 26 
M → M′ 
M′ → N 
N → I 
42 
116 
142 
3.1 
0.2 
0.5 
LV79 - N → I 190 3.0 
Mono-G1 46 N → I 167 4.6 
49 34 N → I 168 5.1 
50 34 
SmA → N 
N → I 
152 
163 
1.7 
3.1 
a
 M and M′: unidentified mesophases, N: nematic phase, I: isotropic phase; b Measurements were made 
at 10°C/min and all the temperatures and transition enthalpies were recorded for the second heating 
cycle. 
 
Comparing two mesogens, LV79 and LV99, to their mono- and disubstituted pyrenyl 
compounds, a decreased in TI is observed (Table 4.2). This change may be due to an overall 
decrease in the strength of interactions between the molecules. In the mesogens, the alcohol 
end groups are stabilised by H-bonds, which get disrupted after binding to the pyrene. The 
pyrenyl compounds are in turn held together by π-π interactions between the pyrene units. 
These π-π interactions, being weaker than the H-bonds in the mesogens, result in an overall 
destabilization of the pyrenyl compounds with a lowering of TI. Increasing in generation of 
dendrons presents an overall increase in TI, probably resulting from increased π-π interactions 
arising from an increased number of aromatic units from G0 to G1.  
 
The 1,6-isomers show higher TI than the 1,8-isomers (Table 4.2). This can be explained in 
terms of the arrangement orders, the 1,6-isomers being more linear and hence stack better 
than the 1,8-isomer. The presence of more order in the 1,6-isomers result in higher stability 
and hence higher TI than the 1,8-isomers. Moreover, from mono- to disubstitution of the 
pyrene compounds, an increase in TI is observed. A possible explanation is that the 
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arrangements of the disubstituted compounds are more stable than the monosubstituted ones, 
resulting in an increase in TI.  
 
All the compounds present a nematic phase, with compounds 47 and 50, the 1,8-isomers, 
displaying an additional unidentified phase and a smectic A phase, respectively (Table 4.2). 
Also, LV99 and LV79 do not present any Tg while the pyrene compounds all do. The 
disubstituted pyrenes present a lower Tg than the monosubstituted ones. The 1,6- and 1,8-
isomers of a particular dendron generation present the same Tg value.  
 
The changes in enthalpy for the compounds of same generation dendron are closely related: 
G0 derivatives (compounds LV99, Mono-G0, 47 and 48) have ∆H in the range 0.5-1.2 
kJ·mol
-1
 and the G1 derivatives (compounds LV79, Mono-G1, 49 and 50) have ∆H between 
3.0-5.1 kJ·mol
-1
 (Table 4.2).  
 
The DSC and POM analyses of the encapsulated dendrimer, compound 56, show that the 
latter is not liquid-crystalline. For this system, entrapment into the Ru cage results in loss of 
the mesomorphic property of the guest instead of transferring this property to the encapsulated 
system. An attempt was made by changing the counter ion, using a softer anion, dodecyl 
sulphate instead of triflate (compound 57), but nevertheless, the mesomorphic properties 
could not be maintained.  
  
4.5 Conclusion   
A family of bifunctional, 1,6- and 1,8-pyrene-core dendrimers bearing cyanobiphenyl 
moieties was synthesised and all members (47-50) were found to be liquid-crystalline. 
Compounds 47-50 present a nematic phase, and compounds 48 and 50 present other phases as 
well, an unidentified one and a nematic phase, respectively. The temperatures and enthalpies 
were consistent with similar systems. The 1,8-somer compounds, 46b and 48, were 
successfully encapsulated into Ru prism 53, while compound 46a was the only 1,6-isomer to 
be encapsulated into an octanuclear Ru system 54; all the encapsulations were carried out by 
the carceplex method. A similar system bearing a different chain, polyester dendrimers, was 
established and in this case as well, encapsulation into the hexanuclear Ru cage was only 
possible for the 1,8-isomer (compound 52). Therefore, it can be concluded that the geometry 
of the compounds and the length of the chains linked to the pyrene-core play a determining 
role in the encapsulation into the hydrophobic cavities of the cages. 
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4.6 Experimental Part 
 
43 
The alcohol derivative (LV99) (0.50 g, 1.06 mmol) and an excess of Meldrum’s acid (1.52 g, 
10.60 mmol) were added to dry toluene (100 mL) under argon and the mixture was stirred at 
65°C. After 24h, the mixture was cooled and the solvent evaporated. The crude product was 
precipitated from methanol and the precipitate was run through a CC (eluent CH2Cl2/EtOAc 
10/4). 43 was obtained as a white powder with a yield of 16% (0.14 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.20 (d, 
3
JH-H = 8.8 Hz, 8H, H20, H24), 7.66-7.79 (m, 
6H, H22, H23), 7.37 (d, 
3
JH-H = 8.6 Hz, 2H, H21), 7.03 (d, 
3
JH-H = 8.9 Hz, 2H, H19), 4.24 (t, 
3
JH-
H = 6.7 Hz, 2H, H18), 4.10 (t, 
3
JH-H = 6.5 Hz, 2H, H15), 3.48 (s, 2H, H14), 1.87 (quint, 
3
JH-H = 
6.7 Hz, 2H, aliphatic chain), 1.71 (quint, 
3
JH-H = 6.9 Hz, 2H, H16), 1.53 (quint, 
3
JH-H = 7.1 Hz, 
2H, H17), 1.35-1.43 (m, 10H, aliphatic chain). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 168.77; 168.13; 164.90; 163.72; 151.61; 144.91; 
136.75; 132.68; 132.39; 128.38; 127.73; 122.59; 121.27; 118.90; 114.40; 111.03; 68.38; 
66.32; 40.00; 29.39; 22.14; 28.39; 25.98; 25.74. 
 
MS (ESI(+)): 580.6 [M+Na]
+ 
 
 
44
 
The alcohol derivative (LV79) (0.84 g, 0.58 mmol) and Meldrum’s acid (0.80 g, 5.86 mmol) 
were stirred in toluene (150 mL) following the procedures as 43. Purification was done by 
two CC (CH2Cl2/EtOAc 10/0.6 to 10/4 and CH2Cl2/MeOH 10/0 to 10/1). 44 was obtained in 
the form of a white powder with a yield of 76% (0.65 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.56 (t, 
4
JH-H = 1.5 Hz, 1H, H26), 8.14 (d, 
3
JH-H = 8.9 
Hz, 6H, H20, H27), 8.06 (d, 
4
JH-H = 1.5 Hz, 2H, H25), 7.77-7.66 (m, 8H, H23, H24), 7.63 (d, 
3
JH-H 
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= 8.7 Hz, 4H, H22), 7.33 (d, 
3
JH-H = 8.6 Hz, 4H, H21), 7.00 (d, 
3
JH-H = 9.0 Hz, 6H, H19, H28), 
4.35 (t, 
3
JH-H = 6.7 Hz, 4H, H15), 4.16 (t, 
3
JH-H = 6.7 Hz, 2H, H29), 4.04 (t, 
3
JH-H = 6.0 Hz, 6H, 
H18, H30), 3.42 (s, 2H, H31), 1.75-1.85 (m, 10H, aliphatic chain), 1.64-1.70 (m, 2H, aliphatic 
chain), 1.32-1.51 (m, 36H, aliphatic chain). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 165.12; 164.15; 152.06; 145.07; 137.07; 
133.04; 132.85; 132.66; 132.56; 128.66; 128.03; 127.91; 127.49; 122.93; 121.63; 121.17; 
119.18; 114.81; 114.73; 111.39; 68.83; 66.72; 66.15; 53.54; 39.89; 29.83; 29.00; 28.72; 
26.34; 26.08. 
 
MS (ESI(+)): 1473.6 [M+Na]
+ 
 
 
         45a              45b 
Pyrene (6.00 g, 30.00 mmol) was dissolved in acetic acid (250 mL) at 90°C. The solution was 
cooled to 40°C and water (20 mL), I2 (7.15 g, 30.00 mmol), KIO3 (2.57 g, 12.00 mmol) and 
concentrated H2SO4 (2 mL) were added. The resulting mixture was stirred at 40°C for 4h, 
after which it was filtered. The residue was washed with CH2Cl2, dried and recrystallization 
was done from hot toluene. 45 was obtained as a mixture of 1,6- and 1,8-isomers, 45a and 
45b respectively, as a light brown solid with a yield of 25% (3.5 g). 
 
1
H NMR (400 MHz, CDCl3, ppm) for mixture 45a/45b: δ = 8.54 (m, 2H, H2, H7), 8.35 (m, 
2H, H5, H10), 8.08 (m, 2H, H4, H9), 7.90 (m, 2H, H3, H8). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm) for mixture 45a/45b: δ = 97.45; 124.82; 126.71; 
127.74; 129.12; 131.38; 131.72; 132.47; 133.05; 137.44. 
 
MS (ESI(+)): 454.0 [M+H]
+ 
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           46a            46b 
45 (0.20 g, 0.44 mmol) was dissolved in dry and degassed CH2Cl2 (10 mL) under argon. CuI 
(0.004 g, 0.02 mmol) and degassed triethylamine (30 mL) were added to the solution and the 
mixture was stirred for 5 min. Pd(PPh3)4 (0.01 g, 0.01 mmol) and 4-pentyn-1-ol (0.08 mL, 
0.88 mmol) were added to the mixture and stirring continued at 60°C. After overnight stirring, 
CH2Cl2 was added and extraction was done with water. The organic phase was dried over 
MgSO4 and the solvent was removed. The residue was run through three CC (eluent 
CH2Cl2/MeOH 10/0.4 then CH2Cl2/EtOAc 10/4) that allowed the separation of the two 
isomers. Pure 46a was obtained by recrystallization from an acetone/CH2Cl2 mixture as a 
yellow solid with a yield of 7% (0.01 g). 46b was purified by recrystallization from a 
CH2Cl2/heptane mixture and was obtained as a yellow solid with a yield of 31% (0.50 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm) for 46a: δ = 8.56 (d, 
3
JH-H = 9.0 Hz, 2H, H2, H7), 8.08-
8.14 (m, 6H, H3, H4, H5, H8, H9, H10), 3.90 (q, 
3
JH-H = 5.9 Hz, 4H, H11), 2.78 (t, 
3
JH-H = 7.0 
Hz, 4H, H13), 2.00 (quint, 
3
JH-H = 6.6 Hz, 4H, H12). 
 
1
H NMR (400 MHz, CD2Cl2, ppm) for 46b: δ = 8.62 (s, 2H, H9, H10), 8.10 (q, 
3
JH-H = 7.9 Hz, 
4H, H2, H3, H6, H7), 8.04 (s, 2H, H4, H5), 3.91 (q, 
3
JH-H = 5.9 Hz, 4H, H11), 2.78 (t, 
3
JH-H = 7.0 
Hz, 4H, H13), 2.00 (quint, 
3
JH-H = 6.6 Hz, 4H, H12). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm) for 46a: δ = 130.28; 128.28; 126.28; 125.27; 62.04; 
32.16; 16.76. 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm) for 46b: δ = 132.11; 131.27; 130.25; 127.99; 
126.55; 125.30; 124.51; 79.93; 62.05; 32.16; 16.78. 
 
MS (ESI(+)) for 46a: 389.6 [M+Na]
+ 
 
MS (ESI(+)) for 46b: 389.4 [M+Na]
+ 
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47 
46a (0.02 g, 0.06 mmol), 51 (0.06 g, 0.13 mmol), DCC (0.07 g, 0.34 mmol) and DPTS (0.02 
g, 0.06 mmol) were stirred in dry CH2Cl2 (50 mL) following similar procedure as 34. The 
crude product was purified by two CC (eluent CH2Cl2/EtOAc 10/0.02) followed by CC of 
Bio-Rad SX1 (eluent THF) and two preparative thick layer chromatographies (eluent 
CH2Cl2/EtOAc 10/0.02). 47 was obtained as a pale yellow solid with a yield of 52% (0.05 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.55 (d, 
3
JH-H = 9.1 Hz, 2H, H2, H7), 8.07-8.14 (m, 
10H, H3, H4, H5, H8, H9, H10, H20), 7.72 (q, 
3
JH-H = 6.6 Hz, 8H, H23, H24), 7.67 (d, 
3
JH-H = 8.6 
Hz, 4H, H22), 7.32 (d, 
3
JH-H = 8.6 Hz, 4H, H21), 6.95 (d, 
3
JH-H = 8.7 Hz, 4H, H19), 4.42 (t, 
3
JH-H 
= 6.3 Hz, 4H, H11), 4.12 (t, 
3
JH-H = 6.7 Hz, 4H, H18), 3.97 (t, 
3
JH-H = 6.6 Hz, 4H, H15), 3.41 (s, 
4H, H14), 2.78 (t, 
3
JH-H = 7.1 Hz, 4H, H13), 2.12 (q, 
3
JH-H = 6.7 Hz, 4H, H12), 1.70-1.77 (m, 
4H, H16), 1.60-1.66 (m, 4H, H17), 1.39-1.26 (m, 24H, aliphatic chain). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 166.99; 166.96; 165.08; 164.12; 152.05; 
145.06; 137.06; 133.03; 132.53; 131.14; 130.34; 128.65; 128.33; 128.02; 126.32; 125.31; 
124.50; 122.92; 121.61; 119.33; 119.18; 114.70; 111.40; 95.41; 80.31; 68.77; 66.00; 64.53; 
42.05; 29.79; 29.78; 29.64; 29.54; 29.41; 28.86; 28.35; 26.26; 26.16; 16.92. 
 
Anal. Calcd. (found) for C92H88N2O14 (1444): C, 76.43 (76.50); H, 6.14 (6.13); N, 1.94 
(1.95)% 
 
MS (ESI(+)): 1468.6 [M+Na]
+ 
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48 
46b (0.05 g, 0.13 mmol), 51 (0.13 g, 0.27 mmol), DCC (0.15 g, 0.68 mmol) and DPTS (0.04 
g, 0.13 mmol) were stirred dry CH2Cl2 (50 mL) following similar procedure as 34. After 
overnight reaction, the solvent was removed and residue was run through CC (eluent 
CH2Cl2/EtOAc 10/0.14). After two CC, the product was further purified by two preparative 
thick layer chromatographies (eluent CH2Cl2/EtOAc 10/0.14). 48 was obtained as a yellow 
solid with a yield of 25% (0.05 g).  
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.61 (s, 2H, H9, H10), 8.09-8.12 (m, 8H, H2, H3, H6, 
H7, H20), 8.04 (s, 2H, H4, H5), 7.72 (q, 
3
JH-H = 8.3 Hz, 8H, H23, H24), 7.67 (d, 
3
JH-H = 8.7 Hz, 
4H, H22), 7.32 (d, 
3
JH-H = 8.6 Hz, 4H, H21), 6.95 (d, 
3
JH-H = 8.9 Hz, 4H, H19), 4.42 (t, 
3
JH-H = 
6.2 Hz, 4H, H11), 4.12 (t, 
3
JH-H = 6.7 Hz, 4H, H18), 3.97 (t, 
3
JH-H = 6.5 Hz, 4H, H15), 3.41 (s, 
4H, H14), 2.78 (t, 
3
JH-H = 7.1 Hz, 4H, H13), 2.12 (quint, 
3
JH-H = 6.6 Hz, 4H, H12), 1.73 (quint, 
3
JH-H = 6.7 Hz, 4H, H16), 1.63 (quint, 
3
JH-H = 6.4 Hz, 4H, H17), 1.39-1.25 (m, 24H, aliphatic 
chain). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 167.00; 133.03; 132.53; 130.35; 128.65; 
128.02; 125.33; 122.92; 114.68; 68.76; 66.00; 64.54; 42.04; 29.79; 29.77; 28.85; 28.38; 
26.25; 26.15; 16.94.  
 
Anal. Calcd. (found) for C92H88N2O14 (1444): C, 76.43 (76.33); H, 6.14 (6.19); N, 1.94 
(1.95)% 
 
MS (ESI(+)): 1468.6 [M+Na]
+ 
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49 
46a (0.02 g, 0.06 mmol), 52 (0.21 g, 0.15 mmol), DCC (0.07 g, 0.34 mmol) and DPTS (0.02 
g, 0.06 mmol) were stirred in dry CH2Cl2 (50 mL) following similar procedure as 34. The 
crude product was purified by two CC (eluent CH2Cl2/EtOAc 10/0.02) followed by two 
preparative thick layer chromatographies (eluent CH2Cl2/EtOAc 10/0.02). 49 was obtained as 
a pale yellow solid with a yield of 63% (0.14 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.55-8.58 (m, 3H, H2, H7, H26), 8.53 (s, 1H, H26), 
8.09-8.17 (m, 18H, H3, H4, H5, H8, H9, H10, H20, H27), 8.04 (d, 
4
JH-H = 1.6 Hz, 4H, H25), 7.72 
(d, 
3
JH-H = 8.7 Hz, 16H, H23, H24), 7.66 (d, 
3
JH-H = 8.7 Hz, 8H, H22), 7.32 (d, 
3
JH-H = 8.6 Hz, 
8H, H21), 6.97 (d, 
3
JH-H = 9.1 Hz, 12H, H19, H28), 4.41 (t, 
3
JH-H = 6.3 Hz, 4H, H11), 4.33 (t, 
3
JH-
H = 6.7 Hz, 8H, H15), 4.12 (t, 
3
JH-H = 6.7 Hz, 4H, H29), 4.03 (t, 
3
JH-H = 6.6 Hz, 8H, H18), 3.97 
(t, 
3
JH-H = 6.6 Hz, 4H, H30), 3.40 (s, 4H, H31), 2.76 (t, 
3
JH-H = 7.0 Hz, 4H, H13), 2.11 (q, 
3
JH-H = 
8.0 Hz, 4H, H12), 1.82-1.70 (m, 20H, aliphatic chain), 1.64 (q, 
3
JH-H = 6.8 Hz, 4H, aliphatic 
chain), 1.45-1.25 (m, 48H, aliphatic chain). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 167.00; 166.97; 165.31; 165.07; 164.84; 
164.30; 164.14; 152.07; 151.60; 145.03; 137.04; 133.03; 132.85; 132.65; 132.56; 130.35; 
128.65; 128.34; 128.01; 127.49; 125.32; 122.93; 121.64; 114.78; 114.73; 111.40; 95.43; 
80.35; 68.82; 66.14; 66.01; 64.54; 42.04; 29.85; 29.81; 29.70; 29.67; 29.62; 29.56; 29.47; 
29.02; 28.88; 26.36; 26.31; 16.93. 
 
Anal. Calcd. (found) for C202H206N4O34 (3231): C, 75.03 (74.93); H, 6.42 (6.44); N, 1.73 
(1.72)% 
 
MS (ESI(+)): 3256.3 [M+Na]
+ 
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50
 
46b (0.02 g, 0.06 mmol), 44 (0.21 g, 0.15 mmol), DCC (0.07 g, 0.34 mmol) and DPTS (0.02 
g, 0.06 mmol) were stirred in dry CH2Cl2 (50 mL) following similar procedure as 34. The 
crude product was purified by three CC (thin SiO2, eluent CH2Cl2/EtOAc 10/0.1) followed by 
two preparative thick layer chromatographies (eluent CH2Cl2/EtOAc 10/0.1). 50 was obtained 
as a pale yellow solid with a yield of 55% (0.12 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.61 (s, 2H, H9, H10), 8.54 (t, 
3
JH-H = 1.5 Hz, 2H, 
H26), 8.10-8.13 (m, 18H, H2-H7, H20, H27), 8.03 (d, 
4
JH-H = 1.5 Hz, 4H, H25), 7.72 (d, 
3
JH-H = 
8.6 Hz, 16H, H23, H24), 7.66 (d, 
3
JH-H = 8.7 Hz, 8H, H22), 7.32 (d, 
3
JH-H = 8.7 Hz, 8H, H21), 
6.97 (d, 
3
JH-H = 9.0 Hz, 12H, H19, H28), 4.41 (t, 
3
JH-H = 6.3 Hz, 4H, H11), 4.33 (t, 
3
JH-H = 6.7 
Hz, 8H, H18), 4.12 (t, 
3
JH-H = 6.8 Hz, 4H, H29), 4.03 (t, 
3
JH-H = 6.5 Hz, 8H, H15), 3.97 (t, 
3
JH-H 
= 6.6 Hz, 4H, H30), 3.41 (s, 4H, H31), 2.77 (t,
 3
JH-H = 7.1 Hz, H13), 2.12 (q, 
3
JH-H = 6.6 Hz, 
H12), 1.82-1.70 (m, 20H, aliphatic chain), 1.64 (q, 
3
JH-H = 6.9 Hz, 4H, aliphatic chain), 1.45-
1.25 (m, 48H, aliphatic chain) 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 164.64; 164.40; 163.84; 163.69; 151.60; 
151.13; 144.59; 136.60; 132.59; 132.39; 132.19; 132.12; 131.66; 130.88; 129.91; 128.22; 
127.58; 127.46; 127.05; 126.14; 124.90; 124.04; 122.50; 121.17; 120.67; 118.88; 118.75; 
114.31; 114.27; 110.94; 95.06; 79.86; 68.37; 65.69; 65.56; 64.11; 41.61; 29.41; 29.38; 29.26; 
29.18; 29.12; 29.02; 28.98; 25.56; 28.42; 27.94; 25.91; 25.87; 25.83.   
 
Anal. Calcd. (found) for C202H206N4O34 (3231): C, 75.03 (74.79); H, 6.42 (6.35); N, 1.73 
(1.75)% 
 
MS (ESI(+)): 3256.3 [M+Na]
+ 
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51 
46a (0.05 g, 0.13 mmol), zba01 (0.05 g, 0.30 mmol), DCC (0.14 g, 0.68 mmol) and DPTS 
(0.05 g, 0.13 mmol) and a catalytic amount of 4-ppy were stirred in dry CH2Cl2 (50 mL) 
following similar procedure as 34. The crude product was purified by two CC (eluent CH2Cl2) 
followed by two preparative thick layer chromatographies (eluent CH2Cl2). 51 was obtained 
as a pale yellow solid with a yield of 51% (0.04 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.52 (d, 
3
JH-H = 9.0 Hz, 2H, H2, H7), 8.08-8.11 (m, 6H, 
H3-H5, H7-H10), 4.45 (t, 
3
JH-H = 6.2 Hz, 4H, H13), 4.24 (d, 
3
JH-H = 11.6 Hz, 4H, H14a), 3.67 (d, 
3
JH-H = 11.6 Hz, 4H, H14b), 2.78 (t, 
3
JH-H = 7.1 Hz, 4H, H11), 2.14 (quint, 
3
JH-H = 6.7 Hz, 4H, 
H12), 1.44 (s, 6H, H16a), 1.40 (s, 6H, H16b), 1.23 (s, 6H, H15). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 174.27; 131.99; 130.74; 129.94; 127.94; 125.99; 
124.87; 124.18; 118.80; 98.09; 94.62; 80.28; 66.11; 63.65; 41.97; 28.04; 24.88; 22.47; 18.67; 
16.63. 
 
MS (ESI(+)): 701.4 [M+Na]
+ 
 
 
52 
46b (0.05 g, 0.13 mmol), zba01 (0.05 g, 0.30 mmol), DCC (0.14 g, 0.68 mmol) and DPTS 
(0.05 g, 0.13 mmol) and a catalytic amount of 4-ppy were stirred in dry CH2Cl2 (50 mL) 
following similar procedure as 34. The crude product was purified by two CC (eluent CH2Cl2) 
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followed by two preparative thick layer chromatographies (eluent CH2Cl2). 52 was obtained 
as a pale yellow solid with a yield of 80% (0.07 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.60 (s, 2H, H2, H7), 8.08 (s, 4H, H4, H5, H9, H10), 8.02 
(s, 2H, H3, H6), 4.45 (t, 
3
JH-H = 6.2 Hz, 4H, H13), 4.24 (d, 
3
JH-H = 11.6 Hz, 4H, H14a), 3.67 (d, 
3
JH-H = 11.6 Hz, 4H, H14b), 2.79 (t, 
3
JH-H = 7.1 Hz, 4H, H11), 2.15 (quint, 
3
JH-H = 6.6 Hz, 4H, 
H12), 1.44 (s, 6H, H16a), 1.41 (s, 6H, H16b), 1.23 (s, 6H, H15). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 174.27; 131.80; 130.92; 129.93; 127.66; 126.25; 
124.85; 124.17; 118.83; 98.09; 94.72; 80.23; 66.10; 63.69; 49.16; 41.96; 33.95; 28.09; 25.60; 
24.94; 24.83; 22.53; 18.68; 16.67. 
 
MS (ESI(+)): 701.3 [M+Na]
+ 
 
 
53 
11 (0.04 g, 0.06 mmol) and AgCF3SO3 (0.03 g, 0.12 mmol) were stirred in methanol (20 mL) 
under reflux for 2h, after which the mixture was filtered. 4-Tpt (0.01 g, 0.04 mmol), 
synthesised following a literature procedure,
[116]
 was added to the filtrate and the mixture was 
stirred under reflux. After overnight reaction, the solvent was removed and the residue was 
dissolved in CH2Cl2 (3 mL) and was filtered. Diethyl ether was added to the filtrate, resulting 
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in the precipitation of a dark green solid, which was isolated by filtration. 53 was dried under 
vacuum and the yield obtained was 70% (0.04 g). 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 8.58 (s, 24H, H1, H2), 7.24 (s, 12H, H3), 5.73 (d, 
3
JH-H 
= 6.1 Hz, 12H, H4), 5.51 (d, 
3
JH-H = 6.1 Hz, 12H, H4), 2.84 (sept, 
3
JH-H = 7.1 Hz, 6H, H5), 2.10 
(s, 18H, H6), 1.34 (d, 
3
JH-H = 6.9 Hz, 36H, H7)  
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 171.83; 170.72; 154.29; 145.25; 138.40; 
125.06; 112.51; 104.93; 100.52; 85.22; 84.24; 31.57; 22.46; 17.32. 
 
 
54 
11 (0.06 g, 0.08 mmol) and AgCF3SO3 (0.04 g, 0.16 mmol) were stirred in methanol (20 mL) 
under reflux for 2h, after which the mixture was filtered. Tetra-pvb (0.02 g, 0.04 mmol), 
synthesised following to literature procedures,
[117]
 was added to the filtrate and the mixture 
was stirred under reflux. After overnight reaction, the solvent was removed and the residue 
was dissolved in CH2Cl2 (3 mL) and was filtered. Diethyl ether was added to the filtrate, 
resulting in the precipitation of a dark green solid, which was isolated by filtration. 54 was 
dried under vacuum and the yield obtained was 64% (0.06 g). 
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1
H NMR (400 MHz, CD3CN, ppm): δ = 8.31 (d, 
3
JH-H = 5.8 Hz, 16H, H1), 8.04 (s, 4H, H2), 
7.75 (d, 
3
JH-H = 16.1 Hz, 8H, H3), 7.65 (d, 
3
JH-H = 5.8 Hz, 16H, H4), 7.25 (s, 8H, H5), 7.24 (d, 
3
JH-H = 16.1 Hz, 8H, H6), 7.23 (s, 8H, H5),  5.73 (d, 
3
JH-H = 5.7 Hz, 16H, H7), 5.51 (d, 
3
JH-H = 
5.7 Hz, 16H, H8), 2.85 (sept, 
3
JH-H = 7.0 Hz, 8H, H9), 2.11 (s, 24H, H10), 1.33 (d, 
3
JH-H = 7.0 
Hz, 48H, H11) 
 
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 172.01; 171.74; 152.90; 148.32; 138.41; 
135.85; 131.33; 128.56; 125.20; 124.25; 112.48; 104.59; 100.09; 85.17; 85.06; 84.18; 31.44; 
22.46; 22.30; 17.32. 
 
 
55 
11 (0.04 g, 0.06 mmol) and AgCF3SO3 (0.03 g, 0.12 mmol) were stirred in methanol (20 mL) 
under reflux for 2h, after which the mixture was filtered. 4-Tpt (0.01 g, 0.04 mmol) and 46b 
(0.008 g, 0.02 mmol) were added to the filtrate and the mixture was stirred under reflux. After 
overnight reaction, the solvent was removed and the residue was dissolved in CH2Cl2 (3 mL) 
and was filtered. Diethyl ether was added to the filtrate, resulting in the precipitation of a dark 
green solid, which was isolated by filtration. 55 was dried under vacuum and the yield 
obtained was 42% (0.03 g). 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 8.67 (s, 4H, Hpyrene), 8.26-8.40 (m, 24H, H4-tpt), 7.37-
7.62 (m, 14H, Hpyrene, Hdhnq), 5.69 (s, 12H, Hp-cym), 5.46 (s, 12H, Hp-cym), 3.74 (s, 4H, Hpyrene), 
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2.78-2.88 (m, 6H, Hp-cym), 2.26-2.32 (m, 4H, Hpyrene), 2.10-2.11 (m, 4H, Hpyrene), 2.02 (s, 18H, 
Hp-cym), 1.29-1.32 (m, 36H, Hp-cym). 
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 170.85; 151.93; 137.69; 125.24; 124.16; 
123.52; 122.07; 118.90; 115.73; 111.28; 103.75; 100.07; 84.70 ; 82.63; 30.53; 21.07; 15.84.  
 
MS (ESI(+)): 1139.1 [M-3Tf]
3+ 
 
 
56 
11 (0.02 g, 0.03 mmol), AgCF3SO3 (0.01 g, 0.06 mmol), 4-tpt (0.007 g, 0.02 mmol) and 48 
(0.01 g, 0.01 mmol) were stirred in methanol (10 mL) under reflux overnight, following the 
same procedure as 55. After precipitation from diethyl ether, 56 was obtained as a dark green 
solid with a yield of 43% (0.02 g). 
 
 1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.60 (s, 24H, H4-tpt), 8.10 (d, 
3
JH-H = 8.7 Hz, 8H, 
Hdendron), 7.66-7.74 (m, 16H, Hdendron, Hpyrene), 7.33 (d, 
3
JH-H = 8.3 Hz, 4H, Hdendron), 7.24 (s, 
6H, Hdhnq), 6.95 (d, 
3
JH-H = 8.5 Hz, 4H, Hdendron), 5.65 (d, 
3
JH-H = 6.1 Hz, 12H, Hp-cym), 5.47 (d, 
3
JH-H = 6.0 Hz, 12H, Hp-cym), 4.42 (t, 
3
JH-H = 6.2 Hz, 4H, Hdendron), 4.13 (t, 
3
JH-H = 6.8 Hz, 4H, 
Hdendron), 3.98 (t, 
3
JH-H = 6.6 Hz, 4H, Hdendron), 3.42 (s, 4H, Hdendron), 2.76-2.81 (m, 10H, Hp-cym, 
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Hdendron), 2.07 (s, 18H, Hp-cym), 1.90-1.96 (m, 4H, Hdendron), 1.34-1.38 (m, 12H, Hdendron), 1.30 
(d, 
3
JH-H = 6.9 Hz, 36H, Hp-cym).  
 
13
C{
1
H} NMR (100 MHz, CD3OD, ppm): δ = 170.81; 169.51; 152.78; 144.60; 137.82; 
137.23; 131.92; 125.71; 124.11; 122.27; 111.02; 103.74; 99.86; 84.57; 82.68; 71.40; 41.11; 
46.90; 30.55; 23.06; 21.03; 15.88. 
  
MS (ESI(+)): 1498.6 [M-3Tf]
3+ 
 
 
57 
Silver nitrate (2.00 g, 11.70 mmol) was dissolved in H2O in the dark and mixed with a 
solution of sodium dodecyl sulfate (0.27 g, 0.90 mmol) in H2O at 70°C. The mixture was 
stirred for 3 min at 50°C in the dark, during which a white precipitate was formed. Mixture 
was filtered and washed abundantly with water. Silver dodecyl sulfate (AgDS) was obtained 
as a white solid with a yield of 30% (0.10 g). AgDS (0.01 g, 0.06 mmol), 11 (0.02 g, 0.03 
mmol), 4-tpt (0.007 g, 0.02 mmol) and 48 (0.01 g, 0.01 mmol) were stirred under reflux in 
methanol (10 mL) overnight, following the same procedures as 55. After precipitation from 
diethyl ether, 57 was obtained as a dark green solid with a yield of 27% (0.01 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.62-8.68 (m, 26H, H2, H7, Htpt), 8.10 (d, 
3
JH-H = 9.0 
Hz, 4H, H20), 7.95-8.06 (m, 6H, H3-H6, H9, H10), 7.73 (d, 
3
JH-H = 3.5 Hz, 8H, H23, H24), 7.66 
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(d, 
3
JH-H = 8.6 Hz, 4H, H22), 7.31 (d, 
3
JH-H = 8.5 Hz, 4H, H21), 7.25 (s, 12H, Hdhnq), 6.97 (d, 
3
JH-H = 8.7 Hz, 4H, H19), 5.67-5.82 (m, 12H, Hp-cym), 5.50-5.62 (m, 12H, Hp-cym), 4.41-4.44 
(m, 4H, H11), 4.13 (t, 
3
JH-H = 6.5 Hz, 4H, H18), 3.90-3.97 (m, 4H, H15), 3.54-3.60 (m, 12H, 
HDS), 3.42 (s, 4H, H14), 2.74-2.82 (m, 10H, Hp-cym, H3), 2.11-2.15 (m, 4H, H12), 2.05 (s, 18H, 
Hp-cym), 1.47-1.66 (m, 132 H, HDS), 1.26-1.33 (m, 94H, Hp-cym, HDS, Hpyrene) 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 132.61; 132.12; 128.24; 127.60; 122.50; 
114.28; 30.68; 29.60; 29.36; 29.01; 25.86; 21.99; 17.06. 
 
 
58 
11 (0.008 g, 0.01 mmol), AgCF3SO3 (0.008g, 0.03 mmol), 4-tpt (0.003 g, 0.01 mmol) and 52 
(0.003 g, 0.005 mmol) were stirred under reflux in methanol (10 mL) overnight, following the 
same procedures as 55. After precipitation from diethyl ether, 58 was obtained as a green 
solid in a yield of 23% (0.01 g).  
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.74 (d, 
3
JH-H = 5.6 Hz, 2H, Hpyrene), 8.57 (d, 
3
JH-H = 
5.8 Hz, 6H, Hpyrene), 7.66-7.70 (m, 2H, Hdhnq), 7.54-7.58 (m, 2H, Hdhnq), 7.48-7.52 (m, 1H, 
Hdhnq), 7.42 (s, 2H, Hdhnq), 7.22-7.29 (m, 3H, Hdhnq), 5.62-5.74 (m, 12H, Hp-cym), 5.43-5.54 (m, 
12H, Hp-cym), 3.93-4.04 (m, 8H, Hpyrene), 2.73-2.85 (m, 6H, Hp-cym), 2.27-2.30 (m, 4H, Hpyrene), 
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2.02 (s, 18H, Hp-cym), 1.64-1.85 (m, 4H, Hpyrene), 1.25-1.32 (m, 48H, Hp-cym, Hpyrene), 0.85 (s, 
6H, Hpyrene). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 171.26; 170.74; 170.66; 168.05; 153.17; 
142.30; 137.88; 137.53; 124.84; 124.34; 122.50; 111.61; 103.98; 100.24; 84.76; 84.67; 84.61; 
82.67; 66.00; 50.02; 39.29; 37.32; 36.99; 32.67; 31.87; 30.65; 29.95; 29.62; 29.30; 27.87; 
24.36; 22.63; 21.92; 19.45; 17.50; 17.01; 16.96; 13.82. 
 
 
59 
11 (0.06 g, 0.08 mmol) and AgCF3SO3 (0.04 g, 0.16 mmol) were stirred in methanol (20 mL) 
under reflux for 2h, after which the mixture was filtered. Tetra-pvb (0.02 g, 0.04 mmol) and 
46a (0.008 g, 0.02 mmol) were added to the filtrate and the mixture was stirred under reflux. 
After overnight reaction, the solvent was removed and the residue was dissolved in CH2Cl2 (3 
mL) and was filtered. Diethyl ether was added to the filtrate, resulting in the precipitation of a 
dark green solid, which was isolated by filtration. 59 was dried under vacuum and the yield 
obtained was 22% (0.02 g). 
 
1
H NMR (400 MHz, CD3CN, ppm): δ = 8.30 (d, 
3
JH-H = 5.8 Hz, 16H, H1), 7.47 (d, 
3
JH-H = 5.8 
Hz, 16H, H2), 7.36 (s, 8H, Hdhnq), 7.31 (s, 8H, Hdhnq), 7.11-7.15 (m, 12H, H4, H5), 6.54-6.66 
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(m, 8H, H3), 5.72 (d, 
3
JH-H = 5.9 Hz, 16H, Hp-cym), 5.47-5.54 (m, 16H, Hp-cym), 3.57-3.64 (m, 
4H, H8), 2.87 (quint, 
3
JH-H = 6.9 Hz, 8H, Hp-cym), 2.13 (s, 18H, Hp-cym), 1.75-1.81 (m, 4H, H7), 
1.56-1.66 (m, 4H, H6), 1.32 (d, 
3
JH-H = 7.0 Hz, 52 H, Hp-cym). 
 
13
C{
1
H} NMR (100 MHz, CD3CN, ppm): δ = 151.88; 137.36; 123.10; 103.47; 84.00; 83.10; 
30.41; 21.33; 21.30; 16.28. 
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5.1 The [60]Fullerene 
After the discovery of the most stable and abundant member of the fullerenes family by Nobel 
Prize winners Harold W. Kroto, Robert F. Curl and Richard E. Smalley, the icosahedron 
molecule, [60]fullerene (C60) has been subject to many studies.
[118]
 Consisting of 12 pentagons 
and 20 hexagons, the 60 sp
2
 hybridised carbon atoms are linked by two types of bonds: double 
bonds  [6,6] between two 6-membered rings of length 1.355 Å and single bonds [5,6] between 
a 5-membered ring and a 6-membered ring, 1.467 Å long (Figure 5.1). Hence, the 6-
membered rings adopt a cyclohexatriene and not a benzene structure as the bond lengths are 
not all equivalent and the double bonds standing out at each carbon of the 5-membered rings 
give it the shape of a [5]radialene. The pyramidalised carbon atoms take up the shape of a 
hollow football with an inner diameter of about 1 nm (Figure 5.1).
[119]
 From its molecular 
orbital diagram, C60 has three degenerate low lying LUMO and is able to accept reversibly up 
to six electrons.
[120]
 Moreover, its high degree of symmetry and its molecular orbital 
arrangement give C60 interesting chemical and physical properties such as electronegativity, 
photophysical properties, conductivity and its redox potentials.
[121]
 
 
 
 Figure 5.1 Structure of C60 molecule  
 
The discovery of a cost-effective production method for fullerenes in 1990 by Krätschmer and 
Huffman marked the beginning of widespread research in C60 chemistry.
[122]
 But due to its 
high tendency of forming aggregates and its poor solubility, C60 needs to be functionalised to 
enhance its processability.
[123]
 The C60 molecule has 30 [6,6] double bonds that are all 
equivalent and have similar reactivity to the double bonds of electron-deficient alkenes.
[121a]
 
Its electrophilic properties and low redox potentials make C60 prone to addition and redox 
reactions across the [6,6] double bonds. Despite the availability of several positions for 
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addition of addends to the C60, 1,2 addition is the preferred mode as it gives the 
thermodynamically most stable structure. In the case of sterically demanding addends, 1,4 and 
1,6 adducts are obtained rather than 1,2 adduct, as seen in Figure 5.2 below.
[124]
  
 
 
Figure 5.2 Examples of 1,2- and 1,4-adducts of C60 
 
One important aspect of functionalisation of C60 is the number of adducts that can be 
obtained. The mono-functionalisation of C60 has been reported to be straightforward, forming 
one single product due to its icosahedral symmetry. Multi-functionalisation of C60 is also 
possible, even though it is more complicated than the mono-adduct formation because of the 
numerous isomers resulting from the process. Multi-functionalisation can occur either by 
stepwise multiple addition to the C60 molecule, which involves tedious separation of isomers 
and hence poor yield and selectivity for the respective isomers, or by tether-directed multiple 
functionalisation, allowing the formation of controlled multiple adducts of C60.
[125]
 
 
C60 can undergo several types of reactions, for example nucleophilic and radical additions, 
cycloadditions, hydrogenations, complexations with transition metals and reactions with 
electrophiles.
[124]
 Among these reactions, cycloadditions are very popular to form both mono- 
and multi-adducts, with the possibility of attaching almost any functional group to the C60 
molecule. During cycloaddition reactions, the [6,6] double bonds act as dienes or dienophiles. 
Mostly, the cycloadducts formed are stable, making them appropriate intermediates for further 
side chain chemistry. Different types of cycloaddition reactions are possible, such as [4+2], 
[3+2], [2+2] and [2+1], giving different cycloadducts (Scheme 5.1).
[124]
 Among these 
reactions, two common examples are  
 Diels-Alder and hetero-Diels-Alder [4+2] reactions between a conjugated diene and 
the C60 acting as dienophile.  
 Bingel [2+1] cyclopropanation reaction between an acidic malonate and electron-
deficient [6,6] double bond of C60. 
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Scheme 5.1 Examples of cycloaddition reactions on C60 
 
Another widely used cycloaddition reaction of C60 is Prato’s reaction that involves a 1,3-
dipolar cycloaddition of a ylide to a double bond of the C60 to form a fulleropyrrolidine. The 
ylide is formed by the decarboxylation of an iminium salt that is in turn formed by the 
condensation of an aldehyde with an α-amino acid (Scheme 5.2).[126]  
 
 
Scheme 5.2 Mechanism of Prato reaction
[126a]
 
 
Depending on the application of the C60 derivatives, R′ and R′′ can be carefully chosen to get 
the appropriate solubility and properties. For instance, Prato added PEG (polyethylene glycol) 
chains and made ammonium salt derivatives in order to make C60 derivatives hydrophilic 
enough for biological testing (Figure 5.3).
[126d]
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Figure 5.3 Derivatives of C60 used for biological testing 
 
Compared to cycloaddition reactions of C60, fewer examples exist in literature for the 
complexation of this molecule with transition metals. The reported studies of such complexes 
are mainly directed towards the photophysical and electrochemical properties because of the 
observed intermolecular electron transfer between the metal donor and the C60 acceptor.
[121a, 
127]
 In most of these cases, complexation takes place on the exterior framework of the 
fullerene, with the electron-rich transition metal coordinating to the electron-deficient C60. 
Among the few examples of complexes whereby the metal centre and the C60 are linked via 
an intermediate moiety is the one reported by Prato; amphiphilic C60-Ru-porphyrin complexes 
were synthesised for Langmuir-Blodgett film deposit (Figure 5.4).
[128]
 Likewise C60 and its 
derivatives have found a wide range of applications such as ballistic missile shield, 
photovoltaic cells, polymer additives, superconductors and surface coatings. Apart from these 
applications, C60 is also viewed as a potential candidate in medicinal chemistry because of its 
unique photo-, electrochemical and physical properties, its relative inertness under mild 
conditions and its negligible toxicity.
[121b]
 
 
 
Figure 5.4 C60-porphyrin Ru complexes 
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Following the footsteps of Prato, many water-soluble fulleropyrrolidines have been 
synthesised bearing polar groups that enable them to cross cell membranes. Hence, 
fulleropyrrolidines found medical applications as listed below:
[121b, 129]
 
 Antiviral: some C60 derivatives, like amino acid ones are active against the human 
immunodeficiency virus, a HIV. They are able to inhibit and make complexes with 
HIV protease by fitting inside the hydrophobic cavity hence preventing the access of 
substrates to the catalytic site of enzyme.
[130]
 
  Antioxidant: the ability of C60 to take up electrons and to penetrate cell membranes 
has given C60 the role of a radical scavenger, protecting cell growth from various 
toxins that can induce apoptotic injuries. 
 Drug-delivery: C60 functionalised with hydrophilic groups, which can be in the form 
of drugs and genes, allows these derivatives to cross cell membrane and bind to 
mitochondria. In doing so, C60 is able to carry drugs and deliver them to cells. 
 Anticancer: C60 bearing functional groups that have biological affinity for nucleic 
acid/proteins and other C60 derivatives upon UV exposure, show increased 
cytotoxicity.  
 
5.2 Aim 
The objective of this work is to synthesise half-sandwich arene-Ru complexes with a C60-
based ligand for potential biological activities. The combination of these two different areas 
of research, the chemistry of C60 and arene-Ru, is quite new and has not been well-explored 
so far.
[131]
 Hence, the aim is to study the type of interaction existing between the C60 
containing ligand and the Ru centre and the properties of the formed products.  
 
5.3 Synthesis 
The first step of the ligand synthesis involves a nucleophilic aliphatic substitution reaction 
between an alkyl bromide and a primary amine, giving a higher substituted amine with the 
loss of HBr (Scheme 5.3).
[132]
 The secondary amine formed undergoes a 1,3-dipolar 
cycloaddition reaction with C60 in the presence of para-formaldehyde.
[126b]
 As described in 
Scheme 5.2, such a reaction is commonly known as Prato’s reaction and it involves two steps: 
the first one is the formation of a ylide by the decarboxylation of the iminium salt and the 
second step is the 1,3-dipolar cycloaddition reaction of the ylide onto a [6,6] double bond of 
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the C60. After purification, the fulleropyrrolidines are obtained as shiny black solids that have 
good solubility in organic solvents (Scheme 5.3).  
 
 
Scheme 5.3 Synthesis of compounds 61 and 66. Reagents and conditions: i. NEt3, THF, 0°C 
to rt, 16h, 60: 60%, 65: 32%, ii. toluene, 110°C, 16h, 61: 51%, 66: 24% 
 
The next step is the complexation with ruthenium para-cymene dichloride dimer, [(η6-p-
cym)Ru(µ2-Cl)Cl]2 whereby the labile chloride ligand is readily replaced by the nitrogen atom 
of the pyridyl group (Scheme 5.4).
[133]
 A neutral half-sandwich C60-Ru-arene dichloride is 
formed that shows high solubility in organic solvents but is insoluble in aqueous medium 
when R is a tertiarybutyl group. Since water solubility is crucial for biological testing, 
compound 62 could not be tested straightaway.  
 
 
Scheme 5.4 Synthesis of compounds 62 and 67. Reagents and conditions: i. CH2Cl2, reflux, 
24h, in dark, 62: 98%, 67: 92% 
 
In order to make the complex more water soluble, a solubilizing group was added to the 
complex. The hydrophilic compound 1,3,5-triaza-7-phosphaadamantane (pta), which has been 
used by Dyson in making RAPTA-C, was used as ligand to improve the solubility of 
compound 62. The reaction involved the abstraction of a labile chloride ligand from the Ru 
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complex by a Ag
+
 ion from silver triflate, forming AgCl precipitate (Figure 5.5).
[134]
 
Unexpectedly, the complex formed not only had poor water solubility, but it had lost its 
solubility in common organic solvents, making its characterization and purification very 
difficult. The mass spectrum of the compound showed the peak corresponding to the mass of 
the expected product, but its insolubility in water made it unsuitable for biological tests. 
 
 
Figure 5.5 Structure of compound 63 
 
Another attempt was made to increase the hydrophilicity of the C60-Ru complex by replacing 
the ester group with a PEG chain. Compound 64 was first synthesised by a reaction between 
bromoacetyl chloride and tri(ethylene)glycol monoethyl ether in dry CH2Cl2 (Scheme 5.5).
[135]
 
The reaction was done  in the presence of 4-(dimethylamino)pyridine (DMAP), which is an 
effective esterification catalyst that allows the reaction to occur at low temperatures, hence 
avoiding degradations. The nucleophilic addition of the alcohol group onto the carbonyl group 
of the acid chloride, followed by the elimination of HCl results in compound 64 (Scheme 5.5).  
 
 
Scheme 5.5 Synthesis of compound 64. Reagents and conditions: i. NEt3, DMAP, CH2Cl2, 
0°C to rt, 20h, quantitative yield 
 
Compound 64 was then reacted with 4-(aminomethyl)pyridine to form 65 in the same manner 
as 60 and after subsequent reactions, product 67 was formed (Scheme 5.4). It was found that 
compound 67 showed similar solubility as compound 62, meaning that the PEG chain was not 
efficient in making the complex hydrophilic. A possible explanation for the solubility problem 
of these two compounds might lie in the hydrophobic nature of the C60 moiety. The 
hydrophilicity of the ruthenium dichloride or the Ru-pta moieties are not able to balance the 
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hydrophobicity of the C60. Hence, the biological activities of these complexes could not be 
evaluated due to their insolubility in aqueous medium. 
 
5.4 Characterization  
5.4.1 Proton NMR Spectroscopy 
The 
1
H NMR spectra of the C60 derivatives 61 and 66 are the typically observed spectra for 
this family of fulleropyrrolidines. One characteristic feature of this family of compounds is 
that the protons closest to the C60 moiety are not equivalent. This loss of equivalence and 
hence of conformation is due to the chiral centre on the pyrrolidine. For instance, H3 protons, 
which appear as a doublet in compound 60 at 3.30 ppm, can be seen as two doublets at 4.93 
and 4.30 ppm in product 61. Similarly, H4 protons are observed as two doublets at 4.69 and 
4.14 ppm in compound 61. 
 
Moreover, complexation with Ru results in a major shift in the proton peaks
 
of compound 62 
compared to compound 61 (Figure 5.6). This chemical shift corresponds to H1 protons of the 
pyridyl group. Complexation with Ru metal causes a downfield shift of these protons from 
8.68 to 9.06 ppm. The other protons of the ligand do not undergo any major shifting as a 
result of complexation. 
 
 
Figure 5.6 
1
H NMR (400 Hz, CD2Cl2) spectra of 61 and 62  
 
61
H1
H1
H2
H7
62
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H8
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H3
H3
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H4 H4
H4H4
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H11 H6
H10
H6
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5.4.2 UV-Visible Spectroscopy 
The UV-Vis spectra of compounds 61 and 62 display two bands around 308 and 429 nm. The 
intense, high in energy band centred at 308 nm is observed in both compounds 61 and 62. 
This band is similar to the one observed at 331 nm in ruthenium para-cymene dichloride 
dimer and it is assigned to the ligand-centred π→π* electronic transitions.[136] The narrow 
band at 429 nm is considered as the fingerprint for fulleropyrrolidines, hence confirming the 
presence of pyrrolidine on C60 for compounds 61 and 62. Another characteristic band of these 
C60 mono-adducts usually appear around 700 nm. But in the case of compounds 61 and 62, 
this band is not visible because of its broadness and low intensity.
[126c]
 The maximum 
wavelength (λmax) and molar absorptivity (ε) values are listed in Table 5.1, where ε was 
determined using the Beer-Lambert law: 
 
𝜀 =
A
lc
                                                   Equation 1 
 
where, A = absorption, 
 l = length of cuvette, cm 
 c = concentration of sample, mol·L
-1
 
 
Table 5.1 UV-Vis measurements of [(η6-p-cym)Ru(µ2-Cl)Cl]2, 61 and 62 in CH2Cl2 
Compound λmax (nm) ε (L·mol
-1
·cm
-1
) 
[(η6-p-cym)Ru(µ2-Cl)Cl]2 331 1500 
61 
429 2400 
308 19300 
62 
429 1400 
308 10400 
 
From the UV-Vis spectra, it can be observed that there is no electron/energy transfer between 
the ruthenium and C60 at ground state (Figure 5.7). 
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Figure 5.7 UV-Vis spectra of [(η6-p-cym)Ru(µ2-Cl)Cl]2, 61 and 62 in CH2Cl2 
 
5.5 Conclusion 
Two new fulleropyrrolidines and their corresponding arene-Ru complexes were successfully 
synthesised and characterised. The two half-sandwich complexes showed poor solubility in 
aqueous medium. Attempts to find the right equilibrium between the hydrophilicity and 
hydrophobicity of the complexes did not result in the desired solubility. Hence, despite the 
progress made in the synthetic part, the biological evaluation of C60-Ru complexes could not 
be carried out and therefore remains to be solved.  
 
5.6 Experimental Part 
 
60 
4-(Aminomethyl)pyridine (0.76 mL, 7.50 mmol) and triethylamine (2.09 mL, 15.00 mmol) 
were dissolved in dry THF (40 mL) at 0°C under argon. To this mixture, a THF solution (25 
mL) of 2-bromoethyl propionate (0.74 mL, 5.00 mmol) was added dropwise over 2h with 
stirring. After 16h of reaction at rt, water (50 mL) was added to the reaction mixture and 
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extraction was done with CH2Cl2. The combined organic phase was dried over anhydrous 
MgSO4 and evaporation of the solvent gave a dark brown liquid. The crude product was 
purified by CC (eluent CH2Cl2/MeOH 10/0.75). Product 60 was obtained as an orange/red 
liquid with a yield of 60% (0.66 g).  
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.54 (d, 
3
JH-H = 6.0 Hz, 2H, H1), 7.27 (d, 
3
JH-H = 5.6 
Hz, 2H, H2), 3.81 (s, 2H, H5), 3.30 (s, 2H, H3), 2.09 (s, 1H, H4), 1.46 (s, 9H, H6). 
 
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 171.25; 149.54; 148.92; 123.18: 81.63; 51.89; 
50.79; 28.12. 
 
MS (ESI(+)) = 223.3 [M+H]
+ 
 
 
61 
After completely dissolving C60 (0.36 g, 0.50 mmol) in dry toluene (300 mL) under argon and 
in the dark, a suspension of 60 (0.11 g, 0.50 mmol) and paraformaldehyde (0.07 g, 2.50 
mmol) in toluene (10 mL) was added to the C60 solution and the mixture was heated under 
reflux for 16h in the dark. The mixture was then cooled and the solvent was evaporated, 
giving a black solid. Purification of the crude product was done by two CC (eluent toluene 
then toluene/MeOH 10/0.5). Product 61 was obtained as shiny black solid with a yield of 51% 
(0.24 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.69 (d, 
3
JH-H = 5.2 Hz , 2H, H1), 7.70 (d, 
3
JH-H = 5.3 
Hz, 2H, H2), 5.04 (s, 1H, H5), 4.96 (d, 
3
JH-H = 9.3 Hz, 1H, H3), 4.69 (d, 
3
JH-H = 14.0 Hz, 1H, 
H4), 4.32 (d, 
3
JH-H = 9.3 Hz, 1H, H3), 4.14 (d, 
3
JH-H = 14.0 Hz, 1H, H4), 1.53 (s, 9H, H6). 
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 168.58; 154.49; 153.76; 152.44; 151.22; 
150.14; 147.34; 146.95; 146.23; 146.01; 145.33; 145.21; 144.58; 144.44; 143.02; 142.56; 
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142.17; 142.11; 142.05; 142.04; 141.74; 140.18; 140.13; 138.69; 139.28; 136.33; 135.99; 
132.27; 123.61; 83.16; 76.79; 72.76; 69.49; 67.73; 64.85; 54.73; 27.98. 
 
MS (ESI(+)) = 956.1 [M+H]
+ 
 
IR (KBr): 3434 (w, CHarom); 2972 (s, CH2); 1713 (s, C=O); 1600 (s, C=C); 1150 (s, COester). 
 
 
62 
Ruthenium para-cymene dichloride dimer (0.05 g, 0.10 mmol) and 61 (0.19 g, 0.20 mmol) 
were stirred under reflux in dry CH2Cl2 (50 mL) under argon for 24h, and then the solvent 
removed. The residue obtained was dried under vacuum. Product 62 was obtained as a brown 
solid with a yield of 98% (0.24 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 9.08 (d, 
3
JH-H = 6.6 Hz, 2H, H1), 7.79 (d, 
3
JH-H = 6.1 
Hz, 2H, H2), 5.45-5.47 (m, 2H, H7), 5.25 (d, 
3
JH-H = 6.0 Hz, 2H, H8), 5.11 (s, 1H, H5), 4.97 (d, 
3
JH-H = 9.4 Hz, 1H, H3), 4.77 (d, 
3
JH-H = 15.1 Hz, 1H, H4), 4.32 (d, 
3
JH-H = 9.4 Hz, 1H, H3), 
4.20 (d, 
3
JH-H = 15.1 Hz, 1H, H4), 2.98 (sept, 
3
JH-H = 6.9 Hz, 1H, H9), 2.09 (s, 3H, H11), 1.53 
(s, 9H, H6), 1.33 (d, 
3
JH-H = 7.0 Hz, 6H, H10).  
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 169.09; 155.45; 150.82; 147.06; 146.86; 
146.63; 146.38; 146.26; 146.19; 145.98; 145.83; 145.22; 145.02; 143.60; 143.23; 142.77; 
142.66; 142.37; 140.78; 136.89; 136.64; 124.62; 103.86; 97.57; 84.01; 83.50; 83.38; 82.75; 
82.72; 77.42; 73.28; 70.11; 65.44; 54.67; 53.46; 31.23; 30.24; 28.61; 22.57; 22.55; 18.53. 
 
MS (ESI(+)) = 1225.12 [M-Cl]
+ 
 
IR (KBr) = 3435 (w, CHarom); 2961 (s, CH2); 1725 (s, C=O); 1613 (s, C=C); 1150 (s, COester). 
                                                                         Chapter 5: [60]Fullerene-Ruthenium Complexes 
145 
 
Anal. Calcd. (found) for C83H32N2O2Cl2Ru (1261.15): C, 78.87 (79.05); H, 2.80 (2.56); N, 
2.20 (2.22)% 
 
 
63 
62 (0.06 g, 0.05 mmol) and an excess of AgCF3SO3 (0.08 g, 0.32 mmol) were dissolved in 
CH2Cl2 (25 mL) and stirred at rt. After overnight stirring, the mixture was filtered and the 
solvent was evaporated. Methanol (20 mL) was added to dissolve the residue and pta (0.01 g, 
0.10 mmol) was added. Mixture was stirred at rt for 4h. The solvent was evaporated, leaving 
63 as a brown solid in a crude yield of 97% (0.06 g). 
 
MS (ESI(+)) = 1382.5 [M-Tf]
+ 
 
 
64 
A solution of bromoacetyl chloride (0.15 g, 1.00 mmol) in dry CH2Cl2 (2 mL) was added 
dropwise to a mixture of tri(ethylene)glycol monoethyl ether (0.16 mL, 1.00 mmol), 
triethylamine (0.14 mL, 1.00 mmol), DMAP (0.006 g, 0.05 mmol) and CH2Cl2 (6 mL) under 
stirring at 0°C. The reaction mixture was stirred for 2h at 0°C and for 16h at rt. The mixture 
was then filtered and the filtrate washed two times with HCl (1N), saturated NaHCO3 and 
brine solution. The organic phase was dried over anhydrous MgSO4 and the solvent was 
evaporated. Product 64 was obtained as a pale yellow liquid with a quantitative yield (0.39 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 4.32-4.36 (m, 2H, H4), 4.10 (s, 1H, H5), 3.87 (s, 1H, 
H5), 3.72-3.75 (m, 2H, H2), 3.64-3.67 (m, 6H, chain), 3.54-3.57 (m, 2H, H3), 3.38 (s, 3H, H1). 
13
C NMR (100 MHz, CDCl3, ppm): δ = 166.35; 75.78; 70.92; 69.65; 69.58; 67.75; 64.30; 
58.02; 39.85; 24.82. 
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MS (ESI(+)) = 309.3 [M+Na]
+ 
 
 
65 
4-(Aminomethyl)pyridine (0.15 mL, 1.50 mmol), triethylamine (0.42 mL, 3.00 mmol) and 64 
(0.28 g, 1.00 mmol) in dry THF (60+20 mL) reacted and the product was purified following 
same procedure as for compound 60. Product 65 was isolated as a pale yellow liquid with a 
yield of 32% (0.10 g). 
 
1
H NMR (400 MHz, CDCl3, ppm): δ = 8.56 (d, 
3
JH-H = 6.1 Hz, 2H, H8), 7.28 (d, 
3
JH-H = 6.1 
Hz, 2H, H7), 4.30 (t, 
3
JH-H = 4.7 Hz, 2H, H4), 3.87 (s, 2H, H6), 3.68-3.71 (m, 2H, H2), 3.63-
3.66 (m, 6H, chain), 3.53-3.55 (m, 2H, H3), 3.45 (s, 2H, H5), 3.37 (s, 3H, H1). 
  
13
C{
1
H} NMR (100 MHz, CDCl3, ppm): δ = 171.86; 149.27; 123.31; 71.90; 70.58; 68.96; 
64.04; 61.64; 59.00; 51.72; 49.82.  
 
MS (ESI(+)) = 313.3 [M+H]
+ 
 
 
66 
C60 (0.13 g, 0.16 mmol), para-formaldehyde (0.02 g, 0.70 mmol) and 65 (0.04 g, 0.14 mmol) 
in dry toluene (250 mL) reacted following same procedures as compound 61. The crude 
product obtained after the evaporation of the reaction solvent was purified by two CC (eluent 
toluene then CH2Cl2/MeOH 10/0.5) and a CC of Bio-Rad SX1 (eluent toluene). Product 66 
was obtained as a brown solid with a yield of 24% (0.07 g). 
 
                                                                         Chapter 5: [60]Fullerene-Ruthenium Complexes 
147 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 8.69 (d, 
3
JH-H = 4.9 Hz, 2H, H8), 7.70 (d, 
3
JH-H = 5.6 
Hz, 2H, H7), 5.23 (s, 1H, H5), 4.97 (d, 
3
JH-H = 9.4 Hz, 1H, H9), 4.68 (d, 
3
JH-H = 14.1 Hz, 1H, 
H9), 4.44-4.48 (m, 2H, H4), 4.35 (d, 
3
JH-H = 9.5 Hz, 1H, H6), 4.14 (d, 
3
JH-H = 14.1 Hz, 1H, H6), 
3.62-3.73 (m, 2H, H3), 3.54-3.45 (m, 8H, H2), 3.30 (s, 3H, H1).  
 
13
C{
1
H} NMR (100 MHz, CD2Cl2, ppm): δ = 170.12; 155.00; 150.79; 147.31; 146.87; 
146.69; 145.65; 146.63; 146.37; 146.24; 146.21; 145.85; 145.83; 143.25; 143.22; 143.19; 
142.83; 142.81; 142.67; 142.54; 142.39; 142.37; 142.36; 124.30; 77.12; 73.32; 72.45; 71.09; 
70.99; 70.06; 69.44; 65.45; 65.19; 59.20; 55.40; 30.26. 
 
MS (ESI(+)) = 1045.4 [M+H]
+ 
 
 
67 
Ruthenium para-cymene dichloride dimer (0.01 g, 0.02 mmol) and 66 (0.05 g, 0.04 mmol) in 
dry CH2Cl2 (5 mL) reacted and the product was purified following same procedure as 
compound 62. Product 67 was obtained as a black solid with a yield of 92% (0.05 g). 
 
1
H NMR (400 MHz, CD2Cl2, ppm): δ = 9.08 (d, 
3
JH-H = 6.7 Hz, 2H, H8), 7.80 (d, 
3
JH-H = 6.4 
Hz, 2H, H7), 5.44-5.47 (m, 2H, H11), 5.31 (s, 1H, H5), 5.25 (d, 
3
JH-H = 5.9 Hz, 2H, H10), 4.98 
(d, 
3
JH-H = 9.5 Hz, 1H, H9), 4.77 (d, 
3
JH-H = 15.1 Hz, 1H, H9), 4.44-4.47 (m, 2H, H4), 4.35 (d, 
3
JH-H = 9.4 Hz, 1H, H6), 4.20 (d, 
3
JH-H = 15.1 Hz, 1H, H6), 3.71-3.60 (m, 2H, H3), 3.45-3.55 
(m, 8H, H2), 3.31 (s, 3H, H1), 2.95-3.02 (m, 1H, H13), 2.09 (s, 3H, H14), 1.33 (d, 
3
JH-H = 6.9 
Hz, 6H, H12).  
 
13
C{
1
H}NMR (100 MHz, CD2Cl2, ppm): δ = 170.04; 155.47; 154.99; 154.74; 153.71; 151.40; 
150.60; 148.00; 149.86; 147.05-145.85; 145.23; 145.11; 144.96; 143.63; 143.21; 142.81; 
142.68-142.44; 142.38; 140.88; 140.81; 140.29; 140.15; 138.25; 136.93; 136.82; 136.10; 
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124.66; 103.90; 97.55; 83.45; 83.36; 82.76; 77.09; 73.20; 72.43; 71.05; 70.97; 70.95; 70.05; 
69.36; 65.42; 65.28; 59.20; 31.24; 22.56; 18.54. 
 
MS (ESI(+)) = 1363.2 [M+Na]
+ 
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6.1 Conclusion 
The first part involved the possibility of designing a new series of supramolecular assemblies 
comprising of H-bond held dimers and Ru clips of various lengths. Bi- and tetranuclear 
complexes were formed and NMR studies and DFT calculations were run in order to better 
understand the organization in these systems. The head-to-tail arrangement of the dimers as 
well as the rectangular assembly of the tetranuclear Ru compounds was hence confirmed. The 
general synthesis for the compounds was straight forward, and the purifications were simple. 
 
In the second part, several problems were faced, like the poor stability of the anthracene 
derivatives. Along the synthetic route, the isolation of pure compounds became increasingly 
challenging. The final product underwent degradation during the purification step, making it 
very difficult to be obtained pure under the conditions used, and hence could not be used for 
further reactions. 
 
Another section of the second part involves the pyrene derivatives. Better stability of these 
compounds enabled more advanced study of the systems. Hence, their liquid-crystalline 
properties were observed and their encapsulation in Ru cages was studied. Compound 54 was 
the successful encapsulated product of 48 into a hexanuclear Ru prism by carceplex method. 
However, 54 did not show any liquid-crystalline properties, even with a softer counter anion 
in compound 55. 
 
In the last part, the synthesis of arene-ruthenium compounds containing [60]fullerene was 
described. But, their poor water solubility did not allow their biological properties to be 
evaluated.  
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6.2 Perspectives
The work carried out in Chapter 2 can be considered as the foundation upon which a new area 
of research in the chemistry of supramolecules and arene-ruthenium metallo-assemblies can 
be built. The development of a new series of tetranuclear metallo-cages bearing a cavity has 
provided a new route towards host-guest chemistry.  
 
Although this work focused on the construction of only rectangular arrangements, there exists 
the possibility of building prismatic and cubic systems by following similar pathways. For 
instance, one potential spacer ligand, held together by H-bonding, to generate hexanuclear 
arrangement may be the rosette-type structure shown in Scheme 6.1. This molecule is a 
tridentate ligand composed of two different units arranged in alternating order, with six H-
bonds around each unit. Hence, 18 H-bonds exist per spacer ligand, with three coordinating 
sites available to link to the ruthenium centres.
[57]
 The possibilities of altering R′ and R′′ 
groups allows for a wide spectrum of arrangements that can be used to tune the solubility 
and/or the affinity of the assembly for particular systems.  
 
After obtaining the ruthenium cages, their potential to host different guests may be studied. 
The larger sizes of the cavity of the different arrangements compared to the typical tpt, bpe 
and porphyrin-based spacer ligands, may allow a wider range of molecules to be encapsulated 
into these ruthenium cages.  
 
From Chapter 4, it was observed that the encapsulation of pyrene-core dendrimers was quite 
challenging in the typical hexanuclear and octanuclear ruthenium cages with 4-tpt and tetra-
pvb spacer ligands. Therefore, another perspective might be the possibility of encapsulating 
these pyrene dendrimers into the above mentioned supramolecular assemblies. The larger 
cavity of these potential hosts might allow the pyrene dendrimers to be trapped more easily. 
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Scheme 6.1 Self-assembly of rosette molecules 
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4-ppy   4-Pyrrolidinopyridine 
Acac   Acetylacetonato 
Anal.   Elemental Analysis 
dpe   1,2-Di(4-pyridyl)ethylene 
Calc.   Calculated 
CC   Column chromatography 
Cisplatin  Cis-diamminedichloroplatinum(II) 
CDI   1,1′-Carbonyldiimidazole 
DCC   N,N′-Dicyclohexylcarbodiimide 
dClbq-H2  2,5-Dichlorido-1,4-benzoquinone 
∆H   Enthalpy gradient 
DFT   Density Functional Theory 
DMAP  4-Dimethylaminopyridine 
DMF   N,N-Dimethylformamide 
DNA   Deoxyribonucleic acid 
DPTS   4-(Dimethylamino)pyridium para-toluenesulfonate 
dhnq-H2  5,8-Dihydroxy-1,4-naphthoquinone 
dhbq-H2  2,5-Dihydroxy-1,4-benzoquinone 
DOSY   Diffusion Ordered Spectroscopy 
DS
-   
Dodecylsulfate ion 
DSC   Differential scanning calorimetry 
EDC   N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
en   Ethane-1,2-diamine 
ESI-MS  Electrospray mass spectrometry 
EtOH   Ethanol 
EtOAc   Ethyl acetate 
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FDA   Food and Drug Administration 
GIAO   Gauge-independent atomic orbitals 
IC50   Drug concentration necessary for 50% inhibition of cell viability 
IR   Infrared 
KP1019  Imidazolium-trans-bis(1H-indazole)-tetraruthenate 
LANL2DZ  Los Alamos national laboratory 2-double-z 
M   Non-identified mesophase 
MeOH   Methanol 
MOPAC  Molecular orbital package 
N   Nematic phase 
NaAsc   Sodium ascorbate 
NAMI-A  Imidazolium-trans-dimethylsulfoxide-imidazole-tetrachlororuthenate 
NEt3   Triethylamine 
ox   Oxalato 
pta   1,3,5-Triaza-7-phosphaadamantane 
p-Cym   Para-cymene 
PEG   Polyethylene glycol 
PAMAM  Poly(amido amine) 
PPh3   Triphenylphosphine 
POM   Polarised optical microscopy 
NOE   Nuclear Overhauser Effect 
NMR   Nuclear magnetic resonance 
ROE   Rotating-frame Overhauser Enhancement 
rt   Room temperature 
Sm   Smectic phase 
t
Bu   Tertiarybutyl 
Tetra-pvb  1,2,4,5-Tetrakis(2-(pyridine-4-yl)vinyl)benzene 
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Tg   Glass transition temperature 
TI   Isotropic temperature 
TBAF   Tetrabutylammonium fluoride 
TBDMSCl  Tertiarybutyldimethylchlorosilane 
Tf
-   
Triflate ion 
THF   Tetrahydrofuran 
tpp   5,10,15-Tris(4-pyridyl)-20-phenylporphyrin 
tpt   2,6-Tri(pyridine-4-yl)-1,3,5-triazine 
UPy   2-Ureido-4-pyrimidinone 
UV-Vis  Ultraviolet-visible 
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Annex 1 
Experimental Techniques 
 Thin layer chromatography 
Thin layer chromatographies (TLC) were done on aluminium sheets covered with a thin layer 
of silica gel 60F254 of 0.2 mm with a fluorescent detector 
 
 Column chromatographies 
Column chromatographies (CC) were carried out using silica gel Brunschwig 0.063-0.2 mm 
or 0.040-0.063 mm and a UV detector K-2000 Knauer. For products that were not UV active, 
a chemical stain (KMnO4, Na2CO3 and water) was used to visualise the spots. 
 
 Size exclusion chromatography 
Size exclusion chromatographies (SEC) were performed using size exclusion gel Bio-Rad 
SX1 with the range of mass operation between 600 and 14000 Da. The grains of Bio-Rad SX1 
were impregnated with THF for 24h at room temperature, under argon before usage. The 
eluents used were THF and toluene.  
 
 Nuclear magnetic resonance 
NMR measurements were recorded on a Brüker AMX-400 (400 and 100 MHz) or a Brüker 
Advance-400. The internal standard corresponds to the residual non-deuterated solvents: 
CDCl3 (δ = 7.26 ppm); CD2Cl2 (δ = 5.32 ppm); CD3CN (δ = 1.94 ppm); DMSO-d6 (δ = 2.50 
ppm); MeOD (δ = 3.31 ppm). The multiplicities of the signals were expressed in the 
following abbreviations: s (singlet), d (doublet), t (triplet), q (quadruplet), quint (quintuplet), 
sext (sextuplet), sept (septuplet), m (multiplet), dd (doublet of doublets) ddd (doublet of 
doublet of doublets) and dt (doublet of triplets). The chemical shifts (δ) were expressed in 
ppm and the coupling constants (J) in Hz. The data were processed using MestRec and 
MestReNova. 
 
 Infrared spectroscopy 
IR measurements were carried out using KBr pellets and were analysed by PerkinElmer 
Spectrum One FT-IR spectroscopy. The spectra were recorded and processed on Spectrum. 
 
 Mass spectrometry 
The MS measurements were carried out in two departments: Service Analytique Facultaire 
(SAF) at the University of Neuchâtel on a LCQ-IT Finnigan for electrospray ionization [ESI 
(+/-)] and at the University of Fribourg on a Bruker FTMS 4.7T BioAPEX II for ESI. 
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 Elemental analysis 
The elemental analyses were performed by the Mikroelementar-analytisches Laboratorium 
laboratory of  Eidgenössische Technische Hochschule (ETH) Zürich  
 
 Polarised optical microscopy 
The observations made on the microscope Axioscope Zeiss equipped with a Linkam THMS 
600 heating plate directed by Linkam 93. The photographs were taken with a camera 
AxioCam MRc (Zeiss) and registered on AxioVision Rel. 4.8. 
 
 Differential scanning calorimetry 
DSC measurements were performed in a measurement cell Mettler Toledo DSC1 Star
e 
system. The samples were analysed in aluminium crucibles of 40 µL under an argon flow. 
The heating and cooling were carried out at 10°C/min. Each measurement consisted of three 
heating and cooling cycles. The data was processed using STARe. The temperatures of 
transitions were determined by the method of tangent (onset) and the enthalpies of transition 
were obtained from the integration of the peaks. 
 
 UV-Visible spectroscopy 
The UV-Vis spectra were recorded using a PerkinElmer Lambda 25 UV-Vis spectrometry in 
quartz cuvettes of 1 cm wide and data was processed using PerkinElmer UV WinLab. 
 
 X-ray structure analysis 
The crystal was mounted on a Stoe Image Plate Diffraction system equipped with a ϕ circle 
goniometry, using Mo Kα graphite-monochromated radiation (λ = 0.71073 Å) with ϕ range 0–
200°, increment of 1.2° and 1.0°, respectively, 2θ range from 4.0° to 52°, Dmax–Dmin = 
12.45-0.81 Å. The structure was solved by direct methods using the program SHELXS-97. 
Refinement and all further calculations were carried out using SHELXL-97. In the compound, 
H atoms were included in calculated positions and treated as riding atoms using the SHELXL 
default parameters. All non H atoms were refined anisotropically, using weighed fullmatrix 
least-squares on F
2
.  
 
 Density functional theory 
Optimization was performed using a semiempirical method PM7 as implemented in 
MOPAC2012 and further optimization was performed with DFT methods utilizing the 
B3LYP hybrid functional and 6-311++G(2d,p) basis set as implemented in Gaussian09. The 
LANL2DZ pseudopotentials were used on the Ru centres to obtain the structures. The 
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magnetic shielding tensors of both 
1
H and 
13
C nuclei were calculated with the GIAO method 
at the same level of theory of the DFT optimizations. 
 
Reagents 
Reactants Quality Supplier 
Glacial acetic acid 99.9% Carlo Erba 
Hydrochloric acid 32% Reactolab 
Meldrum’s acid 98% Aldrich 
4-Pentyn-1-ol 97% Aldrich 
Bromoacetyl chloride ≥95% Aldrich 
4-Hydroxyboronic acid 97% Aldrich 
Bromine  Reagent grade Aldrich 
Iodine 99.8% Fluka 
Sodium chloride Technical grade Fluka 
tert-Butyldimethylsilyl chloride (TBDMSCl) 97% Aldrich 
Tetrabutylammonium fluoride (TBAF) 98% Aldrich 
Fullerene ≥99.9% MER Corp 
Sodium hydroxide >97% Carlo Erba 
N,N′-Dicyclohexylcarbodiimide (DCC) ≥99%  
4-(Dimethylamino)pyridine (DMAP) 99% Acros 
4-Pyrrolidinopyridine ≥98% Fluka 
N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide (EDC) 
≥97% Fluka 
Copper bromide Technical grade Acros 
tert-butyl nitrite 90% Aldrich 
Tetrakis(triphenylphosphine)palladium(0) 99% Aldrich 
Silver trifluoromethanesulfonate ≥99% Aldrich 
Copper iodide  Riedel 
Sulphuric acid 96% Reactolab 
p-Toluene sulfonic acid 98.5% Aldrich 
1,2-Bis(4-pyridyl)ethylene 97% Aldrich 
5,8-Dihydroxy-1,4-naphthoquinone Technical grade Aldrich 
Ruthenium trichloride hydrate - Johnson Matthey 
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Triethylamine ≥99% Aldrich 
1,3,5-Triaza-7-phosphaadamantane (pta) 97% Aldrich 
Paraformaldehyde Reagent grade Aldrich 
4-(Aminomethyl)pyridine 98% Aldrich 
4-(2-Aminoethyl)pyridine 96% Aldrich 
4-(1-Aminoethyl)pyridine 95% Aldrich 
Diethyl carbonate >98% TCI 
Tin(II) chloride dihydrate ≥98% Aldrich 
Sodium dodecyl sulfate ≥98.5% Aldrich 
Silver nitrate ≥99% Aldrich 
Pyrene ≥99% Aldrich 
9,10-Dibromoanthracene 98% Aldrich 
Anthraquinone 97% Aldrich 
2,6-Diaminoanthraquinone 97% Aldrich 
α-Phellandrene Technical grade Fluka 
Hexamethylbenzene 99% Aldrich 
Guanidine carbonate 98% TCI 
1,1′-Carbonyldiimidazole (CDI) >95% TCI 
2-Tridecanone ≥96% Aldrich 
Sodium hydride 60% in paraffin liquid TCI 
2,5-Dihydroxy-1,4-benzoquinone 98% Aldrich 
Chloranilic acid - Aldrich 
2-Hexanone 98% Aldrich 
Sodium acetate - Aldrich 
n-Butyllithium 2.5 M in hexanes Aldrich 
4-Pentynoic acid 95% Aldrich 
Magnesium Sulfate Technical grade Fluka 
Tri(ethylene)glycol monoethyl ether Technical grade Aldrich 
4-Pyridinecarbonitrile 98% Aldrich 
 
Solvents 
The solvents used for the reactions, extractions and chromatographies were of technical grade 
and distilled by rotary evaporator before use.  
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 Distilled solvents  
Solvent Supplier 
Ethyl acetate Reactolab 
Acetone Reactolab, puriss 
Acetonitrile Acros 
Dichloromethane Reactolab 
Ethanol Reactolab 
Diethyl ether Reactolab 
Heptane Reactolab 
Isopropanol Reactolab 
Methanol Reactolab, puriss 
Dimethylsulfoxide Reactolab 
Dimethylformamide Aldrich 
Tetrahydrofuran Reactolab 
Toluene Reactolab 
 
 Dried solvents 
Solvent Drying agent 
Dichloromethane P2O5 
Tetrahydrofuran KOH, then K/Na/benzophenone 
Toluene NaH 
Dimethylformamide CaH2 
 
 Deuterated solvents 
Solvent Supplier Quality 
Chloroform Cambridge Isotope Laboratories, D 99.8% 
Dichloromethane Cambridge Isotope Laboratories, D 99.8% 
Dimethylsulfoxide Cambridge Isotope Laboratories, D 99.9% 
Methanol Cambridge Isotope Laboratories, D 99.8% 
Acetonitrile Cambridge Isotope Laboratories, D 99.8% 
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Annex 2 
In the NOE, when the population difference across the Zeeman eigenstates of a nuclear spin is 
driven away from its equilibrium state, either by saturation or inversion, a change in signal 
intensity may be observed for resonances associated with spins that are dipolar coupled to the 
irradiated one. In other words, if a nuclear spin is in spatial proximity with another one, with 
the latter being perturbed by an rf-pulse, the former will show a variation of signal intensity 
when compared to a spectrum where no spin was irradiated. A requirement for this 
phenomenon to take place is a dipolar coupling between the above-mentioned nuclear spins. 
This interaction is proportional to r
–6
, where r is the distance between the spin pairs. It may be 
shown that, under conditions of linear growth of the NOE enhancements, if one perturbs the 
equilibrium-population difference of spin A and observes NOEs on spins B and X, the 
following relationship applies:  
 
 
1 6
AB AX X Br r I I                                      Equation 2 
 
where Ii = intensity of the i
th
 signal, 
rAi = internuclear distance between the irradiated spin A and the i
th
 spin for which an 
NOE is observed.  
 
In other words, if the internuclear distance rAX is known, then one can readily determine the 
unknown distance rAB. 
 
The structures of 4 in both its monomeric and dimeric forms were preliminarily optimised 
with the semiempirical method PM7 as implemented in MOPAC2012. A further optimization 
was performed with DFT methods utilizing the B3LYP hybrid functional and 6-
311++G(2d,p) basis set as implemented in Gaussian09. The LANL2DZ pseudopotentials 
were used on the Ru centres. The structures thus obtained were used to calculate the magnetic 
shielding tensors of both 
1
H and 
13
C nuclei with the GIAO method at the same level of theory 
of the DFT optimizations. 
 
When analysing NOE enhancements in such dimeric structures one has to consider both intra- 
and intermolecular dipolar couplings, which may both supply pathways for polarization 
transfer. If one considers two spins A and X belonging to one molecule and their chemically-
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equivalent counterparts A′ and X′ belonging to the other molecule of the dimer, it may happen, 
as in our case, that rAX > rAX′. In other words, the NOE enhancement observed for, say, the 
spin A (and A′) when perturbing the spin X (and X′) may be related to both intra- and 
intermolecular dipolar couplings. In order to take into account these effects, Equation 2 needs 
to be modified by considering an effective distance 
 eff
ir  that may be related to the intensity 
of the enhancement Ii of the i
th
 spin that is experiencing n different polarization-transfer 
pathways: 
 
 
1 6
61 6
1
,
6 6 6
6,1 ,2 ,
,
1 1 1
...
n
i j
eff j
i n
i i i n
i j
j
r
r
r r r
r

 
   
               
 


                        Equation 3 
Equation 2 takes into account only intramolecular dipolar couplings whereas the effective 
distances of Equation 3 considers both intra- and intermolecular pathways of polarization 
transfer. 
 
For the tetranuclear arrangement of compound 17, the contribution of the different resonances 
to the peak pattern experiencing in NOE transfer in Figure 2.20 has been measured by 
numerical fit, assuming three Lorentzian lineshapes and performed over the space spanned by 
the isotropic shift, signal intensity and line broadening.  
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